# EDGAR Filing Document

**Accession Number:** 0000037785
**File Stem:** 0001308179-23-000114
**Filing Date:** 2023-3
**Character Count:** 329809
**Document Hash:** 19a869d6cde2e7eade73b80019bfd8e1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001308179-23-000114.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001308179-23-000114

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 47

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FMC CORP
- **CENTRAL INDEX KEY:** 0000037785
- **STANDARD INDUSTRIAL CLASSIFICATION:** CHEMICALS & ALLIED PRODUCTS [2800]
- **IRS NUMBER:** 940479804
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-02376
- **FILM NUMBER:** 23721664

**BUSINESS ADDRESS:**
- **STREET 1:** 2929 WALNUT STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104
- **BUSINESS PHONE:** 215-299-6668

**MAIL ADDRESS:**
- **STREET 1:** 2929 WALNUT STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FOOD MACHINERY & CHEMICAL CORP
- **DATE OF NAME CHANGE:** 19670706

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BEAN SPRAY PUMP CO
- **DATE OF NAME CHANGE:** 19670706

?xml version="1.0" encoding="utf-8"?

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

Washington, DC 20549

**SCHEDULE 14A**

**PROXY STATEMENT PURSUANT TO SECTION 14(a)** 

 **OF THE SECURITIES EXCHANGE ACT OF 1934** 

**(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;)**

---

| | | | |
|:---|:---|:---|:---|
| ![](check01.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;Filed by the Registrant | ![](uncheck.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the Registrant |

---

---

| | |
|:---|:---|
| **Check the appropriate box:** | **Check the appropriate box:** |
| ![](uncheck.jpg) | Preliminary Proxy Statement |
| ![](uncheck.jpg) | **Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(E)(2))** |
| ![](check01.jpg) | Definitive Proxy Statement |
| ![](uncheck.jpg) | Definitive Additional Materials |
| ![](uncheck.jpg) | Soliciting Material under §240.14a-12 |

---

![](lfmc025xlogo.jpg)

**FMC CORPORATION**

*(Name of Registrant as Specified in Its Charter)*

*(Name of Person(s) Filing Proxy Statement, if other than the Registrant)*

---

| | |
|:---|:---|
| **Payment of Filing Fee (Check all boxes that apply):** | **Payment of Filing Fee (Check all boxes that apply):** |
| ![](check01.jpg) | **No fee required.** |
| ![](uncheck.jpg) | **Fee paid previously with preliminary materials.** |
| ![](uncheck.jpg) | **Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.** |

---

**FMC Corporation**

**March 10, 2023**

Dear Stockholder:

It is my pleasure to invite you to attend the Company's 2023 Annual Meeting of Stockholders. The meeting will be held virtually on Thursday, April 27, 2023, at 2:00 p.m. EDT. The meeting can be accessed by visiting www.virtualshareholdermeeting.com/FMC2023, where you will be able to listen to the meeting live, submit questions and vote online. The Notice of Annual Meeting and Proxy Statement accompanying this letter describe the business to be conducted at the meeting.

During the meeting, President and CEO Mark Douglas will report on the Company's earnings, results and other achievements during 2022 and on our outlook for 2023. We welcome this opportunity to have a dialogue with our stockholders and look forward to your comments and questions.

Your vote is important. **Please vote your proxy promptly so your shares can be represented**. Your proxy card includes specific instructions on how to vote.

If you wish to vote during the meeting, please refer to the section of the proxy statement entitled "How to Vote" for specific instructions.

I look forward to the Annual Meeting on April 27<sup>th</sup>.

Sincerely,

![](lfmc025x1x2.jpg)

**Pierre Brondeau**

*Chairman of the Board*

![](lfmc025x2x1.jpg)

**Notice of Annual Meeting of Stockholders**

**Thursday, April 27, 2023**

------

**2:00 p.m.**

***The meeting can be accessed by visiting www.virtualshareholdermeeting.com/FMC2023. There will be no physical location for stockholders to attend.***

Dear Stockholder:

You are invited to the Annual Meeting of Stockholders of FMC Corporation to be held in a virtual meeting format at the time noted above. At the meeting, we will ask you to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Elect ten directors, each for a term of one year.

2. Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2023.

3. Approve the FMC Corporation 2023 Incentive Stock Plan.

4. Hold an advisory (non-binding) vote on executive compensation.

5. Hold an advisory (non-binding) vote on the frequency of executive compensation voting.

6. Consider and act upon any other business properly brought before the meeting.

**THE BOARD RECOMMENDS A VOTE FOR ITS NOMINEES FOR DIRECTOR AND FOR PROPOSALS 2, 3 AND 4. THE BOARD RECOMMENDS A VOTE IN FAVOR OF A FREQUENCY OF ONE YEAR IN PROPOSAL 5.**

**Your vote is important. To be sure your vote counts and ensure a quorum, please vote, sign, date and return the enclosed proxy card whether or not you plan to attend the virtual meeting; or if you prefer, please follow the instructions on the enclosed proxy card for voting by internet or by telephone whether or not you plan to attend the meeting virtually.**

**IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON APRIL 27, 2023:**

**The proxy statement and the annual report to security holders are available at *www.fmc.com.* Upon request of any stockholder, a copy of FMC Corporation's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, including a list of the exhibits thereto, may be obtained, without charge, by writing to the Company's Corporate Secretary, FMC Tower at Cira Centre South, 2929 Walnut Street, Philadelphia, Pennsylvania 19104.**

**March 10, 2023**

By order of the Board of Directors,

![](lfmc025x2x2.jpg)

**Michael F. Reilly**

*Executive Vice President, General Counsel,*

 *Chief Compliance Officer and Secretary*

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**2**

**Table of contents**

---

| | | |
|:---|:---|:---|
| [**I.**](#lfmc025a001) | [**Information About Voting**](#lfmc025a001) | [**5**](#lfmc025a001) |
| [**II.**](#lfmc025a002) | [**The Proposals to be Voted on**](#lfmc025a002) | [**7**](#lfmc025a002) |
| [**PROPOSAL 1** Election of Directors](#lfmc025a003) | [**PROPOSAL 1** Election of Directors](#lfmc025a003) | [7](#lfmc025a003) |
| [**PROPOSAL 2** Ratification of Appointment of Independent Registered Public Accounting Firm](#lfmc025a004) | [**PROPOSAL 2** Ratification of Appointment of Independent Registered Public Accounting Firm](#lfmc025a004) | [7](#lfmc025a004) |
| [**PROPOSAL 3** Approval of the FMC 2023 Incentive Stock Plan](#lfmc025a005) | [**PROPOSAL 3** Approval of the FMC 2023 Incentive Stock Plan](#lfmc025a005) | [8](#lfmc025a005) |
| [**PROPOSAL 4** Advisory (Non-Binding) Vote on Executive Compensation](#lfmc025a006) | [**PROPOSAL 4** Advisory (Non-Binding) Vote on Executive Compensation](#lfmc025a006) | [15](#lfmc025a006) |
| [**PROPOSAL 5** Advisory (Non-Binding) Vote on the Frequency of Executive Compensation Voting](#lfmc025a007) | [**PROPOSAL 5** Advisory (Non-Binding) Vote on the Frequency of Executive Compensation Voting](#lfmc025a007) | [15](#lfmc025a007) |
| [**III.**](#lfmc025a008) | [**Board of Directors**](#lfmc025a008) | [**16**](#lfmc025a008) |
| [Director Qualifications and Board Diversity](#lfmc025a009) | [Director Qualifications and Board Diversity](#lfmc025a009) | [16](#lfmc025a009) |
| [Nominees for Director](#lfmc025a010) | [Nominees for Director](#lfmc025a010) | [18](#lfmc025a010) |
| [**IV.**](#lfmc025a011) | [**Information about the Board of Directors and Corporate Governance**](#lfmc025a011) | [**23**](#lfmc025a011) |
| [Meetings](#lfmc025a012) | [Meetings](#lfmc025a012) | [23](#lfmc025a012) |
| [Committees and Independence of Directors](#lfmc025a013) | [Committees and Independence of Directors](#lfmc025a013) | [23](#lfmc025a013) |
| [Director Compensation](#lfmc025a014) | [Director Compensation](#lfmc025a014) | [25](#lfmc025a014) |
| [Corporate Governance](#lfmc025a015) | [Corporate Governance](#lfmc025a015) | [28](#lfmc025a015) |
| [**V.**](#lfmc025a016) | [**Security Ownership of FMC Corporation**](#lfmc025a016) | [**32**](#lfmc025a016) |
| [Management Ownership](#lfmc025a017) | [Management Ownership](#lfmc025a017) | [32](#lfmc025a017) |
| [Other Security Ownership](#lfmc025a018) | [Other Security Ownership](#lfmc025a018) | [33](#lfmc025a018) |
| [**VI.**](#lfmc025a019) | [**Executive Compensation**](#lfmc025a019) | [**34**](#lfmc025a019) |
| [Compensation Discussion and Analysis](#lfmc025a020) | [Compensation Discussion and Analysis](#lfmc025a020) | [34](#lfmc025a020) |
| [Compensation and Organization Committee Report](#lfmc025a021) | [Compensation and Organization Committee Report](#lfmc025a021) | [54](#lfmc025a021) |
| [Executive Compensation Tables](#lfmc025a022) | [Executive Compensation Tables](#lfmc025a022) | [55](#lfmc025a022) |
| [Pay Ratio Disclosure](#lfmc025a023) | [Pay Ratio Disclosure](#lfmc025a023) | [61](#lfmc025a023) |
| [Potential Payments Upon Termination or Change in Control](#lfmc025a024) | [Potential Payments Upon Termination or Change in Control](#lfmc025a024) | [61](#lfmc025a024) |
| [Pay vs Performance](#lfmc025a025) | [Pay vs Performance](#lfmc025a025) | [65](#lfmc025a025) |
| [**VII.**](#lfmc025a026) | [**Other Matters**](#lfmc025a026) | [**70**](#lfmc025a026) |
| [Audit Committee Report](#lfmc025a027) | [Audit Committee Report](#lfmc025a027) | [70](#lfmc025a027) |
| [Householding](#lfmc025a028) | [Householding](#lfmc025a028) | [70](#lfmc025a028) |
| [Expenses Relating to this Proxy Solicitation](#lfmc025a029) | [Expenses Relating to this Proxy Solicitation](#lfmc025a029) | [71](#lfmc025a029) |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***3**

*This page was intentionally left blank.*

[Back to Contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**I.** INFORMATION ABOUT VOTING

### **Solicitation of Proxies** 
The Board of Directors (also referred to herein as the "Board") of FMC Corporation (the "Company" or "FMC") is soliciting proxies for use at the Company's 2023 Annual Meeting of Stockholders and any postponements or adjournments of that meeting (as so postponed or adjourned, the "2023 Annual Meeting" or the "Annual Meeting"). As permitted by Securities and Exchange Commission ("SEC") rules, we are making this proxy statement available to our stockholders electronically via the internet at www.fmc.com. On or about March 10, 2023, we first mailed to our stockholders a Notice containing instructions on how to access this proxy statement, the accompanying form of proxy and the Company's Annual Report for 2022. If you received a Notice by mail, you will not receive a printed copy of the proxy materials in the mail. Instead, the Notice instructs you on how to access and review all of the important information contained in the proxy statement. The Notice also instructs you on how you may submit your proxy over the internet. If you received a Notice by mail and would like to receive a printed copy of our proxy materials, you should follow the instructions for requesting such materials contained on the Notice.

### **Instructions for the Virtual Annual Meeting** 
This year our Annual Meeting will be virtual. There will be no physical meeting location. The meeting will only be conducted via live webcast. We have adopted a virtual format for the Annual Meeting to make participation accessible for stockholders from any geographic location with internet connectivity, as well as to reduce potential Covid-19 and other respiratory virus risks that continue to be associated with large in-person indoor gatherings. We have worked to offer the same participation opportunities as would be provided at an in-person meeting while further enhancing the online experience available to all stockholders regardless of their location.

To participate in the virtual meeting, visit www.virtualshareholdermeeting. com/FMC2023 and enter the 16-digit control number included on your Notice of Internet Availability of Proxy Materials, on your proxy card, or on the instructions that accompanied your proxy materials. You may begin to log into the meeting platform beginning at 1:30 p.m. Eastern Daylight Savings Time ("EDT") on April 27, 2023. The meeting will begin promptly at 2:00 p.m. EDT on April 27, 2023.

Whether or not you participate in the virtual meeting, it is important that your shares be part of the voting process. You may log on to www.proxyvote.com and enter your 16-digit control number. The virtual meeting platform is fully supported across browsers (Microsoft Edge, Firefox, Chrome, and Safari) and devices (desktops, laptops, tablets, and cell phones) running the most updated version of applicable software and plugins. Participants should ensure that they have a strong WiFi connection wherever they intend to participate in the meeting. Participants should also give themselves plenty of time to log in and ensure that they can hear streaming audio prior to the start of the meeting. We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual meeting. If you encounter any difficulties accessing the virtual meeting during the meeting, please call toll free: 1-844-986-0822, or if calling internationally, please call: 1-303-562-9302.

You may submit a question before or during the meeting online at www.proxyvote.com after logging in with your 16-digit control number. Questions may be submitted during the Annual Meeting through www.virtualshareholdermeeting.com/FMC2023. We will post questions and answers if applicable to our business on our Investor Relations website shortly after the meeting.

### **Agenda Items** 
The agenda for the Annual Meeting is to:

&nbsp;&nbsp;&nbsp;&nbsp;1. Elect ten directors;

2. Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2023;

3. Approve the FMC Corporation 2023 Incentive Stock Plan;

4. Hold an advisory (non-binding) vote on executive
compensation;

5. Hold an advisory (non-binding) vote on the frequency of executive compensation voting; and

6. Conduct other business properly brought before the meeting.

### **Who Can Vote** 
You can vote at the Annual Meeting if you are a holder of the Company's common stock, par value of $0.10 per share ("Common Stock"), on the record date. The record date is the close of business on March 1, 2023. You will have one vote for each share of Common Stock. As of March 1, 2023, there were 125,141,775 shares of Common Stock outstanding.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***5**

[Back to Contents](#toc)

### **How to Vote** 
You may vote in one of four ways:

&nbsp;&nbsp;&nbsp;&nbsp;**•** You can vote by signing and returning the enclosed proxy card. If you do, the individuals named on the card will vote your shares in the way you indicate;

**•** You can vote by internet;

**•** You can vote by telephone; or

**•** You can cast your vote online at the Annual Meeting.

*The meeting can be accessed by visiting www.virtualshareholdermeeting. com/FMC2023, where you will be able to listen to the meeting live, submit questions and vote online. You will need the 16-digit control number provided on your proxy card, voting instruction form or Notice of Internet Availability of Proxy Materials.*

### **Use of Proxies** 
Unless you tell us on the proxy card to vote differently, we plan to vote signed and returned proxies FOR the Board nominees for director and FOR Proposals 2, 3 and 4, and FOR a frequency of one year for Proposal 5, and in the discretion of the proxy holders as to any other matters that may properly come before the Annual Meeting.

### **Quorum Requirement** 
We need a quorum of stockholders to hold a valid Annual Meeting. A quorum will be present if the holders of at least a majority of the outstanding Common Stock entitled to vote at the meeting either attend the Annual Meeting virtually or are represented by proxy at the Annual Meeting. Abstentions, broker non-votes (described below) and votes withheld are counted as present for the purpose of establishing a quorum.

### **Vote Required for Action** 
Directors are elected by a majority of the votes cast in an uncontested election. Because the number of nominees properly nominated for the Annual Meeting is the same as the number of directors to be elected at the Annual Meeting, the election of directors is an uncontested election. As a result, any nominee who receives a majority of the votes cast with respect to his or her election at the Annual Meeting will be elected to the Board (or re-elected, in the case of any nominee who is an incumbent director). Incumbent nominees have tendered a contingent resignation which would become effective if (i) the nominee does not receive a majority of the votes cast with respect to his or her election at the Annual Meeting and (ii) the Board of Directors accepts such resignation. Adoption of Proposals 2, 3 and 4 require the affirmative vote of the majority of shares present in person or represented by proxy and entitled to vote at the meeting. With respect to Proposal 5, the option receiving the greatest number of votes cast on such proposal at the Annual Meeting (every one year, two years, or three years) will be considered the frequency recommended by the stockholders.

### **Abstentions or Lack of Instructions to Banks, Brokers, or Employee Benefit Plan Trustees** 
Abstentions will not be counted as votes cast for the election of directors, and thus will have no effect on the election of directors. With respect to Proposals 2, 3 and 4, abstentions will have the effect of a vote against such proposals. With respect to Proposal 5, abstentions will not be counted as votes cast on such proposal, and thus will have no effect thereon.

A broker non-vote occurs when a bank, broker or other nominee holding shares on behalf of a stockholder does not receive voting instructions from the beneficial owner with respect to a non-routine matter to be voted on at the Annual Meeting by a specified date before the Annual Meeting. Banks, brokers and other nominees may vote undirected shares on matters deemed routine in accordance with New York Stock Exchange rules, but they may not vote undirected shares on matters deemed non-routine in accordance with such rules. For this purpose, the ratification of the appointment of the independent registered public accounting firm is considered a routine matter, but the election of directors, the advisory vote regarding executive compensation, the advisory vote regarding the frequency of executive compensation voting and the approval of the FMC Corporation 2023 Incentive Stock Plan are considered non-routine matters.

In the event of a broker non-vote in the election of directors or with respect to Proposals 3, 4 and 5 at the Annual Meeting, the broker non-vote will not have any effect on the outcome inasmuch as broker non-votes are not counted as votes cast or as shares present and entitled to be voted with respect to any matter on which the broker has expressly not voted.

If you are entitled to vote shares held under an employee benefit plan and you either do not direct the trustee by April 24, 2023 how to vote your shares, or if you vote on some but not all matters that come before the Annual Meeting, the trustee will, in the case of shares held in the FMC Corporation Savings and Investment Plan, vote your undirected shares in proportion to the votes received from other participants, and in the case of the Company's other employee plans, vote your shares in the trustee's discretion, except to the extent that the plan or applicable law provides otherwise.

### **Revoking a Proxy** 
You may revoke your proxy at any time before it is exercised. You can revoke a proxy by:

**•** Sending a written notice to the Corporate Secretary of FMC;

**•** Delivering a properly executed, later-dated proxy;

**•** Attending the Annual Meeting and voting virtually, provided that you comply with the conditions set forth in the section
 of this proxy statement above entitled "How to Vote"; or

**•** If your shares are held through an employee benefit plan, your revocation must be received by the trustee by April 24,
 2023.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***6**

[Back to Contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**II.** THE PROPOSALS TO BE VOTED ON

---

| | |
|:---|:---|
| **Proposal 1** | Election of Directors |

---

### **Nominees for Director** 
The Board of Directors currently consists of 12 directors, each of whom is elected to serve for a term of one year, expiring at the subsequent annual meeting of stockholders. Paul J. Norris, a director since 2006, has reached the age of 75 and, pursuant to our Statement of Governance Principles, Policies and Procedures, has not been nominated for re-election. Vincent R. Volpe, Jr., a director since 2007, has announced that he will not stand for re-election. As such, the Board will be reduced to 10 directors effective at the commencement of the Annual Meeting. We thank Messrs. Norris and Volpe for their many years of service as directors of the Company – we have benefited greatly from their wisdom, candor and strong sense of collegiality, and we wish them all the best.

The nominees for director this year are Pierre Brondeau, Eduardo E. Cordeiro, Carol Anthony (John) Davidson, Mark Douglas, Kathy L. Fortmann, C. Scott Greer, K'Lynne Johnson, Dirk A. Kempthorne, Margareth Øvrum, and Robert C. Pallash, each of whom is an incumbent director. If elected, these directors' next term will expire at the 2024 Annual Meeting. Information about the nominees is contained in the section of this proxy statement entitled "Board of Directors".

The Board of Directors expects that all of the nominees will be able and willing to serve as directors. If any nominee becomes unavailable, the proxies may be voted for another person nominated by the Board of Directors to fill the vacancy, or the size of the Board of Directors may be reduced.

**The Board of Directors recommends a vote FOR the election of Pierre Brondeau, Eduardo E. Cordeiro, Carol Anthony (John) Davidson, Mark Douglas, Kathy L. Fortmann, C. Scott Greer, K'Lynne Johnson, Dirk A. Kempthorne, Margareth Øvrum, and Robert C. Pallash to the Board of Directors as described above.**

---

| | |
|:---|:---|
| **Proposal 2** | Ratification of Appointment of Independent Registered Public Accounting Firm |

---

The Audit Committee of the Board of Directors is directly responsible for the appointment, compensation, retention and oversight of the independent external audit firm retained to audit the Company's financial statements. The Audit Committee has approved KPMG LLP ("KPMG") continuing to serve as the Company's independent registered public accounting firm for 2023.

The Audit Committee periodically reviews the performance of the independent external audit firm. In conjunction with the mandated rotation of KPMG's lead engagement partner, the Audit Committee and its chairperson also evaluate and approve the selection of KPMG's new lead engagement partner.

The Audit Committee is responsible for the audit fee negotiations associated with the Company's retention of KPMG. For the years 2022 and 2021, KPMG's fees, all of which were approved by the Audit Committee, were as follows:

---

| | | |
|:---|:---|:---|
| ***($000)*** | **2022** | **2021** |
| Audit Fees<sup>(1)</sup> | 11160 | 11272 |
| Audit Related Fees<sup>(2)</sup> | 325 | 39 |
| Tax Fees<sup>(3)</sup> | 1139 | 851 |
| All Other Fees<sup>(4)</sup> | 991 | 897 |
| **TOTAL** | **13615** | **13059** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Fees for professional services
 performed by KPMG for the integrated audit of the Company's annual consolidated financial statements included in the
 Company's Form 10-K filing and review of financial statements included in the Company's Form 10-Q filings. The
 amount also includes other services that are normally provided by KPMG in connection with statutory and regulatory filings
 or engagements.

(2) Fees for services performed by
 KPMG that are principally related to employee benefit and compensation plan audits, as well as audit related services in connection
 with attestations by KPMG that are required by statute, regulation, or contractual requirements.

(3) Fees for professional services
 performed by KPMG with respect to tax compliance, tax advice and tax planning. This includes preparation of original and amended
 tax returns for the Company and its consolidated subsidiaries, refund claims, payment planning, and tax audit assistance.

(4) Fees for other permissible work
 performed by KPMG that does not fall within the categories set forth above. For the years listed above, this work is primarily
 related to tax filings for individual employees involved in the Company's expatriate program.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**7**

[Back to Contents](#toc)

### **Pre-Approval of Independent Registered Public Accounting Firm Services** 
The Audit Committee has adopted a Pre-Approval Policy with respect to audit and non-audit services performed by its independent registered public accounting firm. The following is a summary of the Policy.

Prior to the commencement of services for a given year, the Audit Committee will grant pre-approvals of expected services and estimated fees, as presented by the independent registered public accounting firm. The independent registered public accounting firm will routinely update the Audit Committee during the year in which the services are performed as to the actual services provided and related fees pursuant to the Pre-Approval Policy.

Unexpected services or services for which the fees to be incurred would exceed pre-approved amounts will require specific approval before the services may be rendered. Requests or applications to provide such services that require specific approval by the Audit Committee will be submitted to the Chairman of the Audit Committee and to the Company's Chief Financial Officer or his designee by the independent registered public accounting firm.

The request or application must include a statement as to whether, in the view of both the independent registered public accounting firm and the Chief Financial Officer or his designee, such request or application is consistent with the rules of the Securities and Exchange Commission ("SEC") regarding auditor independence. Authority to grant approval for such services has been delegated to the Chairman of the Audit Committee, provided that any such approval would then be reviewed by the full Audit Committee at the next regularly scheduled meeting.

The Audit Committee has determined that the independence of KPMG has not been adversely impacted as a result of the non-audit services performed by such accounting firm.

We expect a representative of KPMG to attend the Annual Meeting. The representative will have an opportunity to make a statement if the representative desires and will also be available to respond to appropriate questions.

**The Board of Directors recommends a vote FOR ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2023.**

---

| | |
|:---|:---|
| **Proposal 3** | Approval of the FMC 2023 Incentive Stock Plan |

---

We are asking our stockholders to approve the FMC Corporation 2023 Incentive Stock Plan (the "2023 Plan"). Our Board approved the 2023 Plan on February 24, 2023, subject to stockholder approval. If approved by stockholders, the 2023 Plan will replace the FMC Corporation Incentive Compensation and Stock Plan, as amended and restated on April 25, 2017 ("2017 Plan").

The purpose of the 2023 Plan is to enable us to recruit and retain highly qualified employees, directors, consultants and other service providers, provide them with an incentive for productivity, and create an opportunity for them to share in the growth and value of the Company. Stockholder approval of the 2023 Plan is being sought to enable the grant of incentive stock options ("ISOs") in accordance with applicable tax rules, among other vehicles, and to comply with New York Stock Exchange ("NYSE") listing rules.

Subject to certain adjustments, the maximum number of shares of our common stock (referred to hereafter in this Proposal Three as "Shares") that may be issued under the 2023 Plan, if approved by our stockholders, is the sum of: (i) 5,000,000 Shares, (ii) the number of Shares remaining available for grant under the 2017 Plan on the Annual Meeting date (up to 1,700,000 Shares), and (iii) the number of Shares underlying 2017 Plan awards that are outstanding as of the Annual Meeting date, to the extent those Shares are recycled into the 2023 Plan (in connection with the forfeiture, termination, cancellation or expiration of 2017 Plan awards on or after the Annual Meeting Date, as described in more detail in the section entitled "Shares of Stock Available for Issuance" below).

The following features of the 2023 Plan may be of particular interest to our stockholders:

**•** *Restrictions Against Liberal Share Recycling.* Shares withheld to satisfy the exercise price or tax withholding obligation associated with an award will not become available for future grants under the 2023 Plan.

**•** *Fungible Share Pool.* Full value awards deplete the share pool quicker than stock options or stock appreciation rights ("SARs"). Each Share underlying a full value award will reduce the share pool by two Shares, while each Share underlying a stock option or SAR will reduce the share pool by one Share.

**•** *Director Compensation Limits*. The 2023 Plan contains annual limits on the compensation payable to our non-employee directors, subject to certain exceptions.

**•** *Clawbacks*. Awards may be subject to recoupment in certain instances under the 2023 Plan, as described below.

**•** *Repricing of stock options or SARs*. The 2023 Plan generally prohibits the repricing of stock options or SARs without stockholder approval.

If the 2023 Plan is approved by our stockholders, no new awards will be granted under the 2017 Plan after the Annual Meeting. If the 2023 Plan is not approved by our stockholders, the 2017 Plan will remain in effect in accordance with its terms. As of February 28, 2023, 1,617,320 Shares remain available for issuance in respect of new awards under the 2017 Plan. If this proposal is not approved, we will be unable to provide equity-based compensation to eligible employees and other service providers once the 2017 Plan share pool is depleted, other than in limited circumstances permitted under NYSE listing rules. Equity-based compensation is a critical feature of our executive and employee compensation program and the inability to grant equity awards in the future may adversely impact our ability to attract and retain talent and accordingly, the Company's long-term success.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***8**

[Back to Contents](#toc)

#### **Monitoring of Dilution, Burn Rate, and Overhang** 
In connection with determining the number of Shares to authorize for issuance under the 2023 Plan, the Compensation Committee considered the potential dilution to current stockholders, as measured by the overhang and burn rate, and projected future Share usage, among other things. The Compensation Committee is cognizant that the Company's equity compensation programs have a dilutive effect on our stockholders, and continuously strives to balance this concern with our need to compete for talent using practices that are prevalent in the market, including equity grants.

#### **Dilution and Overhang** 
A company's overhang reflects potential dilution of stockholders' ownership by actual share-based awards as well as shares available for grant. In determining the number of Shares to reserve under our 2023 Plan, the Compensation Committee considered the resulting overhang as an additional metric to measure the cumulative effect of equity compensation.

The following information regarding outstanding equity awards and Shares available for future awards under all existing equity compensation plans as of February 28, 2023 is provided to facilitate our stockholders' evaluation of this proposal.

---

| | |
|:---|:---|
| **Overhang Detail as of February 28, 2023 (unless otherwise noted below)** | |
| Stock options and SARs outstanding | 1486556 |
| &nbsp;&nbsp;&nbsp;Weighted-average exercise price | $93.81 |
| &nbsp;&nbsp;&nbsp;Weighted-average remaining term | 7.1 years |
| Shares subject to outstanding full-value awards<sup>(1)</sup> | 883469 |
| Shares that remain available for future issuance | 1617320 |
| Proposed Shares to be reserved under 2023 Plan | 5000000 |
| **Total Common Stock outstanding as of March 1, 2023** | 125141775 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Includes the number of Shares in respect of outstanding PRSUs at the target level.
 If the number of PRSUs earned were at the maximum level, the number of Shares subject to outstanding full-value awards would
 be 1,035,358.

Other than the foregoing, no other awards pursuant to which Shares were issuable under any of our existing or prior equity compensation arrangements, including the 2017 Plan, were outstanding as of February 28, 2023.

#### **Burn Rate Detail** 
The following table sets forth information regarding awards granted during our 2020, 2021 and 2022 fiscal years (rounded to the nearest thousand), and our corresponding "burn rate," which is defined for any year as (1) the number of stock options and SARs granted in that year, (2) the number of Shares subject to time-vested full value awards granted in that year, plus (3) the number of Shares subject to performance-based full-value awards earned in that year, all divided by the weighted-average number of Shares outstanding for that year:

---

| | | | |
|:---|:---|:---|:---|
| **Award Type** | **2020** | **2021** | **2022** |
| Stock options and SARs granted (A) | 302000 | 235000 | 248000 |
| Time-based, full-value awards granted (1) (B) | 92000 | 95000 | 103000 |
| Performance-based, full-value awards earned (C) | 115000 | 86000 | 102000 |
| Total (A+B+C) | 509000 | 416000 | 453000 |
| Weighted-average common shares (D) | 129701000 | 128403000 | 125975000 |
| Burn Rate ((A+B+C)/D) | 0.39% | 0.32% | 0.36% |
| Three (3) Year Average |  |  | 0.36% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Time-based full-value Shares granted consists of all RSU awards granted during the
 applicable year that, upon grant, either were vested or were subject to vesting based solely on continued employment or service.

### **Description of the 2023 Plan** 
The principal provisions of the 2023 Plan are summarized below. This summary is qualified in its entirety by reference to the 2023 Plan document, a copy of which is attached as an appendix to the electronic copy of this proxy statement filed with the SEC and may be accessed from the SEC's home page (<u>www.sec.gov</u>) or the Investor Relations link of FMC's website (<u>www.fmc.com</u>). In addition, a copy of the 2023 Plan may be obtained upon written request to: Corporate Secretary, FMC Corporation, FMC Tower at Cira Centre South, 2929 Walnut Street, Philadelphia, PA, 19104. To the extent the description below differs from the text of the 2023 Plan, the text of the 2023 Plan will control.

#### **Administration** 
The 2023 Plan vests broad powers in a committee to administer and interpret the 2023 Plan. Until and unless otherwise determined by the Board, that committee will be the Compensation Committee. In this capacity, the Compensation Committee has the authority to (among other things) select the persons to be granted awards, determine the type, size and terms and conditions of such awards, accelerate the vesting or exercisability of an award (notwithstanding anything in the 2023 Plan to contrary), waive any conditions or restrictions associated with an award, and extend the period of time during which an award may be exercised (as long as the extension is not beyond the original term of the award). The Compensation Committee may also amend outstanding awards, although an award amendment would require

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***9**

[Back to Contents](#toc)

the consent of affected participants if it would materially impair their rights. Subject to the requirements of applicable law and our governing documents, the Board or the Compensation Committee may delegate any of the authorities of the committee under the 2023 Plan, including its authority to grant awards to one or more individuals. In addition, subject to applicable law, the Board may at any time exercise the rights and duties of the Compensation Committee under the 2023 Plan. Accordingly references herein to the Compensation Committee will also include, as applicable, the Board or any duly authorized delegate.

In order to comply with foreign law or to otherwise ensure the viability of the benefits from awards granted under the 2023 Plan to foreign participants, the Compensation Committee may also modify the terms of outstanding awards held by foreign participants, establish subplans and take other actions that it deems advisable, provided that no subplans or modifications may increase the number of Shares available for grant under the 2023 Plan.

#### **Amendment and Termination** 
Unless the 2023 Plan is extended with the approval of our stockholders, it will expire on February 24, 2033 (ten years after the Board adopted the 2023 Plan).

However, the Board may amend or terminate the 2023 Plan at any earlier time, provided that stockholder approval may be required for certain amendments, to the extent required by applicable law or exchange listing requirements. Examples of amendments that require stockholder approval under current NYSE rules include those that: materially increase the number of shares available for awards under a plan (other than an increase to reflect a reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or similar change), expand the types of awards available under a plan, materially expand the classes of persons eligible to receive awards under a plan, materially extend the term of a plan, materially change the method for determining the exercise price of options, or delete or limit a provision prohibiting the repricing of awards.

#### **Eligibility** 
Any of our employees, directors, consultants, and other service providers, and those of our affiliates, are eligible to participate in the 2023 Plan. However, in accordance with applicable tax rules, only our employees (and the employees of our parent or subsidiary corporations) are eligible to be granted ISOs.

As of February 28, 2023, there were approximately 6,600 employees, 12 directors (1 of which was also an employee), 500 consultants and 500 other service providers who would be eligible to participate in the 2023 Plan. Participants will be selected in the discretion of the Compensation Committee.

#### **Fungible Share Ratio** 
The Compensation Committee may utilize any of the Shares authorized under the 2023 Plan toward the grant of any type of award under the plan. However, the 2023 Plan contains a fungible share ratio. This means that if a stock option or SAR is granted, each Share underlying the award will reduce the available share pool by one Share. However, if a full value award (i.e., a restricted stock award, RSU award, or other stock-based award) is granted, each Share underlying the Award will reduce the available share pool by two Shares.

#### **Shares of Stock Available for Issuance** 
Subject to certain adjustments, the maximum number of Shares that may be issued under the 2023 Plan is the sum of: (i) 5,000,000 Shares, (ii) the number of Shares remaining available for grant under the 2017 Plan on the Annual Meeting date (up to 1,700,000 Shares), and (iii) the number of Shares underlying 2017 Plan awards that are outstanding as of the Annual Meeting date, to the extent those Shares are recycled into the 2023 Plan as described in the next paragraph.

If and to the extent that an award under the 2023 Plan or the 2017 Plan terminates, expires, is canceled or is forfeited for any reason on or after the Annual Meeting date, the underlying Shares will become available for new grants under the 2023 Plan, based on the applicable fungible share ratio described above. As noted above, there were awards outstanding under the 2017 Plan as of February 28, 2023 with respect to 2,370,025 Shares (counting outstanding PRSUs at target).<sup>(1)</sup> 

Subject to certain adjustments, the maximum aggregate number of Shares under the 2023 Plan that may be issued in respect of ISOs is 5,000,000.

Any Shares issued in respect of awards granted in substitution for equity-based awards of an entity acquired by us or a subsidiary, or with which we or a subsidiary combine, will not count against the number of Shares available for issuance under the 2023 Plan.

The market value of a share of our common stock as of February 28, 2023 was $129.15.

If the 2023 Plan is approved by stockholders, we intend to file, when administratively practicable, a registration statement on Form S-8 pursuant to the Securities Act of 1933, to register the Shares available for issuance under the 2023 Plan.

#### **Restrictions Against Liberal Share Recycling** 
The following restrictions against liberal recycling of Shares apply under the 2023 Plan:

**•** The full number of Shares subject to the exercise of a stock option granted under the 2023 Plan or 2017 Plan will be unavailable for new grants under the 2023 Plan, even if the exercise price is satisfied through net-settlement of Shares or the delivery of Shares to the Company.

**•** The full number of Shares subject to the exercise of a stock-settled SAR granted under the 2023 Plan or 2017 Plan will be unavailable for new grants under the 2023 Plan, even though only a net number of Shares are delivered upon exercise.

**•** Shares withheld to satisfy tax withholding obligations for a 2023 Plan or 2017 Plan award will be unavailable for new grants under the 2023 Plan.

**•** Shares repurchased on the open market with proceeds from the exercise of a 2023 Plan or 2017 Plan award will be unavailable for new grants under the 2023 Plan.

&nbsp;&nbsp;&nbsp;&nbsp;(1) Taking into account the maximum number of Shares issuable
 under outstanding PRSUs and applying the fungible share ratios described above, a maximum of 3,557,272 Shares could be recycled
 into the 2023 Plan in respect of outstanding 2017 Plan awards. Historically, however, only a fraction of the awards we grant
 have been forfeited.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**10**

[Back to Contents](#toc)

#### **Non-Employee Director Limitations on Awards** 
Beginning with our first fiscal year following the year in which the 2023 Plan is approved by stockholders, the aggregate amount of equity and cash compensation payable to a non-employee director with respect to a fiscal year, whether under the 2023 Plan or otherwise, for services as a non-employee director, shall not exceed $750,000; provided, however, that such maximum amount shall be $1,000,000 for the fiscal year in which the applicable non-employee director is initially elected or appointed to the Board. For this purpose, the amount of compensation will be measured under SEC director compensation proxy rules. This director compensation limit will not apply to (i) compensation earned by a non-employee director solely in the individual's capacity as chairman of the Board or lead independent director, (ii) compensation earned by a non-employee director for services the individual performs outside of the individual's role as a non-employee director (i.e., as an advisor or consultant), or (iii) compensation awarded by the Board to a non-employee director in extraordinary circumstances, as determined by the Board in its discretion, so long as, in each case, the non-employee director does not participate in the decision to award him or herself the additional compensation.

#### **Types of Awards** 
The 2023 Plan provides for the grant of the following types of awards: (i) stock options (both ISOs and non-qualified stock options), (ii) SARs, (iii) restricted stock, (iv) restricted stock units ("RSUs"), (v) other stock-based awards, and (vi) cash-based awards. Each award may, but need not be, subject to vesting conditions in the Compensation Committee's discretion. Vesting conditions may include the continued employment or service of the participant, the attainment of specified individual or corporate performance goals or other factors.

##### **Stock Options** 
A stock option entitles the holder to purchase from us a stated number of Shares at a specified price for a limited period of time. The Compensation Committee will specify the number of Shares subject to each option and the exercise price for such option, provided that the exercise price may not be less than the fair market value of a Share on the date the option is granted. However, for an ISO granted to a 10% stockholder, the exercise price shall not be less than 110% of the fair market value of common stock on the date the option is granted.

Generally, options may be exercised in whole or in part through a cash payment. The Compensation Committee, however, may in its discretion permit payment of the exercise price through other methods. For example, the Compensation Committee may permit the option holder to pay the exercise price of an option through the surrender of previously acquired Shares or to "net settle" an option (which involves the cancellation of a portion of the option to cover the cost of exercising the balance of the option). An outstanding in-the-money option will generally be automatically exercised and net-settled immediately prior to its expiration, so long as the participant's service has not been terminated for cause (and no basis for such a termination then exists).

Options shall be exercisable in accordance with the terms of the applicable award agreement. The maximum term of an option shall be determined by the Compensation Committee but will not exceed 10 years (5 years in the case of ISOs granted to a 10% stockholder). In the case of ISOs, the aggregate fair market value (determined as of the date of grant) of common stock with respect to which such ISOs become exercisable for the first time during any calendar year cannot exceed $100,000. ISOs granted in excess of this limitation will be treated as non-qualified stock options.

##### **Stock Appreciation Rights** 
A SAR represents the right to receive, upon exercise, any appreciation in a Share over a particular time period. SARs shall be exercisable in accordance with the terms of the applicable award agreement. The base price of a SAR shall not be less than the fair market value of a Share on the date the SAR is granted. The maximum term of a SAR shall be determined by the Compensation Committee but shall not exceed 10 years. SAR payouts may be made in cash, Shares, or a combination of both, at the Compensation Committee's discretion.

Each individual award agreement for a stock option or SAR will dictate to what extent, if any, the stock option or SAR will remain exercisable upon or following termination of employment or other service.

##### **Restricted Stock** 
A restricted stock award is a grant of Shares that are subject to forfeiture and transfer restrictions during a specified period. The Compensation Committee will determine the price, if any, to be paid by the participant for each Share of restricted stock. If there are specified vesting conditions that are not attained, the underlying common stock will be forfeited to us. Conversely, if and when specified vesting conditions are satisfied, the restrictions imposed will lapse. During the restriction period, a participant will have the right to vote the Shares underlying the restricted stock. Unless otherwise provided in an award agreement or determined by the Compensation Committee, upon termination of service a participant will forfeit all restricted stock that then remains subject to forfeiture.

##### **Restricted Stock Units** 
An RSU represents a right to receive an amount equal to the fair market value of one Share and may be conditioned on the achievement of specified vesting conditions. An RSU may be settled in Shares, cash or a combination of both, at the discretion of the Compensation Committee. Unless otherwise provided in an award agreement or determined by the Compensation Committee, upon a termination of service, a participant will forfeit any RSUs that then remain subject to forfeiture.

##### **Other Stock-Based Awards** 
Other stock-based awards may be granted to participants (including awards to receive unrestricted shares, or awards that are payable in, valued in whole or in part by reference to, or otherwise based on or related to our common stock). The Compensation Committee will determine the terms and conditions of each such award, including, as applicable, the term, any exercise or purchase price, vesting conditions and other terms and conditions.

##### **Cash-Based Awards** 
Cash-based awards (including immediate cash payments) may be granted to participants, either alone or in conjunction with other awards under the 2023 Plan. Cash-based awards may be granted in lieu of other compensation, subject to applicable law. The Compensation Committee will determine the terms and conditions of each such award, including, if applicable, vesting conditions.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***11**

[Back to Contents](#toc)

#### **Dividends and Dividend Equivalent Rights** 
No dividends or dividend equivalent rights will be payable with respect to options or SARs.

Dividends that become payable with respect to restricted stock while it remains subject to restriction may, in the Compensation Committee's discretion, be subjected to the same vesting conditions as the restricted stock to which they relate. The Compensation Committee may alternatively require that the dividends be reinvested in additional Shares of restricted stock, which may, in the Compensation Committee's discretion, be subjected to the same vesting conditions as the restricted stock to which they relate.

Dividend equivalent rights may be granted in connection with restricted stock units and other stock-based awards under the 2023 Plan in the discretion of the Compensation Committee. A dividend equivalent right entitles the participant to payments or credits equal to the cash dividends that would otherwise have been paid with respect to the Shares underlying the award, had such Shares been outstanding on the dividend payment date. The Compensation Committee may provide that dividend equivalent rights will be paid or credited in cash or Shares. Dividend equivalent rights granted under the 2023 Plan may, in the Compensation Committee's discretion, be subject to the same vesting conditions as the underlying awards to which they relate.

#### **Adjustments** 
If the number of outstanding Shares is increased or decreased or our common stock is changed into or exchanged for a different number or kind of our shares or other securities on account of any recapitalization, reclassification, stock split, reverse split, combination of shares, exchange of shares, stock dividend or other distribution payable in capital stock, or other increase or decrease in our outstanding Shares effected without receipt of consideration by us, or there occurs any spin-off, split-up, extraordinary cash dividend or other distribution of assets by us, the Compensation Committee shall, in such manner as it deems equitable, make adjustments to the number and kind of shares issuable under the 2023 Plan, the number and kind of shares subject to outstanding awards, the exercise prices of outstanding awards and any other affected term or condition of the 2023 Plan or outstanding awards.

#### **Corporate Transactions** 
Unless otherwise specified in the applicable award agreement and subject to the "Change in Control" section below, in the event of a reorganization, merger, statutory share exchange, consolidation, sale of all or substantially all of our assets, or the acquisition of assets or stock of another entity by us, or other corporate transaction involving us (each, a "Corporate Transaction"), outstanding awards will be treated in accordance with the applicable transaction agreement. If no treatment is provided for in the transaction agreement, each award holder will be entitled to receive the same consideration that our stockholders receive in the transaction for each Share subject to the award upon the exercise, payment or transfer in respect of the award, but unless otherwise determined by the Compensation Committee, the award will remain subject to the same terms, conditions and performance criteria applicable to the awards before the Corporate Transaction. In addition, if a Corporate Transaction occurs, outstanding stock options and SARs may be cancelled at the election of the Compensation Committee if (i) the holders of such awards are afforded the opportunity to exercise those awards immediately prior to (and contingent upon the occurrence of) the transaction, to the extent otherwise exercisable, or (ii) with respect to each Share subject to such an award, the holder is paid the excess (if any) of the per share consideration paid to our stockholders in the transaction, minus the applicable option or SAR exercise price. The Compensation Committee is not required to treat each award uniformly upon a Corporate Transaction.

#### **Change in Control** 
Unless otherwise specified in the applicable award agreement or any applicable transaction document, outstanding awards will be treated as follows upon the occurrence of a change in control, subject to the requirements of Section 409A of the Internal Revenue Code.

**•** For awards granted to non-employee directors, all vesting conditions will be deemed satisfied.

**•** For awards granted to all other service providers:

---

| |
|:---|
| If the awards are assumed, converted or replaced by the resulting entity, there is no automatic single trigger vesting and the awards (as adjusted to reflect the transaction) will continue in accordance with their terms. However, if within two years after the change in control, the participant's service is terminated without "cause" or for "good reason," then (subject to the execution of a release, if required by the applicable award agreement) time-based vesting conditions will be deemed satisfied, and performance-based vesting conditions for open performance periods will be deemed satisfied at the greater of the "target" or "actual" performance level, as determined by the Compensation Committee in its discretion. |
| If the awards are not assumed, converted or replaced by the resulting entity, then time-based vesting conditions will be deemed satisfied and performance-based vesting conditions for open performance periods will be deemed satisfied at the greater of the "target" or "actual" performance level, as determined by the Compensation Committee in its discretion. |

---

#### **Repricing Prohibited** 
The Compensation Committee and the Board may not reprice options or SARs without stockholder approval, whether such repricing is accomplished by (i) means of a cancellation/re-grant program, whereby outstanding options or SARs are cancelled and replacement options or SARs are granted with a lower exercise or base price; (ii) cancellation of outstanding options or SARs with an exercise or base price in excess of the then current fair market value per share for consideration payable in our equity securities or cash; (iii) any other action that may be considered "repricing" under GAAP or the stockholder approval rules of any securities exchange or inter-dealer quotation system on which our securities are listed or quoted; or (iv) otherwise directly reducing the exercise or base price of outstanding options or SARs (except in each case for appropriate adjustments in connection with certain corporate events or transactions).

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***12**

[Back to Contents](#toc)

#### **Clawback and Other Policies** 
In the event of a participant's serious misconduct or activity in competition with our business, the Compensation Committee may cancel all or a portion of any outstanding award granted to the participant (regardless of whether such award is vested or deferred) or, if the misconduct or competitive activity occurs within one year of the exercise or payment of an award, require the participant to repay us for any gain realized or payment received. This clawback provision will only apply prior to the occurrence of a change in control of the Company.

Additionally, the 2023 Plan provides that each participant will be subject to any current or future clawback policy of the Company that is applicable to the participant or any clawback that may be required by applicable law. Further, all awards and associated Shares will also be subject to the Company's stock ownership, securities trading, anti-hedging, anti-pledging and other similar policies, as in effect from time to time.

#### **Miscellaneous** 
Generally, awards granted under the 2023 Plan may not be transferred, except by will or intestate succession. However, the Compensation Committee may in its discretion authorize the gratuitous transfer of awards (other than ISOs) to family members of the participant, partnerships owned by such family members, trusts for the benefit of such family members or other similar estate planning vehicles.

Awards under the 2023 Plan will be subject to withholding for applicable taxes, to the extent required by law, and the Compensation Committee may authorize the withholding of Shares subject to an award to satisfy required tax withholding.

Awards under the 2023 Plan are generally intended to be exempt from or comply with the requirements of Section 409A of the Internal Revenue Code and will be interpreted accordingly. However, we do not guaranty any particular tax treatment for any award under the 2023 Plan.

#### **Federal Income Tax Consequences** 
The federal income tax consequences of the issuance, exercise and/or settlement of awards under the 2023 Plan are described below. The following information is only a summary and does not address all aspects of taxation that may be relevant to a particular participant in light of the participant's personal circumstances. Participants should consult with their own tax advisors with respect to the tax consequences inherent in the ownership and exercise of the awards and the ownership and disposition of any underlying securities. The summary does not address the effects of other federal taxes (including possible "golden parachute" excise taxes) or taxes imposed under state, local or foreign tax laws. Tax laws are subject to change.

Generally, all amounts taxable as ordinary income to participants in respect of awards granted under the 2023 Plan are expected to be deductible by us as compensation at the same time the participant recognizes the ordinary income, subject to the limitations of the Internal Revenue Code (including the limitations of Sections 162(m), which provides that we cannot deduct compensation paid to certain covered employees in excess of $1 million per year).

*Nonqualified Stock Options:* A participant recognizes no taxable income when a non-qualified stock option is granted. Upon exercise of a non-qualified stock option, a participant will recognize ordinary income equal to the excess of the fair market value of the Shares received over the exercise price of the non-qualified stock option. A participant's tax basis in Shares received upon exercise of a non-qualified stock option will generally be equal to the fair market value of those Shares on the exercise date, and the participant's holding period for such Shares will begin at that time. Upon sale of Shares received upon exercise of a non-qualified stock option, the participant will realize short-term or long-term capital gain or loss, depending on the period the Shares are held. The amount of such gain or loss will be equal to the difference between the amount realized in connection with the sale of the Shares and the participant's tax basis in such Shares.

*Incentive Stock Options:* A participant recognizes no taxable income when an ISO is granted or exercised. As long as the participant meets the applicable holding period requirements for Shares received upon exercise of an ISO (two years from the date of grant and one year from the date of exercise), gain or loss realized by a participant upon sale of the Shares received upon exercise will be long-term capital gain or loss, and we will not be entitled to a deduction. If, however, the participant disposes of the Shares before meeting the applicable holding period requirements (a "disqualifying disposition"), the participant will then recognize ordinary income. The amount of ordinary income recognized by the participant is limited to the lesser of the gain on such sale and the difference between the fair market value of the Shares on the date of exercise and the option exercise price. Any gain realized in excess of this amount will be treated as short- or long-term capital gain (depending on how long the Shares are held). If the option price exceeds the amount realized upon such a disposition, the difference will be short- or long-term capital loss (depending on how long the Shares are held). Notwithstanding the above, individuals subject to Alternative Minimum Tax may recognize ordinary income upon exercise of an ISO.

*Stock Appreciation Rights:* A participant recognizes no taxable income when a SAR is granted or vests. Upon the exercise of a SAR, a participant will recognize ordinary income equal to the excess of the fair market value of the Shares underlying the SAR over the grant price of the SAR. A participant's tax basis in Shares received upon exercise of a SAR will generally be equal to the fair market value of those Shares on the exercise date, and the participant's holding period for such Shares will begin at that time. Upon the sale of Shares received upon exercise of a SAR, the participant will realize short-term or long-term capital gain or loss, depending on the period the Shares are held. The amount of such gain or loss will be equal to the difference between the amount realized in connection with the sale of the Shares and the participant's tax basis in such Shares.

*Restricted Stock:* If a participant receives restricted stock under the 2023 Plan and does not make the election described in the next paragraph, the participant will recognize no taxable income upon the receipt of the Shares. When the forfeiture conditions applicable to the restricted stock lapse, the participant will recognize ordinary income equal to the fair market value of the Shares at that time, less any amount paid for the Shares. A participant's tax basis in restricted stock will generally be equal to the fair market value of the Shares when the forfeiture conditions lapse, and the participant's holding period for the Shares will begin at that time. Upon sale of the Shares, the participant will realize short- or long-term gain or loss, depending on how long the Shares are held after the forfeiture conditions lapse. Such gain or loss will be equal to the difference between the amount realized upon the sale of the Shares and the participant's tax basis in the Shares.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***13**

[Back to Contents](#toc)

Participants receiving Shares of restricted stock may make an election under Section 83(b) of the Internal Revenue Code. By making a Section 83(b) election, the participant elects to recognize compensation income when the Shares are received rather than at the time the forfeiture conditions lapse. The amount of such compensation income will be equal to the fair market value of the Shares upon receipt (valued without regard to the forfeiture conditions and transfer restrictions applicable to the Shares), less any amount paid for the Shares. By making a Section 83(b) election, the participant will recognize no additional compensation income when the forfeiture conditions lapse. The participant's tax basis in Shares with respect to which a Section 83(b) election is made will generally be equal to the fair market value of those Shares at grant, and the participant's holding period for such Shares will begin at that time. Upon sale of the Shares, the participant will realize short- or long-term capital gain or loss, depending on the period the Shares were held. Such gain or loss will be equal to the difference between the amount realized upon the sale of the Shares and the participant's tax basis in the Shares. However, if the Shares are forfeited, the participant will not be entitled to claim a deduction with respect to any income tax paid upon making the Section 83(b) election. To make a Section 83(b) election, a participant must file an appropriate form of election with the Internal Revenue Service and with the participant's employer, in each case within 30 days after the restricted stock is issued.

*Restricted Stock Units:* When Shares or cash with respect to RSU awards are delivered to the participant, the value of the Shares or cash is then taxable to the participant as ordinary income. A participant's tax basis in Shares received upon settlement of an RSU award will generally be equal to the fair market value of those Shares on the date the Shares are issued, and the participant's holding period for such Shares will begin at that time. Upon sale of Shares received upon settlement of an RSU award, the participant will realize short-term or long-term capital gain or loss, depending on the period the Shares are held. The amount of such gain or loss will be equal to the difference between the amount realized in connection with the sale of the Shares and the participant's tax basis in such Shares.

*Other Stock-Based Awards:* The taxation of other stock-based awards will depend upon the design of such awards.

*Cash-Based Awards:* Generally, any cash payments a participant receives in connection with a cash-based award under the 2023 Plan are taxable as ordinary income in the year received or made available to the participant without substantial limitations or restrictions.

#### **Equity Compensation Plan Information** 
The table below sets forth information with respect to compensation plans under which equity securities of FMC are authorized for issuance as of December 31, 2022. All of the equity compensation plans pursuant to which we are currently granting equity awards have been approved by stockholders.

---

| | | | |
|:---|:---|:---|:---|
| **(Shares in thousands)** | **Number of Securities to**<br> **be issued upon**<br> **exercise of outstanding**<br> **options and restricted**<br> **stock awards (A)<sup>(2)</sup>** | **Weighted-average exercise**<br> **price of outstanding**<br> **options awards (B)<sup>(1)</sup> ($)** | **Number of Securities remaining<br> available for future issuance<br> under equity compensation<br> plans (excluding securities<br> reflected in column (A)) (C)** |
| Equity Compensation Plans approved by stockholders | 1982 | 87.35 | 2100 |
| Equity Compensation Plans not approved by stockholders |  |  |  |
| Total | 1982 | 87.35 | 2100 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Taking into account all outstanding awards included in this table, the weighted-average
 exercise price of such stock options is $87.35 and the weighted-average term-to-expiration is 6.1 years.

(2) Includes 1,305 thousand stock options and 393 thousand restricted stock awards granted to employees
 and 284 thousand restricted stock units held by directors.

#### **New Plan Benefits** 
The future awards that participants may receive under the 2023 Plan are discretionary, and therefore, not determinable at this time. However, at least $140,000 of the annual compensation payable to the members of the Board of Directors is currently paid in the form of RSUs. The number of RSUs that will be granted to the directors will depend on the fair market value of our common stock on the date of grant as well as on the exact amount of a director's annual cash retainer that he or she elects to receive instead in the form of RSUs. If the 2023 Plan is approved by our stockholders at the Annual Meeting, we expect that grants to our directors will be made immediately on the date of our Annual Meeting under the 2023 Plan, pursuant to our Compensation Policy for Non-Employee Directors. If the 2023 Plan is not approved by our stockholders at the Annual Meeting, such director awards will instead be made under the 2017 Plan. See the section of this proxy statement entitled "Information About the Board of Directors and Corporate Governance — Director Compensation."

**The Board of Directors recommends a vote FOR approval of the FMC 2023 Incentive Stock Plan.**

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**14**

[Back to Contents](#toc)

---

| | |
|:---|:---|
| **Proposal 4** | Advisory (Non-Binding) Vote on Executive Compensation |

---

In accordance with the requirements of Section 14A of the Exchange Act and the related rules of the SEC, our Board of Directors is submitting a proposal providing our stockholders the opportunity to cast a non-binding advisory vote on the executive compensation paid to the Company's executive officers named in this proxy statement ("named executive officers" or "NEOs").

This advisory vote on executive compensation is non-binding on the Board, will not overrule any decision by the Board and does not compel the Board to take any action. However, the Board and the Compensation and Organization Committee (the "Compensation Committee") may consider the outcome of the vote when considering future executive compensation decisions. Specifically, to the extent there is any significant vote against the named executive officer compensation as disclosed in this proxy statement, the Board will consider our stockholders' concerns and the Compensation Committee will evaluate whether any actions are necessary to address those concerns.

The Board and the Compensation Committee believe that the Company's executive compensation programs and policies and the compensation decisions described in this proxy statement (i) support the Company's business objectives, (ii) link the interests of the executive officers and stockholders, (iii) align NEO pay with the individual's and the Company's performance, without encouraging excessive risk-taking that could have a material adverse effect on the Company, (iv) provide NEOs with a competitive level of compensation and (v) promote retention of the NEOs and other senior leaders. In 2022, 91.49% of the shares present and entitled to vote at the meeting, approved the executive compensation discussed and disclosed in the Compensation Discussion and Analysis, the Summary Compensation Table and other related tabular and narrative disclosures contained in the 2022 proxy statement.

For the reasons discussed above (and further amplified in the compensation disclosures made in this proxy statement), the Board recommends that stockholders vote in favor of the following resolution:

RESOLVED that the stockholders approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission (which disclosure includes the Compensation Discussion and Analysis, the Summary Compensation Table and other related tabular and narrative disclosures set forth in this proxy statement).

**The Board of Directors recommends a vote FOR the above resolution.**

---

| | |
|:---|:---|
| **Proposal 5** | Advisory (Non-Binding) Vote on the Frequency of Executive Compensation Voting |

---

In addition to requesting the shareholder advisory approval of the compensation of our named executive officers in Proposal 4, and in accordance with the requirements of the Exchange Act and the related rules of the SEC, our Board of Directors is submitting a proposal providing our stockholders the opportunity to cast a non-binding advisory vote on how frequently we conduct a Say on Pay vote, as disclosed pursuant to the SEC's compensation disclosure rules. By voting on this Proposal 5, stockholders may indicate whether they would prefer a Say on Pay vote every one, two or three calendar years.

In 2017, our stockholders voted on a similar proposal, with the majority voting to hold the Say on Pay vote every year. We continue to believe that Say-on-Pay votes should be conducted every year so that our stockholders may annually express their views on our executive compensation program.

You may cast your vote on your preferred voting frequency by choosing the option of one year, two years, three years, or abstain from voting. Because this vote is advisory and not binding on the Board or the Company in any way, the Board may decide that it is in the best interests of our stockholders and the Company to hold an advisory vote on executive compensation more or less frequently than the option approved by our stockholders.

**The Board of Directors recommends a vote FOR an advisory vote on executive compensation once every calendar year.**

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***15**

[Back to Contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**III.** BOARD
 OF DIRECTORS

## **Director Qualifications and Board Diversity** 
Directors are selected based on integrity, successful business experience, stature in their own fields of endeavor and the diversity of perspectives they bring to the Board. Desired attributes of all directors include (i) ability to reach thoughtful, independent and logical judgments on difficult and complex issues; (ii) demonstrated leadership; (iii) knowledge, experience and skills in at least one specialty area relevant to the Company's lines of business; (iv) accountability; (v) objectivity; and (vi) willingness and ability to cooperate and engage with other members of the Board openly and constructively. Directors must also be able to view the issues the Company faces from the stockholders' perspective and be committed to representing the long-term interests of our stockholders. Our Statement of Governance Principles, Policies and Procedures requires that a substantial majority of directors (at least two thirds) must be independent. We also require that our directors be able to commit the time necessary to ensure the diligent performance of their duties.

In addition, the Board as a whole should reflect a range of experience, skills, diversity and expertise. Areas of interest may include: (i) senior management (C-suite) experience, (ii) global business experience, (iii) accounting or financial expertise, (iv) innovation experience, (v) agriculture and related industry experience, (vi) sustainability/ESG experience, (vii) government, public affairs, or regulatory experience, (viii) human capital or talent management experience, (ix) corporate strategy or M&A experience, (x) public company governance experience, and (xi) cybersecurity experience. To understand the context in which these skills, diversity and expertise are required, please see the description of the Company in the "<u>Executive Summary</u>" of the Compensation Discussion and Analysis section.

We believe that maintaining a diverse Board membership with varying backgrounds, skills, expertise and other differentiating personal characteristics enhances the quality and diversity of thought in the Board's deliberations and enables the Board to better represent all of the Company's constituents. In seeking candidates who possess diversity of experience, background and perspective, the Nominating and Corporate Governance Committee assesses a broad set of candidates whose diversity is based on race/ethnicity, gender, industry experience, type of position held, and other board experience. In addition, we have set a goal of at least one-third female directors by the end of 2026 and thereafter, subject to periods of director transitions. Whenever feasible, women and minorities will be included in the initial pool of candidates when selecting new director nominees. In addition to reviewing a candidate's background and accomplishments, candidates are evaluated in the context of the current composition of the Board and the evolving needs of the Company.

The table below highlights the qualifications and experience of each director nominee to be a member of our Board of Directors, identifying the unique capabilities and perspectives that the director nominee brings to effectively represent the interests of our stockholders and also to effectively oversee and advise management. While a dot notation indicates competency or experience in the relevant area, this summary is not intended to be an exhaustive list of each director nominee's capabilities, skills or insights which are valued by the Board. Mr. Cordeiro and Mr. Davidson — 17% of the Board as currently constituted and 20% of the Board effective as of the commencement of the Annual Meeting (when the Board is reduced to 10 directors) — identify as racially or ethnically diverse.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***16**

[Back to Contents](#toc)

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **FMC Corporation <br> Board of Directors — 2022 Nominees** | **Pierre<br> Brondeau** | **Eduardo<br> Cordeiro** | **John<br> Davidson** | **Mark<br> Douglas** | **Kathy<br> Fortmann** | **C. Scott<br> Greer** | **K'Lynne<br> Johnson** | **Dirk<br> Kempthorne** | **Margareh**<br> **Øvrum** | **Robert<br> Pallash** |
| **KEY SKILLS/COMPETENCIES** |  |  |  |  |  |  |  |  |  |  |
| **Senior Management (C-suite) Experience** | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) |  |
| **Global Business Experience —** *managed multinational/global business* | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |  | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |
| **Accounting or Financial Expertise —** *meets SEC audit committee financial expert standard or current/former CPA* |  | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) |  |  | ![](lfmc025x17x1.jpg) |  |  |  |  |
| **Innovation Experience —** *experience managing innovation, R&D, or information technology* | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |  | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |  | ![](lfmc025x17x2.jpg) |  | ![](lfmc025x17x2.jpg) |  |
| **Agriculture Industry experience —** *managed business involved in agriculture or has served as director >3 years on ag-related company* | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) |  | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) |
| **Sustainability/ESG Experience —** *experience on sustainability issues or managed organization with significant environmental, health or safety issues* | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |  | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |  | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |
| **Government/Public Affairs/Regulatory Experience —** *experience as former government official, public affairs professional or regulator, or management of regulated business* | ![](lfmc025x17x1.jpg) |  |  | ![](lfmc025x17x1.jpg) |  |  |  | ![](lfmc025x17x1.jpg) |  |  |
| **Human Capital/Talent Management Experience —** *managed large organization or HR function* | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |
| **Corporate Strategy/M&A Experience —** *managed corporate strategy or significant M&A transactions* | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) | ![](lfmc025x17x1.jpg) |  |  |  |
| **Public Company Governance Experience —** *experience as officer or director of public company* | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |
| **Cybersecurity Experience —** *experience managing/mitigating information technology, data privacy and cybersecurity risks/threats and/or implementing strategies to prevent same* |  |  | ![](lfmc025x17x1.jpg) |  |  |  |  |  |  |  |
| **DIVERSITY** |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Female |  |  |  |  | ![](lfmc025x17x1.jpg) |  | ![](lfmc025x17x1.jpg) |  | ![](lfmc025x17x1.jpg) |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Racially/Ethnically Diverse |  | ![](lfmc025x17x2.jpg) | ![](lfmc025x17x2.jpg) |  |  |  |  |  |  |  |

---

The professional experience, qualifications, skills and expertise of each director nominee is set forth below.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**17**

[Back to Contents](#toc)

## **Nominees for Director** 

### **New Term Expiring in 2024** 

---

| | |
|:---|:---|
| ![](lfmc025x18x1.jpg) | ***Pierre Brondeau*** |
| ![](lfmc025x18x1.jpg) | **Principal Occupation: Former Executive Chairman, Chief Executive Officer and President of FMC Corporation**<br> **Age: 65**<br> **Director Since: 2010**<br> **Non-Independent Director, Chairman of the Board, Executive Committee Chair** |

---

Mr. Brondeau has served as Chairman of the Board since October 2010, and was also Chief Executive Officer of FMC from January 2010 until May 2020, President from January 2010 until May 2018, and Executive Chairman from June 2020 to April 2021. Before joining the Company as President and Chief Executive Officer in January 2010, Mr. Brondeau served as President and Chief Executive Officer, Dow Advanced Materials Division, until his retirement in September 2009. Prior to Dow's acquisition of Rohm and Haas Company in April 2009, he was President and Chief Operating Officer of Rohm and Haas from May 2008. Mr. Brondeau held numerous executive positions during his tenure at Rohm and Haas from 1989 through May 2008.

**Other Board Experience**

Mr. Brondeau is Chairman of the Board of Directors of Livent Corporation.

**Qualifications**

Mr. Brondeau has extensive senior executive leadership experience at large multi-national public companies engaged in the specialty materials and chemicals industries, as well as many years of international business experience in the United States and Europe. In addition, he has significant expertise in finance and mergers and acquisitions, as well as other areas of business, all of which make him an important contributor to the Board. He has a Ph.D. in Biochemical Engineering.

---

| | |
|:---|:---|
| ![](lfmc025x18x2.jpg) | ***Eduardo E. Cordeiro*** |
| ![](lfmc025x18x2.jpg) | **Principal Occupation: Former Executive Vice President, Chief Financial Officer, and President, Americas Region, of Cabot Corporation, a global specialty chemicals and performance materials company**<br> **Age: 55**<br> **Director Since: 2011**<br> **Independent Director, Audit Committee Chair** |

---

Mr. Cordeiro served as Executive Vice President and Chief Financial Officer of Cabot Corporation from 2009 until May 2018, and served as an advisor to Cabot through the remainder of 2018. From 2014 to 2018 he also served as President, Americas Region. He joined Cabot in 1998 and has held several corporate, business and executive management positions including General Manager of Cabot's Fumed Metal Oxides and Tantalum businesses and Vice President of Corporate Strategy. Prior to joining Cabot, Mr. Cordeiro was a consultant with The Boston Consulting Group and a founding partner of The Economics Resource Group.

**Other Board Experience**

Mr. Cordeiro is a member of the Board of Directors of Owens Corning.

**Qualifications**

Mr. Cordeiro brings extensive strategy, finance and chemical industry experience to the Board. He has developed corporate strategy experience working for The Boston Consulting Group and more specifically chemical industry strategy experience leading Cabot's corporate strategy function. He also brings deep financial experience having held multiple finance roles at Cabot throughout his twenty-year career, including, most recently, the CFO position. Mr. Cordeiro also brings operational and chemical industry business experience to the Board having been General Manager for two of Cabot's core specialty chemical businesses. Mr. Cordeiro meets the SEC requirements for an "audit committee financial expert" and is "financially literate" as defined by the NYSE.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**18**

[Back to Contents](#toc)

---

| | |
|:---|:---|
| ![](lfmc025x19x1.jpg) | ***Carol Anthony ("John") Davidson*** |
| ![](lfmc025x19x1.jpg) | **Principal Occupation: Former Senior Vice President, Controller and Chief Accounting Officer of Tyco International**<br> **Age: 67**<br> **Director Since: 2020**<br> **Independent Director** |

---

Mr. Davidson was elected to the Company's Board of Directors in July 2020. He served as Senior Vice President, Controller and Chief Accounting Officer of Tyco International from 2004 to 2012 where he led financial reporting, internal controls and accounting policies and processes. Prior to Tyco, Mr. Davidson held senior global leadership positions in finance and related disciplines at Eastman Kodak Company and Dell Computer Corporation. He is a Certified Public Accountant and began his career at Arthur Andersen & Co.

**Other Board Experience**

Mr. Davidson is a board member of TE Connectivity and International Flavors & Fragrances. He previously was a director at Allergan, Plc., DaVita, Inc., Pentair, Plc., and Legg Mason, Inc., and served on the board of governors of the Financial Industry Regulatory Authority, which regulates and oversees the U.S. financial industry in the interest of investor protection and market integrity.

**Qualifications**

Mr. Davidson was a trustee of the Financial Accounting Foundation, an organization that oversees the processes for setting financial accounting and reporting standards in the U.S. He has a strong track record of building and leading global teams and implementing governance and controls processes. He brings to the Board his extensive experience as a finance leader in global corporations across multiple industries. Mr. Davidson meets the SEC requirements for an "audit committee financial expert" and is "financially literate" as defined by the NYSE.

---

| | |
|:---|:---|
| ![](lfmc025x19x2.jpg) | ***Mark Douglas*** |
| ![](lfmc025x19x2.jpg) | **Principal Occupation: President and CEO, FMC Corporation**<br> **Age: 60**<br> **Director Since: 2020** <br> **Non-Independent Employee Director** |

---

Mr. Douglas was appointed President and Chief Executive Officer on June 1, 2020. He previously served as President and Chief Operating Officer of FMC since June 2018. He joined FMC in March 2010 as Vice President, Global Operations and International Development, and has served as President of the Industrial Chemicals Group and President of the Agricultural Solutions business. Mr. Douglas joined FMC from The Dow Chemical Company where he was Vice President, President Asia, Dow Advanced Materials. Prior to Dow, he was Corporate Vice President, President Asia, Rohm and Haas Company, based in Shanghai. During his twenty-one years with Rohm and Haas, Mr. Douglas held sales, marketing and executive management positions in London, Singapore, Shanghai and Philadelphia.

**Other Board Experience**

Mr. Douglas is a director of Quaker Houghton and is a member of the Crop Life International Board of Directors. He also serves on the Board of Trustees of the Pennsylvania Academy of the Fine Arts.

**Qualifications**

Mr. Douglas has more than thirty years of global business and operational experience in the chemical industry, including most of the last twelve years leading FMC's agricultural business, which is now FMC's sole business segment.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**19**

[Back to Contents](#toc)

---

| | |
|:---|:---|
| ![](lfmc025x20x1.jpg) | ***Kathy L. Fortmann*** |
| ![](lfmc025x20x1.jpg) | **Principal Occupation: CEO of ACOMO N.V.**<br> **Age: 56**<br> **Director Since: 2021**<br> **Independent Director** |

---

Since September 2021, Ms. Fortmann has served as CEO of ACOMO N.V. (formerly known as Amsterdam Commodities N.V.), a Euronext Amsterdam listed natural food ingredients company, focusing on spices, nuts, edible seeds, tea, food ingredients and organic ingredients. Ms. Fortmann began her career with DuPont where she held many technical and business roles over her fifteen years there, including serving as Business Director from 2002 to 2005. After leaving DuPont in 2005, Ms. Fortmann spent twelve years at Cargill Inc., leading its progressively larger and more complex food ingredient businesses. She was promoted to the executive team and was appointed to helm Cargill Business Services until she left the company in September 2017 to join Royal FrieslandCampina N.V. as President, FrieslandCampina Ingredients. In her three years there, she restructured their food ingredients business. In April 2020, she joined International Flavors & Fragrances Inc. where she led the integration of the company and DuPont's ingredients businesses to form the largest ($6 billion) business within International Flavors & Fragrances from 2020 to 2021.

**Other Board Experience**

Ms. Fortmann served on the Board of Directors of James Finlay Limited from December 2019 to September 2021.

**Qualifications**

With approximately one quarter of the Company's business being in EMEA, Ms. Fortmann's experience living and working in the European market since 2006 provides a valuable perspective on the Board. Further, Ms. Fortmann has significant experience managing global business operations in industries directly connected to agriculture. Her background related to sustainability and mergers and acquisitions also makes her well qualified to serve as a director.

---

| | |
|:---|:---|
| ![](lfmc025x20x2.jpg) | ***C. Scott Greer*** |
| ![](lfmc025x20x2.jpg) | **Principal Occupation: Retired principal in Greer and Associates**<br> **Age: 72**<br> **Director Since: 2002**<br> **Independent Director, Lead Director** |

---

Beginning in June 2006, Mr. Greer was a principal in Greer and Associates, a private investment management firm, until his retirement in 2021. Until June 2005, he was Chairman, President and Chief Executive Officer of Flowserve Corporation, a manufacturer of industrial flow management equipment. He served as Chairman from April 2000 and as its President and Chief Executive Officer from January 2000. Mr. Greer joined Flowserve Corporation in 1999 as President and Chief Operating Officer. Prior to joining Flowserve, Mr. Greer was President of UT Automotive, a subsidiary of United Technologies Corporation, a supplier of automotive systems and components, from 1997 to 1999. He was President and a director of Echlin, Inc., an automotive parts supplier, from 1990 to 1997, and its Chief Operating Officer from 1994 to 1997.

**Other Board Experience**

Mr. Greer served on the Board of Directors of Washington Group from 2002 to 2007. He was also a member of the Board of Directors of eMedicalFiles, Inc.

**Qualifications**

Mr. Greer's experience in senior executive roles, including as Chairman and CEO of a publicly-traded global manufacturing operation, as well as his service as a director of other public companies, have given him deep expertise in the governance and operation of large multinational companies as well as in the management of business activities across North America, South America, Europe and Asia. His tenure with Flowserve Corporation, a supplier of equipment to chemical companies, provided him with significant knowledge of the chemical industry. Finally, having passed the CPA exams, he has financial expertise which enhances his contribution to the Board.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**20**

[Back to Contents](#toc)

---

| | |
|:---|:---|
| ![](lfmc025x21x1.jpg) | ***K'Lynne Johnson*** |
| ![](lfmc025x21x1.jpg) | **Principal Occupation: Former CEO, President and Executive Chair of Elevance Renewable Sciences, Inc., a global specialty chemicals company**<br> **Age: 54**<br> **Director Since: 2013**<br> **Independent Director, Compensation Committee Chair** |

---

Ms. Johnson was Executive Chair of Elevance Renewable Sciences, Inc. from October 2015 until the end of February 2016. Prior to being named Executive Chair, Ms. Johnson served for eight years as CEO and President. Elevance products and technologies are used in personal care products, detergents and cleaners, lubricants and additives, engineered polymers and other specialty chemicals markets. Previously, Ms. Johnson served as Senior Vice President of the Global Derivatives operating company within BP Innovene, one of the world's largest global petrochemical and refining companies. She has served in a variety of leadership and executive positions for twenty-five years at Amoco, BP Chemicals, Innovene and Elevance.

**Other Board Experience**

Ms. Johnson is the Chair of the Board of Directors of Trinseo S.A. and is a member of the Board of Directors of J.M. Huber Corporation. She became a director of BlueScope Steel Limited in January 2022. She was previously a member of the Board of Directors of TPC Group, Inc. from 2011 to 2012.

**Qualifications**

As a result of her work experience, Ms. Johnson has acquired significant knowledge of Asia and Europe, markets which represent approximately one half of the Company's business, as well as new technology and technology development. Given the Company's patented crop protection technologies and discovery research capabilities, such expertise is invaluable to the Board.

---

| | |
|:---|:---|
| ![](lfmc025x21x2.jpg) | ***Dirk A. Kempthorne*** |
| ![](lfmc025x21x2.jpg) | **Principal Occupation: Retired President and CEO, American Council of Life Insurers**<br> **Age: 71**<br> **Director Since: 2009**<br> **Independent Director, Sustainability Committee Chair** |

---

Governor Kempthorne served as President and CEO of the American Council of Life Insurers from 2010 to 2018. Prior to that, he served as the 49th United States Secretary of the Interior from June 2006 until January 2009. From January 1999 until his appointment as Secretary of the Interior, Governor Kempthorne served as the Governor of Idaho. He was also a United States Senator representing the State of Idaho from 1993 to 1999 and was the Mayor of Boise, Idaho from 1986 to 1993. Governor Kempthorne has been Chairman of the National Governors Association, Chairman of the Western Governors Association and President of the Council of State Governments. He also served as a member of the Homeland Security Task Force.

**Other Board Experience**

Governor Kempthorne is a member of the Board of Directors of Olympic Steel, and also serves on the Board of Directors of Robert Half International.

**Qualifications**

Governor Kempthorne's lengthy experience in government, both on the federal and state level, makes him well qualified to serve as a director of the Company, which interfaces with numerous regulatory agencies in several facets of its operations. In his various governmental positions, Governor Kempthorne was responsible for submitting budgets for governmental entities, fulfilling fiduciary responsibilities for the proper use of such funds, addressing inquiries from rating agencies and adhering to the highest accounting and ethical standards.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**21**

[Back to Contents](#toc)

---

| | |
|:---|:---|
| ![](lfmc025x22x1.jpg) | ***Margareth Øvrum*** |
| ![](lfmc025x22x1.jpg) | **Principal Occupation: Retired Executive Vice President, Development & Production Brazil of Equinor ASA, an international oil and gas exploration and production company, and President of Equinor Brazil**<br> **Age: 64**<br> **Director Since: 2016**<br> **Independent Director** |

---

Until her retirement in January 2021, Ms. Øvrum served as Executive Vice President of Equinor ASA (formerly known as Statoil ASA) and served on the company's Corporate Executive Committee, to which she had been appointed in 2004. In October 2018, she was named Executive Vice President, Development & Production Brazil. Over her career, Ms. Øvrum has had global responsibility for new energy, health, safety & environment, technology, research, procurement, projects and drilling. Prior to her current position, she held numerous senior leadership positions within Equinor, including Executive Vice President, Technology, Projects & Drilling; Executive Vice President, Technology and New Energy; Executive Vice President, Health, Environment and Safety; Senior Vice President, Operations Support; Vice President, Veslefrikk Field; and Platform Manager.

**Other Board Experience**

Ms. Øvrum was appointed to the Board of Directors of TechnipFMC on October 1, 2020, became a director of Harbour Energy in April 2021 and Transocean Ltd. in May 2021. She was formerly a member of the Board of Directors of Alfa Laval AB, Atlas Copco, and Ratos.

**Qualifications**

Ms. Øvrum's strong operations background provided her with deep experience in process technology, safety, sustainability and environmental management, all of which are critically important to a chemical company. Further, her wide international view and exceptional knowledge of European markets, where the Company has approximately one quarter of its business, acquired while executing very large projects in a number of different countries, make her a valuable contributor to the Board of the Company. Her experience in Brazil, which is a significant market for the Company, also enhances her value as a director.

---

| | |
|:---|:---|
| ![](lfmc025x22x2.jpg) | ***Robert C. Pallash*** |
| ![](lfmc025x22x2.jpg) | **Principal Occupation: Retired President, Global Customer Group and Senior Vice President of Visteon Corporation, an automotive parts manufacturer**<br> **Age: 71**<br> **Director Since: 2008**<br> **Independent Director** |

---

Until December 2013, Mr. Pallash served as President, Global Customer Group and Senior Vice President of Visteon Corporation, an automotive parts manufacturer, since January 2008. From August 2005 to January 2008, Mr. Pallash was Senior Vice President, Asia Customer Group for Visteon. He joined Visteon in September 2001 as Vice President, Asia Pacific. Visteon filed for bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code in May 2009 and exited in October 2010. Prior to joining Visteon, Mr. Pallash served as President of TRW Automotive Japan from 1999.

**Other Board Experience**

Mr. Pallash is a member of the Board of Directors of Livent Corporation. Previously, he served on the Board of Directors of Halla Climate Controls in South Korea, a majority-owned subsidiary of Visteon Corporation.

**Qualifications**

Mr. Pallash's international experience, particularly in Asia where the Company has approximately one-quarter of its business, enables him to bring significant value as a member of the Board. Mr. Pallash is "financially literate" as defined by the NYSE.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**22**

[Back to Contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**IV.** INFORMATION ABOUT THE BOARD OF
 DIRECTORS AND CORPORATE GOVERNANCE

## **Meetings** 
During 2022, the Board of Directors held five in-person meetings. All incumbent directors attended at least 75% of the total number of meetings of the Board and all Committees on which they served.

## **Committees and Independence of Directors** 
The Board of Directors has five standing Committees: an Audit Committee, a Compensation and Organization Committee, a Nominating and Corporate Governance Committee, an Executive Committee, and a Sustainability Committee.

The Audit Committee, Compensation and Organization Committee, Nominating and Corporate Governance Committee and Sustainability Committee are all composed of non-employee directors, each of whom has been determined by the Board to be independent on the basis set forth below. With the exception of the Chairman of the Board (Mr. Brondeau) and the President and Chief Executive Officer (Mr. Douglas), no director or nominee is currently, or was within the past three years, employed by the Company, its subsidiaries or affiliates. Mr. Brondeau was employed by the Company until April 27, 2021.

With the exception of Mr. Brondeau and Mr. Douglas, the Board has affirmatively determined that none of the non-employee directors has any material business, family or other relationship with the Company, its subsidiaries or affiliates other than as a director, and that they all qualify as independent. Specifically, the independent directors are Messrs. Cordeiro, Davidson, Greer, Kempthorne, and Pallash, and Ms. Fortmann, Ms. Johnson, and Ms. Øvrum. Messrs. Norris and Volpe also each qualified as an independent director during their respective terms as a director. In order to be considered independent by the Board, a director or nominee must meet the requirements set forth in the SEC and New York Stock Exchange ("NYSE") rules regarding independence. Mr. Brondeau ceased to be an employee of the Company on April 27, 2021 and he serves as a non-employee director; however, he is not considered to be independent under NYSE rules as he was an employee of the Company within the last three years.

One of our non-employee directors, Mr. Kempthorne, serves as an outside director for Robert Half International, a company with which FMC conducts an immaterial amount of business in the ordinary course. The Board has determined that Mr. Kempthorne does not have a material interest in these transactions given that his sole relationship with Robert Half International is as an outside director. On the basis of its evaluation, the Board has concluded that Mr. Kempthorne meets the independence standards applied by the Board.

### **Audit Committee** 
The Board of Directors has adopted a written charter that outlines the duties of the Audit Committee, including conducting an annual self-assessment. A current copy of the Charter is posted on the Company's website, as described in the section below entitled "Corporate Governance Documents". The principal duties of this Committee, among other things, include:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Review
 the effectiveness and adequacy of the Company's internal controls

**•** Review
 and discuss with management significant issues regarding accounting principles, financial
 reporting, financial statement presentation, and judgments made in the preparation of
 the Company's financial statements, including any significant changes in the Company's
 selection or application of accounting principles

**•** Review
 the annual report, proxy statement and periodic SEC filings such as the Company's
 reports on Form 10-K and 10-Q, including Management's Discussion and Analysis,
 and ensure that the Company's financial reports fairly represent its operations

**•** Review
 the effectiveness, scope and performance of activities of the independent registered
 public accounting firm and the internal auditor function

**•** Review
 significant changes in accounting policies

**•** Select
 the independent registered public accounting firm and confirm its independence

**•** Review
 potentially significant litigation

**•** Review
 federal income tax issues

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement***&nbsp;&nbsp;&nbsp;&nbsp;23**

[Back to Contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**•** Review
 the Company's policies with respect to risk assessment and risk management, including
 cyber security and data privacy

**•** Review
 with management the Company's earnings releases

**•** Monitor
 the Company's compliance with legal and regulatory requirements

**•** Pre-approve
 audit and non-audit services provided by the independent registered public accounting
 firm

*Members:* Mr. Cordeiro (Chair), Mr. Davidson, Mr. Pallash, and Mr. Volpe. The Board of Directors has determined that both Messrs. Cordeiro and Davidson meet the SEC requirements for an "audit committee financial expert" and all current members of the Committee are "financially literate" as required by the NYSE. The Board has also determined that no current Audit Committee member sits on the audit committee of more than three public companies.

*Number of Meetings in 2022: **9***

### **Compensation and Organization Committee** 
The Board of Directors has adopted a written charter that outlines the duties of the Compensation Committee, including conducting an annual self-assessment. A current copy of the Charter is posted on the Company's website, as described in the section below entitled "Corporate Governance Documents".

The principal duties of this Committee are discussed more fully in the Compensation Discussion and Analysis, and include, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Review and approve compensation policies and practices for senior executives

**•** Review and approve corporate goals and objectives relevant to the compensation of the Chief Executive Officer and the other
executive officers

**•** Review as necessary the Company's compensation programs, policies and practices with respect to risk assessment

**•** Review performance and establish the total compensation for the Chief Executive Officer and other senior executives

**•** Administer the Company's Incentive Compensation and Stock Plan and determine whether to authorize any delegation permitted
under the plan

**•** Review the Compensation Discussion and Analysis and, based on such review, recommend to the Board of Directors that it be included
in the annual proxy statement

**•** Review stockholder votes and other input on executive compensation practices and independently determine if any changes are
necessary

**•** Review
significant organizational changes and management succession planning

**•** Recommend to the Board of Directors
candidates for officers of the Company

**•** Review the terms of employment agreements, severance agreements, change in control agreements and other compensatory arrangements
for senior executives

**•** Oversee evaluation of management performance and development

**•** Review executive stock ownership guidelines and oversee clawback, hedging, and pledging policies

The Compensation Committee may form and delegate authority to subcommittees other than any power or authority required by law or stock exchange requirements to be exercised by the Board of Directors or the Compensation Committee as a whole.

*Members:* Ms. Johnson (Chair), Ms. Fortmann, Mr. Kempthorne, Mr. Norris, and Mr. Volpe.

*Number of Meetings in 2022: **4***

### **Nominating and Corporate Governance Committee** 
The Board of Directors has adopted a written charter that outlines the duties of the Nominating and Corporate Governance Committee, including conducting an annual self-assessment, which is within The Statement of Governance Principles, Policies and Procedures. A current copy of the Charter is posted on the Company's website, as described in the section below entitled "Corporate Governance Documents". The principal duties of this Committee, among other things, include:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Review and recommend candidates for director

**•** Recommend Board of Directors meeting formats and processes

**•** Oversee corporate governance, including an annual review of governance principles

&nbsp;&nbsp;&nbsp;&nbsp;**•** Review
and approve director compensation policies, including the determination of director compensation

**•** Oversee Board of Directors and Committee
evaluation procedures

**•** Determine director independence

**•** Recommend whether to accept or reject a
director resignation or take other action, where a director has failed to receive a majority of votes cast in an uncontested director
election

*Members:* Mr. Norris (Chair), Mr. Cordeiro, Ms. Fortmann, Mr. Greer, and Ms. Øvrum, A new chair will be elected by the Board effective as of April 27, 2023.

*Number of Meetings in 2022: **4***

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement***&nbsp;&nbsp;&nbsp;&nbsp;24**

[Back to Contents](#toc)

### **Executive Committee** 
The Executive Committee acts in place of the Board of Directors when the full Board of Directors is not in session.

*Members:* Mr. Brondeau (Chair), Mr. Douglas, Mr. Greer (Lead Director), Ms. Johnson, and Mr. Cordeiro (Alternate).

*Number of Meetings in 2022: **3***

### **Sustainability Committee** 
The Board of Directors has adopted a written charter that outlines the duties of the Sustainability Committee, including conducting an annual self-assessment. A current copy of the Charter is posted on the Company's website, as described in the section below entitled "Corporate Governance Documents". The principal duties of this Committee, among other things, are to:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Review and provide guidance on the Company's Sustainability programs and progress relating
to:

---

| | |
|:---|:---|
| **–** | Integration of sustainability into the Company's business strategy and operations |
| **–** | Environmental and climate related issues, including progress toward Net Zero |
| **–** | Global community engagement and social impact initiatives |
| **–** | Diversity and inclusion strategies and initiatives |
| **–** | Employee occupational safety and health, and process safety, environmental responsibility and product safety and stewardship *Members:* Mr. Kempthorne (Chair), Mr. Davidson, Ms. Johnson, Ms. Øvrum, and Mr. Pallash. |

---

*Number of Meetings in 2022: **4***

### **Director Who Presides Over Executive Sessions** 
In accordance with the FMC Corporation Statement of Governance Principles, Policies and Procedures, the non-employee members of the Board of Directors meet in regularly scheduled executive sessions without management. The Lead Director, Mr. Greer, presides over these sessions.

See the section below entitled "Board Leadership Structure" for additional information regarding the role of the Lead Director. In addition, see the section below entitled "Communicating with the Board" for procedures for communicating with the Lead Director.

## **Director Compensation** 

### **Overview** 
The Company believes that having quality non-employee directors is critical to our success. Non-employee directors represent the interests of our stockholders, and they contribute their experience and wisdom to guide our Company, our strategy and our management. The Board believes that compensation for directors should reflect the work required in both their ongoing oversight and governance role, and their continuous focus on driving long-term performance and stockholder value.

### **Review Process** 
The Nominating and Corporate Governance Committee, consisting solely of independent directors, has the primary responsibility for reviewing director compensation and considering any changes in how we compensate our directors. The full Board reviews the Nominating and Corporate Governance Committee's recommendations and determines the amount of director compensation. The Nominating and Corporate Governance Committee is empowered to engage outside advisors, experts, and others to assist it. The Nominating and Corporate Governance Committee periodically reviews assessments prepared by outside consultants that the Nominating and Corporate Governance Committee has engaged in order to gain an understanding of current market levels of compensation being paid for board service and to gauge current practices with respect to the forms of director compensation currently in use.

Our Board compensation for 2022 was established as a result of a process commenced in late 2020, under which the Nominating and Corporate Governance Committee engaged the Rewards Solutions practice at Aon plc ("Aon") to conduct a director compensation assessment based on peer companies. The assessment analyzed peer company director compensation levels and practices, evaluated the competitiveness of the Company's director compensation program from multiple perspectives relative to the peer group, and described recent market trends in director compensation. See "Compensation Discussion and Analysis – Compensation Determination Process – Peer Group".

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**25**

[Back to Contents](#toc)

The Nominating and Compensation Committee typically benchmarks and, if needed, recommends adjusting non-employee director compensation on a biennial basis, and thus, commenced a similar process in late 2022. Considering this peer group assessment and exercising its judgment, the Nominating and Governance Committee determined to keep 2023 non-employee director compensation at the same levels as in 2022, other than an increase of the compensation of the chair of the Compensation Committee from $15,000 to $20,000.

### **Compensation Policy For Non-Employee Directors** 
The Company maintains the FMC Corporation Compensation Policy for Non-Employee Directors (the "Director Compensation Policy"). The Director Compensation Policy is not applicable to directors who are also employees of the Company. Accordingly, for so long as Mr. Douglas remains an employee of the Company, Mr. Douglas will receive no additional compensation for his service as a director. For a description of the compensation paid to Mr. Douglas for his service during 2022, see below under the heading "Executive Compensation".

### **Retainer and Fees** 
Under the Director Compensation Policy, each non-employee director is paid an annual retainer of $100,000. The retainer is paid in quarterly installments in cash, unless the director elects to receive all or part of it in restricted stock units (the "retainer grant"). Audit Committee members receive an additional $5,000 in committee fees for each year. The chairs of the Compensation Committee, Nominating and Corporate Governance Committee and Sustainability Committee are paid an additional $15,000 per year, while the chair of the Audit Committee is paid an additional $20,000 per year. Commencing on the Annual Meeting date, the fee paid to the chair of the Compensation Committee will increase to $20,000 per year. The Lead Director is paid an additional $30,000 per year. The Non-Executive Chairman is paid an additional $150,000 per year.

### **Restricted Stock Units** 

#### **Retainer Grant** 
Retainer grants are awarded to non-employee directors who have elected to receive all or a portion of their retainer in restricted stock units. These grants vest ratably over a one-year period, with accelerated vesting of any unvested restricted stock units upon a change in control of the Company.

#### **Annual Grant** 
Currently, each non-employee director also receives an annual grant of restricted stock units having a value of $140,000 on the date of grant (the "annual grant"). These restricted stock units generally vest at the Annual Meeting of Stockholders held in the year following the date of grant or, if sooner, upon a change in control of the Company.

#### **Dividend Equivalent Rights** 
If a cash dividend is paid to FMC stockholders while a director holds restricted stock units, dividend equivalent rights are credited to the director in the form of additional restricted stock units equal in value to the cash dividend. These dividend equivalent rights will be subject to the same vesting schedule as the underlying restricted stock units to which they relate.

#### **Payment of Vested Restricted Stock Units** 
A director is permitted to specify, prior to the year in which an annual grant or retainer grant is made, the date upon which the director wishes to receive payment in Common Stock of the fully vested restricted stock units. In the absence of an election, payment will be made upon the earlier of a director's cessation of service on the Board or a change in control of FMC. The directors' ability to sell any distributed shares remains subject to the restrictions of the Company's Director Stock Ownership Policy, described below.

### **Mid-Year Cessation of Service** 
Under the Director Compensation Policy, if a director ceases to serve on the Board prior to the next annual meeting date, all committee, chairman, lead director, and annual retainer (whether in cash or stock) fees will be paid out pro rata based on time served. A director's annual grant of restricted stock units, on the other hand, will be forfeited in full upon a cessation of service mid-year. However, if the director's cessation of service is due to the director's death or disability, the director's annual retainer (whether in cash or stock) will be paid in full and the director's annual grant will vest in full.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**26**

[Back to Contents](#toc)

### **Other Compensation** 
The Company supports the charitable donations of directors under its matching gifts plan that provides a dollar-for-dollar match of gifts up to $15,000 per year to certain educational institutions, arts and cultural organizations, and conservation and civic organizations.

No other remuneration is paid to non-employee directors for services as a director of the Company. Non-employee directors do not participate in the Company's nonqualified deferred compensation plan or employee benefit plans, including, but not limited to, the qualified and nonqualified pension plans.

### **Director Stock Ownership Policy** 
We believe that we and our stockholders are best served when non-employee directors oversee the business with a long-term perspective. As such, we adopted stock ownership guidelines, under the belief that stock ownership is an important tool to strengthen the alignment of interests among our non-employee directors and our stockholders, to demonstrate our commitment to sound corporate governance. The Company has established guidelines setting expectations for the ownership of Common Stock by directors. The Director Stock Ownership Policy requires that directors hold a minimum of five times the value of the base annual retainer (the "ownership requirement"), currently $500,000 (five times $100,000). For this purpose, undistributed shares underlying restricted stock units (both vested and non-vested) are considered "held" by a director. Shares underlying unexercised stock options, whether such stock options are vested or unvested, are not considered "held" by a director. A director has five years from the date of his or her election to the Board to achieve compliance with the ownership requirement. However, even during the initial five-year phase-in period, directors are not permitted to sell shares of Common Stock, other than to satisfy tax liabilities triggered by Company equity grants, unless they will be in compliance with the ownership requirement (calculated based on the then-current annual cash retainer) immediately following any sale of Common Stock. Compliance with the ownership requirement is measured at the time of any proposed sale or disposition of shares of Common Stock by a director, and after the initial five-year phase-in period, on December 31 of each year. As of December 31, 2022, all the directors who were required to be in compliance with the Director Stock Ownership Policy were in compliance.

**DIRECTOR COMPENSATION TABLE 2022**

The table below shows the total compensation paid to each non-employee director who served on the Board during 2022.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name** <br> **(a)** | **Fees Earned** <br> **or Paid in Cash<sup>(1)</sup>** <br> **($)** <br> **(b)** | **Stock Awards<sup>(2)</sup>** <br> **($)** <br> **(c)** | **All Other** <br> **Compensation<sup>(3)</sup>** <br> **($)** <br> **(d)** | **Total** <br> **($)** <br> **(e)** |
| Pierre Brondeau | 250000 | 140088 |  | 390088 |
| Eduardo E. Cordeiro | 125000 | 140088 | 15000 | 280088 |
| Carol Anthony ("John") Davidson | 105000 | 140088 | 15000 | 260088 |
| Kathy L. Fortmann | 100000 | 140088 |  | 240088 |
| C. Scott Greer | 130000 | 140088 |  | 270088 |
| K'Lynne Johnson | 115000 | 140088 |  | 255088 |
| Dirk A. Kempthorne | 115000 | 140088 | 10174 | 265262 |
| Paul J. Norris | 115000 | 140088 | 15000 | 270088 |
| Margareth Øvrum | 100000 | 140088 |  | 240088 |
| Robert C. Pallash | 105000 | 140088 |  | 245088 |
| Vincent R. Volpe, Jr. | 105000 | 140088 | 15000 | 260088 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Ms. Fortmann and Messrs. Cordeiro, Norris, and Volpe elected to receive their April 2022 –
April 2023 annual retainer in RSUs rather than cash, which resulted in the grant of 743 RSUs to Ms. Fortmann and Messrs. Cordeiro,
Norris, and Volpe on April 28, 2022. Ms. Øvrum had similarly elected to receive 50% of her April 2022 – April 2023
annual retainer in RSUs rather than cash, which resulted in the grant of 372 RSUs to Ms. Øvrum. All RSU grants described
in this footnote are reported in cash amounts earned.

(2) The amounts in Column (c) reflect the grant date fair value of directors' stock awards for
2022 computed in accordance with FASB ASC Topic 718. See Note 16 to the Consolidated Financial Statements contained in the Company's
report on Form 10-K for the year ended December 31, 2022 for the assumptions used in the valuations that appear in this column.
The grant date for all directors was April 28, 2022. In each case, the number of shares granted was based on our closing price
on the grant date. The aggregate number of unvested FMC restricted stock units outstanding at fiscal year-end for each non-employee
director was as follows: Mr. Brondeau, 1,040; Mr. Cordeiro, 1,280; Mr. Davidson 1,040; Ms. Fortmann, 1,280; Mr. Greer, 1,040; Ms.
Johnson, 1,040; Mr. Kempthorne 1,040; Mr. Norris, 1,280; Ms. Øvrum, 1,160; Mr. Pallash, 1,040; and Mr. Volpe, 1,280.

(3) This amount consists of Company charitable donations under the matching gifts plan, which are limited
to $15,000 per director per year.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**27**

[Back to Contents](#toc)

## **Corporate Governance** 

### **Communicating with the Board** 
Stockholders and any interested parties may communicate with the Board of Directors, the Lead Director, or any individual member of the Board as follows: Communications must be in writing, sent care of the Corporate Secretary, FMC Corporation, FMC Tower at Cira Centre South, 2929 Walnut Street, Philadelphia, PA 19104. All communications with the Board, the Lead Director or any individual director will be delivered as addressed.

### **Director Nomination Process** 
The Nominating and Corporate Governance Committee and other members of the Board identify candidates for consideration by the Nominating and Corporate Governance Committee. An executive search firm may also be utilized to identify qualified candidates for consideration. The Nominating and Corporate Governance Committee evaluates candidates based on the qualifications for director described in its Charter and summarized in the section above entitled "Director Qualifications and Board Diversity". The Nominating and Corporate Governance Committee then presents qualified candidates to the full Board of Directors for consideration and selection. The Nominating and Corporate Governance Committee will consider nominees for election to the Board that are recommended by stockholders, applying the same criteria for candidates as discussed above, provided that a description of each nominee's qualifications for the directorship, experience and background, a written consent by a nominee to act as such, and other information specified in the By-Laws, accompany the stockholder's recommendation.

In addition to proposing a candidate for possible nomination by the Nominating and Corporate Governance Committee, any stockholder is entitled to directly nominate one or more candidates for election to the Board of Directors in accordance with the Company's By-Laws. Notice of a stockholder's intent to nominate one or more candidates for election as directors at the 2024 Annual Meeting must be delivered to the Company at the address set forth below, not later than January 28, 2024. All nominations, together with the additional information required by the Company's By-Laws, must be sent to the Corporate Secretary, FMC Corporation, FMC Tower at Cira Centre South, 2929 Walnut Street, Philadelphia, PA 19104. A copy of the Company's By-Laws may be obtained by writing to the Corporate Secretary at the same address. The Board reserves the right not to include such nominees in the proxy statement.

Our By-Laws include a proxy access provision which allows a stockholder, or a group of up to 20 stockholders, owning 3% or more of our outstanding Common Stock continuously for at least three years, to nominate and include in our proxy materials director nominees constituting up to two individuals or 20% of the Board (whichever is greater), provided that the stockholder(s) and the nominee(s) satisfy the requirements specified in Article IV, Sections 2 and 2A and other applicable provisions of our By-Laws. Notice of any such nomination for the 2024 Annual Meeting must be received by the Corporate Secretary of the Company at FMC Tower at Cira Centre South, 2929 Walnut Street, Philadelphia, PA 19104, no earlier than October 12, 2023 nor later than November 11, 2023. However if the date of our 2024 Annual Meeting is more than 30 days before or more than 60 days after April 27, 2024 (the anniversary of the 2023 Annual Meeting) then notice by the stockholder must be received no earlier than the close of business on the 120<sup>th</sup> day prior to the 2024 Annual Meeting and not later than the close of business on the later of (i) the 90<sup>th</sup> day prior to the 2024 Annual Meeting or (ii) the tenth day following the day on which notice or prior public disclosure of the date of the 2024 Annual Meeting is given or made to stockholders.

Stockholders who intend to solicit proxies in support of nominees other than the Company's nominees must provide the notice required under Rule 14a-19 under the Exchange Act to the Corporate Secretary no later than January 28, 2024.

### **Director Onboarding and Continuing Education** 
The Company is committed to supporting and educating directors on business operations, performance and strategy, as well as emerging issues, so that they can effectively carry out their responsibilities. The Company provides new directors with an orientation to familiarize them with the Company, including: financial performance and budget; commercial, manufacturing and research operations; strategic plans; sustainability; executive compensation; compliance programs; and other important policies and procedures. This orientation is facilitated through a series of meetings with senior executives, review of relevant background materials, and opportunities to visit the Company's headquarters and primary research facility. Orientation materials are always available to all directors for their reference. At board meetings, directors receive regular updates from senior management leaders on overall business performance and deeper reviews of specific business units or functions, and key issues facing the Company. From time to time, the board meets at a major location other than the Company's headquarters office, to gain further insight into local operations. The Company also regularly brings in outside experts to participate in board committee or full board meetings, to provide expert insight and education. During 2022, outside experts presented to directors on various topics including cybersecurity, sustainability data reporting, and director fiduciary responsibilities. In addition, the Company provides all directors with membership in the National Association of Corporate Directors.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**28**

[Back to Contents](#toc)

### **Annual Performance Review** 
The Board and Committees perform annual self-evaluations of their performance. A lengthy questionnaire is sent to each director covering several topics, including Board structure and composition (and what additional skills, if any, may be needed), preparation of members and whether they stay abreast of issues, understanding of Company strategy, whether expectations and concerns are adequately communicated to the CEO, CEO succession planning procedures, performance of committees, and length and content of Board meetings. Each Committee member also completes a shorter questionnaire assessing the performance of his or her Committee.

After obtaining written responses to the questionnaires, the Corporate Secretary conducts a telephone interview with each director to elicit elaboration of views expressed and any other issues the director wishes to discuss. A written report summarizing the responses from the questionnaires and the telephone interviews is presented to the Nominating and Corporate Governance Committee to determine whether any action is required, with a copy of the report also going to the full Board. Individual responses remain anonymous to ensure complete candor.

Any concern or issue with regard to an individual director's performance would be reviewed with the Lead Director for discussion with the director and any further action. The Board is committed to ensuring that its members maintain the necessary skills, qualifications, experience and diversity, and the Board will continue to consider and implement changes to the composition of the Board in light of its annual performance evaluations and new skills, if any, required in connection with strategic initiatives.

### **Retirement/Resignation Policy for Directors** 
The Board believes that long-tenured directors can be beneficial because of their deep knowledge of the Company acquired through service, the continuity and stability they offer, and their grasp of the historical perspectives that can inform Company strategy. However, pursuant to our Statement of Governance Principles, Policies and Procedures, it is the policy of the Board that non-employee Directors will not be nominated for re-election no later than the annual meeting following their 75<sup>th</sup> birthdays. Accordingly, Paul J. Norris, who has reached the age of 75, has not been nominated for re-election at the 2023 Annual Meeting. As noted before, the Board extends its thanks to Mr. Norris for his counsel and service.

In addition, our Statement of Governance Principles, Policies and Procedures requires that a non-employee Director submit his or her resignation from the Board upon termination of his or her active service as an employee of his/her current employer or a significant change in responsibilities. The Nominating and Corporate Governance Committee shall review the situation and make a recommendation to the Board as to whether to accept the resignation. In the case of any such required retirement or resignation, the Board may request that a director who would otherwise be due to retire or resign continue his or her service if (a) the policy would result in multiple director retirements in any 12-month period or (b) the Board deems such service to be in the best interest of our stockholders.

In accordance with our majority voting standard for the election of directors in uncontested elections, incumbent director nominees are required to tender a contingent resignation which would become effective if (i) the nominee does not receive a majority of the votes cast with respect to his or her election at any meeting of stockholders at which directors are being elected and (ii) the Board accepts such resignation.

Directors who are also executive officers of the Company are expected to retire from the Board simultaneous with retirement as an executive of the Company unless requested by the Board to continue as a Board member for an agreed period.

### **Attendance at Annual Meetings** 
The Company's policy is that all directors are expected to attend the Annual Meeting of Stockholders. All incumbent directors attended the 2022 Annual Meeting.

### **Stockholder Proposals for the 2024 Annual Meeting** 
Stockholders may make proposals to be considered at the 2024 Annual Meeting. In order to make a proposal for consideration at the 2024 Annual Meeting, a stockholder must deliver notice to the Company at the address set forth below, containing certain information specified in the By-Laws, not less than 60 or more than 90 days before the date of the meeting. However, if the Company provides public disclosure of the date of the 2024 Annual Meeting less than 70 days in advance of the meeting date, then the deadline for the stockholder's notice and other required information is 10 days after the date of the Company's notice or public disclosure of the date of the Annual Meeting.

In addition to being able to present proposals for consideration at the 2024 Annual Meeting, stockholders may also be able to have their proposals included in the Company's proxy statement and form of proxy for the 2024 Annual Meeting. In order to have a stockholder proposal included in the proxy statement and form of proxy, the proposal must be delivered to the Company at the address set forth below not later than November 11, 2023, and the stockholder must otherwise comply with applicable SEC requirements. If the stockholder complies with these requirements for inclusion of a proposal in the Company's proxy statement and form of proxy, the stockholder need not comply with the notice requirements described in the preceding paragraph.

A copy of the Company's By-Laws may be obtained by writing to the Corporate Secretary, and all notices referred to above must be sent to the Corporate Secretary, FMC Corporation, FMC Tower at Cira Centre South, 2929 Walnut Street, Philadelphia, PA 19104.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**29**

[Back to Contents](#toc)

### **Corporate Governance Documents** 
The Company's website is located at www.fmc.com. The following corporate governance documents are posted on the Investor Relations page of the website:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Audit Committee Charter

**•** Compensation and Organization Committee Charter

**•** FMC Statement of Governance Principles, Policies and Procedures (This document includes both
the Nominating and Corporate Governance Committee Charter and the Company's Corporate Governance Principles.)

**•** Sustainability Committee Charter

### **Board Leadership Structure** 
Our Corporate Governance principles provide that the Board should consider the issue of separation of the Chairman and Chief Executive Officer positions under the circumstances prevailing from time to time. Since June 2020, the positions of Chairman and Chief Executive Officer have been separated. Pierre Brondeau, formerly our Chief Executive Officer and then our Executive Chairman, currently serves as the Company's non-executive Chairman, a position he has held since April 2021.

Mr. Brondeau's current term as a director of the Company will expire at the 2023 Annual Meeting. The Board has requested, and Mr. Brondeau has agreed, that he be re-nominated as a director and, assuming his re-election at the 2023 Annual Meeting, that he continue to serve as non-executive Chairman. Assuming his re-election, Mr. Brondeau is expected to continue to serve as a member of the Executive Committee of the Board of Directors.

C. Scott Greer has served as the Lead Director of the Company since April 2022, and, assuming his re-election at the 2023 Annual Meeting, his current term runs through the date of the 2024 Annual Meeting. As set forth in the Corporate Governance Principles, the responsibilities of the Lead Director under this structure include: serving as the liaison between the Chairman and the independent directors, advising on information sent to the Board, calling meetings of the independent directors, and presiding at all meetings at which the Chairman is not present, including executive sessions.

### **Board's Role in Overseeing the Risk Management Process** 
As part of the Company's risk management process, the Board regularly discusses with management the Company's major risk exposures, their potential financial impact on the Company, and the steps the Company takes to manage them. The Board also reviews the designation of the management person or entity responsible for managing such risks, and evaluates the steps being taken to mitigate the risks. The Board's monitoring role is carried out by either the full Board or a Committee that reports to the Board, depending on the risk in question. The Board has determined that a separate Risk Committee is not warranted at this time.

### **Overview of Stockholder Engagement** 
The Company is committed to engaging with our stockholders. We regularly connect with stockholders throughout the year to answer their questions and solicit their views. In addition, we also conduct a regular outreach process during January and February to solicit stockholder feedback for the Board prior to its review and approval of the proxy statement.

Following the strong stockholder support (approximately 92%) of our Say on Pay proposal last spring and the engaging conversations with stockholders on environmental, social and governance (ESG) topics over the last year, we conducted another outreach on ESG. In addition, global supply chains have been another area of focus for stockholders over the past few years, and we included content related to the actions FMC has taken to develop and sustain resilience in our operations, as part of the outreach.

Since the 2022 proxy statement, we contacted 50 stockholders (representing approximately 70% of our common shares outstanding) offering to engage with them and held 20 calls or meetings with stockholders (representing approximately 32% of our common shares outstanding) during this engagement cycle. We discussed the Company's continued progress on environmental goals including the reduction of Scope 1 and 2 emissions at our operating sites in 2022, and steps taken to develop and sustain resilience in the Company's supply chain such as qualifying new suppliers in different geographies, developing safety stock at the supplier-level for key raw materials and managing multiple energy sources for our European assets.

Additional highlights from those calls included:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Acknowledgment of FMC's sustainability progress by various sustainability/ESG rating agencies
– resulting in improved ESG scores

**•** Discussion of FMC completing measurement and externally assuring Scope 1, 2 and 3 emissions

**•** Several investors inquired about our engagement with suppliers on our net zero goal

**•** Diversity, equity and inclusion (DEI) and human capital topics centered around recruitment, development
and retention programs

**•** Executive compensation came up only in the context of whether additional sustainability metrics
will be included as performance measures

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**30**

[Back to Contents](#toc)

### **Code of Ethics and Business Conduct Policy** 
The Company has a Code of Ethics and Business Conduct that applies to all directors, officers (including its Chief Executive Officer, Chief Financial Officer and Controller) and employees. It is posted on the Investor Relations page of the Company's website at www.fmc.com, under "Governance — Corporate Policies". The Company intends to post any amendments to, or waivers from, the Code of Ethics and Business Conduct required to be disclosed by either SEC or NYSE regulations on the Governance — Corporate Policies section of the Investor Relations page of the Company's website.

### **Compensation and Organization Committee Interlocks and Insider Participation** 
During the last fiscal year, Ms. Johnson, Ms. Fortmann and Messrs. Kempthorne, Norris and Volpe served as members of the Compensation Committee. All members of the Compensation Committee during 2022 were non-employee directors, each of whom was determined by the Board to be independent on the basis described in the above section entitled "Committees and Independence of Directors". None of the current or former members listed above has been an officer or employee of the Company, and no executive officer of the Company has served on any board of directors or compensation committee of any other company for which any of the Company's directors served as an executive officer at any time during 2022.

### **Related Party Transactions Policy** 
The Board of Directors has adopted a written Statement of Policy with respect to Related Party Transactions sets forth the Company's position and procedures with respect to review, approval or ratification of related party transactions, including the types of transactions addressed by the Policy, and the corporate function responsible for applying the Policy and related procedures.

Under the Policy, "related parties" are defined to include executive officers and directors of the Company and their immediate family members, a stockholder owning in excess of 5% of the Company (or its controlled affiliates), and entities in which any of the foregoing have a substantial ownership interest or control. With respect to any transaction where a related party receives a benefit in excess of a de minimis amount of $5,000 (when aggregated with all similar transactions) the Policy requires that the transaction be pre-approved (or, if less than $120,000, ratified) by the Audit Committee and disclosed where required by SEC rules. The Policy also provides that any related party who is presented with a "corporate opportunity" within the Company's line of business, must first offer that opportunity to the Company.

Notwithstanding the foregoing, in the case of an ordinary course of business transaction between the Company and an entity of which a director of the Company is an executive officer or significant stockholder of the entity, provided the director does not otherwise have a material interest in the transaction, the Policy provides a different standard for the review and approval of transactions that involve payments in any year to or from the Company in excess of either: (i) 1% of the Company's annual consolidated revenue for the most recently completed fiscal year or (ii) the greater of $1 million or 1% of the other entity's consolidated revenue for the most recently completed fiscal year. If the transaction does not exceed the above-mentioned thresholds (and the director does not have a material interest in the transaction), the transaction will be reviewed by the Nominating and Corporate Governance Committee as part of its review of director independence. If the director does have a material interest in the transaction, regardless of whether the above-mentioned thresholds are exceeded, the transaction must be approved or ratified by the Audit Committee in accordance with the preceding paragraph.

In the event of an ordinary course of business transaction that exceeds the above-mentioned thresholds where the director does not have a material interest, the transaction is not required to be pre-approved by the Audit Committee. Instead, the Audit Committee will review the transaction as soon as possible and will determine whether to either ratify or disallow the transaction. In the case of any such transaction associated with prospective directors, review and approval by the Audit Committee must occur prior to the director's election. After approval or ratification, in each case the director will provide updated information at least annually on the aggregate payments involved in the transaction. This information will be reviewed by the Nominating and Corporate Governance Committee in connection with its review of directors' independence. If the aggregate amounts involved in the transaction exceed the thresholds noted above, the Audit Committee shall be required again to review and ratify the transaction.

The Related Party Transactions Policy does not apply to transactions available to all employees generally and transactions involving solely matters of executive compensation.

There were no related party transactions required to be approved or ratified by the Audit Committee under the Policy or disclosed pursuant to SEC rules since January 1, 2022.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**31**

[Back to Contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**V.** SECURITY OWNERSHIP OF FMC CORPORATION

## **Management Ownership** 
The following table shows, as of December 31, 2022, the number of shares of Common Stock beneficially owned by each current director or nominee for director, the executive officers named in the Summary Compensation Table, and all current directors, nominees for director and executive officers as a group. Each director or nominee and each executive officer named in the Summary Compensation Table ("NEOs") beneficially owns less than 1% of the Common Stock.

---

| | |
|:---|:---|
| **Name** | **Beneficial Ownership**<br> **on December 31, 2022**<br> **FMC Common Stock** |
| Pierre Brondeau<sup>(2)</sup> | 346936 \* |
| Eduardo E. Cordeiro<sup>(2)</sup> | 22007 \* |
| Carol Anthony ("John") Davidson<sup>(2)</sup> | 4633 \* |
| Mark Douglas<sup>(1)</sup> | 199570 \* |
| Kathy L. Fortmann<sup>(2)</sup> | 751 \* |
| C. Scott Greer<sup>(2)</sup> | 63447 \* |
| K'Lynne Johnson<sup>(2)</sup> | 24533 \* |
| Dirk A. Kempthorne<sup>(2)</sup> | 43832 \* |
| Paul J. Norris<sup>(2)</sup> | 77061 \* |
| Margareth Øvrum<sup>(2)</sup> | 12668 \* |
| Robert C. Pallash<sup>(2)</sup> | 40847 \* |
| Ronaldo Pereira<sup>(1)</sup> | 29045 \* |
| Michael F. Reilly<sup>(1)</sup> | 42027 \* |
| Andrew Sandifer<sup>(1)</sup> | 70579 \* |
| Kathleen Shelton<sup>(1)</sup> | 18210 \* |
| Vincent R. Volpe, Jr.<sup>(2)</sup> | 52244 \* |
| All current directors and executive officers as a group — 17 persons<sup>(1)(2)</sup> | 1067655 \* |

---

\* Less than 1% of class.

(1) Shares "beneficially owned" include: (i) shares owned or controlled by the individual; (ii) shares held in the FMC Corporation Savings and Investment Plan for the account of the individual as of December 31, 2022; (iii) restricted stock units that will vest within 60 days of December 31, 2022 (7,310 for Mr. Douglas, 3,101 for Mr. Sandifer, 1,331 for Mr. Pereira, 1,528 for Mr. Reilly, 964 for Dr. Shelton, 601 for an executive officer not listed above, and 14,835 for all executive officers as a group); (iv) shares subject to options that are exercisable within 60 days of December 31, 2022 (98,199 for Mr. Douglas, 34,406 for Mr. Sandifer, 13,094 for Mr. Pereira, 24,780 for Mr. Reilly, 11,802 for Dr. Shelton, 15,179 for an executive officer not listed above, and 197,460 for all executive officers as a group); and (v) shares subject to performance-based restricted stock units that will be settled within 60 days of December 31, 2022 (20,906 for Mr. Douglas, 4,740 for Mr. Sandifer, 1,527 for Mr. Pereira, 2,341 for Mr. Reilly, 1,107 for Dr. Shelton, 690 for an executive officer not listed above, and 31,311 for all executive officers as a group). Item (iii) includes restricted stock units which the holder has no power to vote or dispose of, but in respect of which the holder is entitled to a cash payment equal to the amount of any dividends paid by the Company on its Common Stock.

(2) Includes vested restricted stock units credited to individual accounts of non-employee directors (see section above entitled "Director Compensation"). The number of restricted stock units credited to directors included in the table above is as follows: Mr. Brondeau, 11,579; Mr. Cordeiro, 13,028; Mr. Davidson, 3,133; Ms. Fortmann, 751; Mr. Greer, 21,292; Ms. Johnson, 21,325; Mr. Kempthorne, 36,220; Mr. Norris, 70,061; Ms. Øvrum, 12,668; Mr. Pallash, 40,847; and Mr. Volpe, 52,244; and all directors as a group, 283,148. Directors have no power to vote or dispose of shares represented by restricted stock units until the shares are distributed and, until such distribution, directors have only an unsecured claim against the Company. The holders of these restricted stock units will be credited with additional restricted stock units having a value equal to the amount of any dividends paid by the Company on its Common Stock. Previously credited amounts are included in the table above. Shares "beneficially owned" by Mr. Brondeau also include (i) 5,316 restricted stock units that will vest within 60 days of December 31, 2022 (ii) 211,284 shares subject to options that are exercisable within 60 days of December 31, 2022 and (iii) 15,197 shares subject to performance-based restricted stock units that will be settled within 60 days of December 31, 2022. Such shares were granted to Mr. Brondeau during his time as an employee of the Company; Mr. Brondeau ceased to be an employee of the Company on April 27, 2021 and currently serves as a non-employee director.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**32**

[Back to contents](#toc)

## **Other Security Ownership** 
Based on available information, the persons listed below beneficially own more than 5% of the Company's outstanding shares of Common Stock as of December 31, 2022:

---

| | | |
|:---|:---|:---|
| **Name and Address of Beneficial Owner** | **Amount and Nature**<br> **of Beneficial Ownership** | **Percent of Class** |
| The Vanguard Group, Inc. <br> 100 Vanguard Blvd. <br> Malvern, PA 19355 | 14,411,402 shares<sup>(1)</sup> | 11.44% |
| BlackRock, Inc. <br> 55 East 52<sup>nd</sup> Street <br> New York, NY 10055 | 11,408,727 shares<sup>(2)</sup> | 9.1% |
| Wellington Management Group LLP<br> 280 Congress Street<br> Boston, MA 02210 | 8,726,628 shares<sup>(3)</sup> | 6.93% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Based on a Schedule 13G/A filing dated February 9, 2023, as of December 30, 2022,
 The Vanguard Group, Inc. had shared voting power as to 180,506 shares, sole dispositive power as to 13,892,684 shares
 and shared dispositive power as to 518,718 shares.

(2) Based on a Schedule 13G/A filing dated February 7, 2023, as of December 31, 2022, BlackRock,
 Inc. had sole voting power as to 10,188,559 of such shares and sole dispositive power as to all of the shares.

(3) Based on a Schedule 13G/A filing dated February 6, 2023, as of December 30, 2022, Wellington
 Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP had shared voting power
 as to 7,479,369 of such shares and shared dispositive power as to all of the shares. Wellington Management Company LLP had
 shared voting power as to 6,895,480 of such shares and shared dispositive power as to 7,516,496 of the shares.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**33**

[Back to contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**VI.** EXECUTIVE COMPENSATION

## **Compensation Discussion and Analysis** 
The following Compensation Discussion & Analysis describes the philosophy, objectives, process, structure and additional aspects of our 2022 executive compensation program. This section is intended to be read in conjunction with the tables which immediately follow, which provide further historical compensation information for our named executive officers ("NEOs") as identified below.

The NEOs in 2022 were:

---

| | |
|:---|:---|
| Mark Douglas | President and Chief Executive Officer |
| Andrew Sandifer | Executive Vice President and Chief Financial Officer |
| Ronaldo Pereira | Executive Vice President and President, FMC Americas |
| Michael F. Reilly | Executive Vice President, General Counsel, Chief Compliance Officer and Secretary |
| Kathleen Shelton | Executive Vice President and Chief Technology Officer |

---

#### **Quick CD&A Reference Guide** 

---

| | |
|:---|:---|
| [**Executive Summary**&nbsp;&nbsp;&nbsp;&nbsp;Section I](#lfmc025b001) | [**34**](#lfmc025b001) |
| [**Objectives and Philosophy**&nbsp;&nbsp;&nbsp;&nbsp;Section II](#lfmc025b002) | [**38**](#lfmc025b002) |
| [**Compensation Determination Process**&nbsp;&nbsp;&nbsp;&nbsp;Section III](#lfmc025b003) | [**38**](#lfmc025b003) |
| [**Components of Executive Compensation**&nbsp;&nbsp;&nbsp;&nbsp;Section IV](#lfmc025b004) | [**40**](#lfmc025b004) |
| [**Additional Compensation Policies and Practices**&nbsp;&nbsp;&nbsp;&nbsp;Section V](#lfmc025b005) | [**52**](#lfmc025b005) |

---

### **Executive Summary** 

#### **Financial Highlights** 
FMC posted strong results in 2022, despite significant cost headwinds. FMC grew revenue by 15% in 2022 as compared to 2021. FMC's long-term fundamentals remain solid, driven by our balanced geographic and crop exposure, as well as a technologically advantaged portfolio.

2022 highlights include, as compared to 2021 results:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Revenue of $5.8 billion, representing a 15% increase. On a regional
 basis, sales in North America increased 29%, sales in Latin America increased by 28%, sales in Europe, Middle East and Africa
 remained flat and sales in Asia decreased 1%.

**•** GAAP net income of $742 million, representing a 1% increase

**•** Adjusted EBITDA of $1.407 billion, representing a 7% increase

**•** GAAP earnings of $5.81 per diluted share, representing a 1% increase

**•** Adjusted earnings of $938 million, representing a 6% increase

**•** GAAP cash flow from operations of $660 million, representing a 27% decrease

**•** Free cash flow of $514 million, representing a 28% decrease

All of the aforementioned achievements are reflective of our culture, our people and our accomplishment of strategic business goals. Further, we believe our executive team has been properly motivated through our executive compensation program to focus on the achievement of these goals, both in the short term and long term. We realize that an intense focus on the long-term health and direction of the Company is essential. As such, our executive compensation program has been carefully constructed to appropriately motivate executives to accomplish short-term objectives that are part of our strategy and to create long-term, sustainable stockholder value, and it predominantly rewards executives for the achievement of various goals. In fact, we link a significant portion of compensation, including approximately 87% of our CEO's compensation, directly to key measures of our corporate performance – including adjusted earnings, operating cash flow and share price performance (both absolute and relative).

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**34**

[Back to contents](#toc)

As an important input to our process, our Compensation Committee and management have also continued to engage in broad stockholder engagement and dialogue regarding our corporate governance, including executive compensation.

In the process, we have established critical feedback channels to ensure that we receive and consider such input. Incorporating stockholder feedback continues to be a vibrant and consistent part of the compensation design process.

For a discussion of certain non-GAAP financial measures referred to in this proxy statement, including Adjusted EBITDA, Adjusted Earnings, and Free Cash Flow, as well as a reconciliation of these items to the most directly comparable financial measures calculated and presented in accordance with GAAP, reference is made to the sections captioned "Results of Operations – 2022, 2021 and 2020" on p. 25-26 and "Liquidity and Capital Resources – Free Cash Flow" on p. 37, in each case in our Form 10-K for the year ended December 31, 2022, filed with the SEC on February 24, 2023. We believe that these non-GAAP measures are helpful to management and investors as a measure of operating performance because they exclude various items that do not relate to or are not indicative of operating performance. Such non-GAAP measures should not be considered as a substitute for net income (loss), cash provided (required) by operating activities of continuing operations, or other measures of performance or liquidity reported in accordance with GAAP.

#### **Key Aspects of Our 2022 Executive Compensation Program** 

##### **Base Salaries** 
Mr. Douglas, our President and CEO, received a base salary increase of 4.3%. Also, as part of the continuation of the gradual, multi-year transition to bring the base salaries of the other NEOs into alignment with the market median for their positions, their base salaries were increased by amounts ranging from 8.0% to 15.0%.

##### **Annual Incentive Opportunity** 

---

| | |
|:---|:---|
| ![](lfmc025x35x1.jpg) | Company-wide performance accounted for 70% of the annual incentive performance goals; individual performance goals accounted for the other 30%. |
| ![](lfmc025x35x1.jpg) | Adjusted Earnings was maintained as the sole Company-wide metric for Messrs. Douglas, Sandifer, and Reilly, with Free Cash Flow continuing to serve as a modifier. |
| ![](lfmc025x35x1.jpg) | The Compensation Committee set the Adjusted Earnings target at a level that it considered rigorous and challenging to achieve. Factoring in industry forecasts and other factors, the target was set slightly above the prior year levels. |
| ![](lfmc025x35x1.jpg) | The Adjusted Earnings goal had a threshold performance level of approximately 92% of target, which must be exceeded in order for any payout to be earned. |
| ![](lfmc025x35x1.jpg) | Adjusted EBITDA was set as a Company-wide metric for Mr. Pereira and Dr. Shelton, and was set at a demanding level and with the same Free Cash Flow modifier as was used in conjunction with the Adjusted Earnings metric. Regional operating profitability was set as the other metric for Mr. Pereira, with a corresponding cash flow modifier. |

---

The target opportunity percentages for Messrs. Douglas and Pereira were increased to 130% from 125% and to 75% from 70%, respectively.

Adjusted Earnings for the purposes of the annual incentive were $959 million, compared to a target of $896 million, a target set slightly above the prior year level. Free Cash Flow was $514 million, below the threshold performance level of $575 million, which resulted in a 10% reduction in the final rating. Adjusted EBITDA was $1,434 million, compared to a target of $1,344 million, and the corresponding rating was subject to the same Free Cash Flow modifier and corresponding 10% reduction in the final rating.

##### **Long-Term Incentive Awards** 

---

| | |
|:---|:---|
| ![](lfmc025x35x1.jpg) | The primary (70%) performance metric for the performance-based RSUs remained TSR relative to a custom peer group using the S&P 1500 Composite Chemical Index plus select additional companies. |
| ![](lfmc025x35x1.jpg) | The secondary (30%) performance metric, three-year cumulative operating cash flow, remained. |
| ![](lfmc025x35x1.jpg) | Performance-based RSUs represented 50% of the long-term equity granted to Mr. Douglas and 40% of the long-term equity granted to the other NEOs. |
| ![](lfmc025x35x1.jpg) | Time-based RSUs represented 20% of the total long-term equity grants to Mr. Douglas and 30% of the grants to the other NEOs. |
| ![](lfmc025x35x1.jpg) | Stock options represented 30% of the total long-term equity grants to Mr. Douglas and the other NEOS. |

---

&nbsp;&nbsp;&nbsp;&nbsp;**•** **2020-2022 Performance-Based RSUs Payout.** The performance-based RSUs granted
 in 2020 included both the relative TSR primary metric and the three-year cumulative operating cash flow secondary metric.
 The Company generated a 16.77% 2022 annual and 31.91% cumulative TSR from 2020 to 2022, and its relative percentile ranking
 for these performance periods were 87.80% and 61.20%, respectively. Based on this performance, the NEOs earned a total of
 122.5% of the target number of performance-based RSUs that had relative TSR as the metric. The Company also produced three-year
 cumulative operating cash flow of $3,475 million, relative to a target of $3,602 million. Based on this performance, the NEOs
 earned a total of 84% of the target number of performance-based RSUs that had operating cash flow as the metric.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**35**

[Back to contents](#toc)

#### **2022 Say on Pay Vote and Stockholder Engagement** 
At our 2022 annual meeting of stockholders, our stockholders approved, on an advisory basis, the compensation of our NEOs, with approximately 92% of the votes cast on the matter "For" such approval. The Compensation Committee viewed the approval by stockholders of the executive compensation program at such a strong level as evidence that a substantial majority of stockholders are aligned with our executive compensation program.

The Compensation Committee and management continue to engage regularly in dialogue with a broad spectrum of the Company's stockholders. Following the filing of the 2022 proxy statement, we reached out to our top 50 stockholders, representing approximately 70% of our common shares outstanding. We held calls with 20 stockholders, representing approximately 32% of our common shares outstanding, and a member of our Compensation and Sustainability Committees and members of our management participated in these discussions in order to demonstrate our commitment to strong corporate governance and our effort to gather input from our stockholders, which we believe enables us to better understand their perspectives. Our discussion included, without limitation, ESG topics, supply chain resilience and our sourcing strategy. We also reached out to the research teams at proxy advisory firms Institutional Shareholder Services Inc. and Glass Lewis & Co.; both declined our offer to engage in discussions.

#### **How Our Pay Program Works** 
We believe that the design and structure of our pay program, and in particular our incentive plans, support FMC's business strategy. Our program reflects our pay for performance approach and our objective to align executive officer focus and interest with that of stockholders. Our annual incentive plan reflects a focus on income statement metrics, while our long-term performance awards were based 70% on relative TSR performance to align with stockholder value and 30% on three-year cumulative operating cash flow, a key strategic priority and value driver. All elements have been carefully chosen and utilized; the value received and realizable for FMC executives is aligned with corporate performance.

##### **Elements of Pay** 
Our compensation program is designed to reward executives for achievement of our Company's short-term and long-term goals. In doing so, we have also constructed the pay program to attract and retain world-class talent and to align executive compensation pay opportunities with the interests of stockholders. The Compensation Committee has selected the following framework to achieve these objectives:

![](lfmc025x36x1.jpg)

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**36**

[Back to contents](#toc)

##### **Target Total Direct Compensation Mix** 
Consistent with our objectives as stated above, and our overarching focus on pay and performance alignment, the pay mix was set as follows:

&nbsp;&nbsp;&nbsp;&nbsp;**•** The largest portion of compensation is variable, at-risk pay,
 in the form of annual and long-term incentives (including annual incentive, performance-based RSUs ("PRSUs"),
 options and time-based RSUs)

**•** Our program provides a balance between long-term and short-term awards, and
 the performance objectives are consistent with our business strategy

![](lfmc025x37x1.jpg)

Percentage of total direct compensation ("TDC") as shown in the above charts is based on the 2022 base salary, the 2022 annual incentive compensation opportunity (assuming achievement at the target level), the grant date fair value of the performance-based RSUs (assuming vesting at the target achievement level) and the grant date fair value of the time-based stock options and RSU awards. Each compensation element is outlined in more detail in the 2022 Summary Compensation Table below.

#### **Compensation Program Governance** 
Our Compensation Committee is responsible for oversight of the Company's compensation program and values. A significant part of this is aligning management interests with the Company's business strategies and goals, as well as the interest of our stockholders, while also mitigating excessive risk taking. To that end, FMC has committed to numerous governance practices and safeguards to ensure the compensation program does not misalign those interests.

---

| | | | |
|:---|:---|:---|:---|
| **What We Do** | **What We Do** | **What We Don't Do** | **What We Don't Do** |
| ![](lfmc025x37x2.jpg) | &nbsp;&nbsp;Use equity for long-term incentive awards | ![](lfmc025x37x4.jpg) | &nbsp;&nbsp;No highly leveraged incentive plans that encourage excessive risk taking |
| ![](lfmc025x37x3.jpg) | &nbsp;&nbsp;Determine performance-based RSUs based on relative TSR and operating cash flow | ![](lfmc025x37x5.jpg) | &nbsp;&nbsp;No excessive perquisites |
| ![](lfmc025x37x2.jpg) | &nbsp;&nbsp;Provide change in control benefits under double-trigger circumstances only | ![](lfmc025x37x4.jpg) | &nbsp;&nbsp;No guaranteed bonuses |
| ![](lfmc025x37x3.jpg) | &nbsp;&nbsp;Benchmark against peers whose profile, operations, and business markets share similarities with the Company | ![](lfmc025x37x5.jpg) | &nbsp;&nbsp;No discounted stock options |
| ![](lfmc025x37x2.jpg) | &nbsp;&nbsp;Maintain an executive share ownership policy | ![](lfmc025x37x4.jpg) | &nbsp;&nbsp;No repricing without stockholder approval or backdating of stock options |
| ![](lfmc025x37x3.jpg) | &nbsp;&nbsp;Apply anti-pledging and anti-hedging policy for Company shares | ![](lfmc025x37x5.jpg) | &nbsp;&nbsp;No immediate vesting of stock options or restricted stock units except for certain change-in-control with termination and retirement-eligible situations |
| ![](lfmc025x37x2.jpg) | &nbsp;&nbsp;Maintain a clawback policy designed to recoup incentive compensation paid to executive officers based on erroneously prepared financial statements | ![](lfmc025x37x4.jpg) | &nbsp;&nbsp;No excise tax gross-ups under our executive officer compensation program |
| ![](lfmc025x37x3.jpg) | &nbsp;&nbsp;Engage independent advisors |  |  |
| ![](lfmc025x37x2.jpg) | &nbsp;&nbsp;Maintain an appropriate balance between short-term and long-term compensation which discourages short-term risk taking at the expense of long-term results |  |  |
| ![](lfmc025x37x3.jpg) | &nbsp;&nbsp;Cap annual incentive plan payouts and number of PRSUs that may be earned under long-term incentive plan |  |  |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**37**

[Back to contents](#toc)

### **Objectives and Philosophy** 
The Company's executive compensation program is designed to attract, motivate and retain top talent, to pay for performance and to align the financial interests of the NEOs with those of the Company's stockholders. In designing compensation arrangements for NEOs, the Compensation Committee has considered the importance of:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Balancing variable compensation components so that appropriate
 focus is put on achieving both short-term and long-term operating and strategic objectives;

**•** Motivating NEOs to achieve desired financial and operational results using
 sound business judgment and without inappropriate risk taking; and

**•** Ensuring that the achievement of key financial goals and strategic objectives
 is financially rewarding for NEOs.

In general, we believe it is critical to pay executives at a competitive level relative to our peer group in order to attract and retain the talent we need to deliver high performance. In addition to looking at our peer group, we make individual pay decisions based on a variety of factors such as Company, business unit and individual performance, scope of responsibility, critical needs and skills, experience, time in the role, leadership potential and succession planning.

The Compensation Committee believes that subjecting a significant percentage of TDC to performance conditions helps focus the executive on achieving key objectives that are important to executing our strategy and delivering the performance expected by stockholders.

### **Compensation Determination Process** 

#### **Role of Compensation and Organization Committee** 
The Compensation Committee establishes our compensation philosophy and objectives, determines the structure, components and other elements of executive compensation, and reviews and approves the compensation of the NEOs or recommends it for approval by the Board. The Compensation Committee structures the executive compensation program to accomplish its articulated compensation objectives in light of the compensation philosophy described above.

The Compensation Committee recognizes its responsibility to maintain a competitive executive compensation program that will support the Company's ability to attract, motivate and retain top talent while at the same time aligning the financial interests of the executives with those of stockholders. Pay for performance and market-based compensation are important elements of the Company's compensation philosophy. The Company considers several measures of corporate performance, job performance and labor market dynamics, as well as stockholder feedback, in the design and administration of the NEO compensation arrangements described later in this section.

The Compensation Committee establishes total compensation for the CEO annually at its February meeting. The Compensation Committee reviews and evaluates the performance of the CEO and develops base salary and incentive opportunity recommendations for the review and approval of the full Board of Directors. The CEO does not participate in Compensation Committee or Board discussions regarding his own compensation.

#### **Role of the CEO** 
The Compensation Committee, with the input of the CEO, also establishes compensation for the other NEOs. Specifically, the CEO evaluates the performance of the other NEOs annually and makes recommendations to the Compensation Committee each February regarding the compensation of those other NEOs. The CEO's input is particularly important in connection with base salary adjustments and the determination of the Individual Measures ratings (Annual Performance Incentive ("API")) as part of our Annual Incentive program. In each of these instances, the process starts with the CEO's recommendation, and that recommendation is afforded great weight by the Compensation Committee. The CEO participates in Compensation Committee discussions regarding other NEOs' compensation. The Compensation Committee views the CEO's significant role in the compensation process for other NEOs, and the deference afforded to his recommendations, as appropriate in light of his greater familiarity with the day-to-day performance of his direct reports and the importance of incentive compensation in driving the execution of managerial initiatives developed and led by the CEO. That said, the Compensation Committee makes the ultimate determination regarding the compensation of each of the NEOs.

#### **Role of Compensation Consultant** 
The Compensation Committee recognizes that there is value in procuring independent, objective expertise and counsel in connection with fulfilling its duties and has the authority to retain an independent compensation consultant to assist it in carrying out its responsibilities.

The Compensation Committee retained Aon as its independent compensation consultant for 2022 compensation decisions. Aon reported directly to the Compensation Committee, and the Compensation Committee has the sole authority to retain, terminate and obtain the advice of Aon at the Company's expense.

Aon's advice was taken into consideration for all aspects of 2022 compensation as delineated in the Summary Compensation Table.

For 2022, Aon provided the Compensation Committee with advice and counsel on a broad range of executive compensation matters. The scope of Aon's services included, but was not limited to, the following:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Apprising the Compensation Committee of compensation-related
 trends and developments in the marketplace;

**•** Informing the Compensation Committee of regulatory developments relating
 to executive compensation practices;

**•** Advising the Compensation Committee on appropriate peer companies for compensation
 pay levels and design practices, as well as relative performance comparisons;

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**38**

[Back to contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**•** Providing the Compensation Committee with an assessment of the
 market competitiveness of the Company's executive compensation;

**•** Assessing the executive compensation structure to confirm that no design
 elements encourage excessive risk taking;

**•** Assessing the relationship between executive compensation and corporate performance;
 and

**•** Recommending changes to the executive compensation program to maintain competitiveness
 and ensure consistency with business strategies, good governance practices and alignment with stockholder interests.

At the time that FMC engaged Aon as its executive compensation advisor, the Compensation Committee was aware of the types and general magnitude of the fees for other services that Aon provided to FMC. Aon was selected because the Compensation Committee is confident that the team advising on executive compensation issues was both highly qualified and would be independent.

For 2022, in determining the independence of Aon, the Compensation Committee considered independence in light of the six independence factors set forth in the SEC rules and NYSE listing standards. In total, fees paid to Aon during 2022 for services not related to Aon's work with the Compensation Committee, such as global pension, investment and consulting services and risk brokerage services, were approximately $3,924,041. Fees paid to Aon during 2022 for services related to recommending the amount and form of executive and director compensation were approximately $278,592. Aon had been providing services in areas other than executive compensation consulting to FMC prior to the Compensation Committee's selection of Aon for executive compensation consulting services.

In terms of assessing independence, the Compensation Committee also gave credit to the safeguards that Aon's executive compensation practice has put in place to maintain its independence. The Compensation Committee also considered that no business or personal relationships exist between any members of the consultants' teams advising the Company on the one hand, and the Company, any members of the Compensation Committee or any executive officers on the other hand, other than in connection with the services provided. Therefore, the Compensation Committee has concluded that Aon is independent, as no conflict of interest exists between Aon and the Company.

#### **Peer Group** 
The Compensation Committee believes that obtaining relevant market and benchmark data is very important in making determinations about executive compensation. Such information provides a solid reference point for making decisions and very helpful context, even though, relative to other companies, there are differences and unique aspects of the Company.

The Company relies on both industry surveys and analysis of proxy statements from peer companies (the "Market") prepared by its compensation consultant to assess the market competitiveness of the components of its NEO compensation and to validate the appropriateness of TDC, including the appropriate mix of cash and equity, as well as NEO benefits and perquisites. Proxy statement data may not be available for all jobs that are direct comparisons to jobs held by the Company's NEOs. In such cases, the Company relies more on the broader survey data to assess acceptable ranges for the elements of executive compensation. The Company also believes that internal equity is an important and necessary consideration in valuing jobs. The Company may, as a matter of policy, adjust individual components of TDC to align with the Market or with its general executive pay philosophy as described in the preceding section. However, the Company does not adjust components of TDC based on the amount of compensation earned by an NEO in any prior period.

In connection with determining 2022 executive compensation, the Company reviewed a market study of executive compensation at peer companies. The peer group is reviewed periodically for appropriateness, comparability in market segment and to account for merger and acquisition activity affecting the companies. Guidelines used for developing the peer group include similar industry representation and revenue and market capitalization generally within the range of one-third to three times that of FMC. W.R. Grace was removed because it was acquired.

---

| | |
|:---|:---|
| Albemarle Corporation | Huntsman Corporation |
| Ashland Global Holdings, Inc. | Ingredion Incorporated |
| Avient Corporation | International Flavors and Fragrances, Inc. |
| Axalta Coating Systems Ltd. | The Mosaic Company |
| Cabot Corporation | Nutrien Ltd. |
| Celanese Corporation | Olin Corporation |
| CF Industries Holdings, Inc. | PPG Industries, Inc. |
| Corteva, Inc. | RPM International, Inc. |
| The Chemours Company | The Scotts Miracle-Gro Company |
| Eastman Chemical Company | Westlake Chemical Corporation |

---

---

| | | |
|:---|:---|:---|
|  | **Market Cap**<br> **($mm)** | **2020 Revenue**<br> **($mm)** |
| **2022 Peers** |  |  |
| 25<sup>th</sup> percentile | $6526 | $4027 |
| Median | $12500 | $5581 |
| 75<sup>th</sup> percentile | $18717 | $7746 |
| **FMC Corporation** | $15153 | $4642 |
| ***Rank*** | ***66%*** | ***35%*** |

---

Note: Revenue amounts are for the most recent year ended prior to June 1, 2021. Market capitalization amounts were 30-day averages as of June 1, 2021.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**39**

[Back to contents](#toc)

### **Components of Executive Compensation** 
The NEO compensation program consists of three primary elements: base salary, an annual incentive and a long-term incentive. The Compensation Committee regularly reviews all components of the program in order to verify that each executive officer's total compensation is consistent with its compensation philosophy and objectives and that the component is serving a purpose in supporting the execution of our strategy. The value of, and allocation to, each of these elements is commensurate with the level of responsibility and impact of our results for each executive.

#### **Base Salary** 
Salary ranges for NEOs are established based on similar positions in other companies of comparable market capitalization, revenue, size and complexity included in the Market. Performance levels from "does not meet expectations" to "exceeds expectations" provide guidance for the administration of salaries.

Starting salaries are based on the NEO's skills, experience, expertise and expected job performance. Subsequent salary adjustments for the NEOs (except the CEO) are based on job performance as assessed by the CEO, who recommends the appropriate base salary to the Compensation Committee for their approval. The Compensation Committee itself determines any salary adjustment for the CEO. Base salary reviews are part of the broader compensation review that occurs at the February meeting of the Compensation Committee and focuses on the performance of the NEOs in their respective major responsibility areas. These include, but are not limited to, financial management, customer relations, strategic planning and business development, operational excellence, safety performance, staffing and talent management, performance management, and litigation management.

In 2022, Mr. Douglas, our President and CEO, received a base salary increase of 4.3%. Also, as part of the continuation of the gradual, multi-year transition to bring the base salaries of the other NEOS into alignment with the market median for their positions, their base salaries were increased by amounts ranging from 8.0% to 15.0%. The table below shows these changes in base salary from 2021 to 2022.

---

| | | | |
|:---|:---|:---|:---|
| **NEO** | **Annualized 2021**<br> **Base Salary** | **Annualized 2022**<br> **Base Salary** | **% Change** |
| Mark Douglas | $1102500 | $1150000 | 4.3% |
| Andrew Sandifer | $595100 | $684400 | 15.0% |
| Ronaldo Pereira | $432600 | $467200 | 8.0% |
| Michael Reilly | $510840 | $551700 | 8.0% |
| Kathleen Shelton | $372960 | $410300 | 10.0% |

---

#### **Annual Incentive** 
The annual incentive plan for executive officers is a cash plan that rewards NEOs for the achievement of key short-term objectives. Its structure aligns our NEOs' interests with those of our stockholders by providing incentives to the NEOs to achieve certain short-term financial and operational results that the Compensation Committee views as critical to the execution of our business strategy.

The amount of the annual incentive opportunity and payout for the NEOs is determined as follows:

##### **Target Opportunities** 
The Compensation Committee determines a target cash incentive opportunity by taking the individual's base salary and multiplying it by the individual's target incentive percentage. The target incentive percentages are determined with reference to the peer company percentages of salary and the proportion of TDC represented by the annual incentive, among other factors.

The target opportunity percentages for Messrs. Douglas and Pereira were increased to 130% from 125% and to 75% from 70%, respectively. The target opportunity percentages for the other NEOs remained unchanged from the prior year.

---

| | |
|:---|:---|
|  | **2022 Target Level** <br> **Opportunity**<br> **(as % of Applicable Base Salary)** |
| Mark Douglas | 130% |
| Andrew Sandifer | 85% |
| Ronaldo Pereira | 75% |
| Michael Reilly | 70% |
| Kathleen Shelton | 60% |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**40**

[Back to contents](#toc)

##### **Performance Measures** 
To determine payouts earned, the annual incentive plan has two categories of performance measures: a Company Measure and Individual Measures.

***Company Measure and Modifier for Messrs. Douglas, Sandifer and Reilly***

The Company Measure ("Business Performance Incentives," or "BPI"), which represents 70% of the annual incentive opportunity, is:

***Adjusted Earnings***

As it has for several years, the Compensation Committee determined to make Adjusted Earnings the Company-wide metric, in order to focus those executive officers on what the Compensation Committee believes is the most critical strategic priority of profitability.

---

| | |
|:---|:---|
| ![](lfmc025x35x1.jpg) | Adjusted Earnings is defined as net income (loss) attributable to FMC stockholders (a GAAP measure) plus the sum of discontinued operations attributable to FMC Stockholders, net of income taxes and the after-tax effect of Corporate special charges (income) and Non-GAAP Tax adjustments. |
| ![](lfmc025x35x1.jpg) | Adjusted Earnings amounts in the annual incentive plan might differ from the amounts reported in our financial statements because the amounts shown for these performance measures have been adjusted to exclude gains or losses attributable to (i) certain extraordinary and/or non-recurring events (such as business acquisitions or dispositions or business restructuring charges), and (ii) certain other items not reflective of operating performance (such as the impact of changes in accounting principles). |

---

The Compensation Committee defined a payout curve for the Adjusted Earnings metric which sets out the amount to be paid depending on actual performance. In order to motivate performance and underscore the centrality of achieving target, the Compensation Committee set the payout for achieving the threshold level of performance at 0%, with the payout increasing through various bend points to 100% of the target opportunity for achieving target performance, and through additional bend points to 200% of the target opportunity for maximum performance or above.

***Free Cash Flow***

The Compensation Committee also included again in 2022 a modifier in the design of the annual incentive. The Compensation Committee views the achievement of target performance with respect to free cash flow as critical, as the ability of the Company to generate cash is vital to funding operations and returning capital to shareholders, and it is something that is more directly within management's control. In addition to serving as a part of the annual incentive for the NEOs, the annual incentive program for a larger group of our senior leaders used the same or similar metrics, so that the full management team is aligned. The Compensation Committee added this modifier in part to motivate all of the members of this larger group to achieve the Free Cash Flow goal, and believes it was effective in doing so. Because of how critical it is to achieve cash flow performance within the target range, the modifier only applies if cash flow is either above a maximum level or below a threshold level. If cash flow achievement is either higher than the maximum or lower than the threshold, then the Committee applies a performance modifier factor of +10% or -10%, respectively, to the Company's Adjusted Earnings Company Measure Rating. The modifier does not apply when cash flow is at or above the threshold level but does not exceed the maximum amount.

We define free cash flow, a Non-GAAP financial measure, as all cash inflows and outflows excluding those related to financing activities (such as debt repayments, dividends, and share repurchases) and acquisition related investing activities. Free cash flow is calculated as all cash from operating activities reduced by spending for capital additions and other investing activities as well as legacy and transformation spending.

***Performance Goals for the Company Measure for Messrs. Douglas, Sandifer and Reilly***

***Target***

The Compensation Committee obtains input from executive officers regarding the annual operating plan, expected financial results, industry forecasts and related risks. Based on this information, the Compensation Committee establishes the targets for the annual incentive plan. For each metric, the Committee sets appropriate threshold and maximum levels of performance designed to motivate achievement without incentivizing excessive risk-taking.

In setting the target for the Company Measure, the Compensation Committee set it at a level that it considered rigorous and challenging, which took into account the relevant risks and opportunities. The target was set slightly above the prior year level of actual performance. It then reviewed the relevant financial objectives set as a result of the detailed budgeting process, and assessed various factors related to the achievability of the budget target.

These factors include:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Risks associated with achieving specific actions which underpin
 the budget target, such as achieving manufacturing targets, launching new products, completing capital investments on-schedule,
 taking inflation into account and obtaining cost savings;

**•** The implied performance relative to peers;

**•** The implied performance relative to prior years; and

**•** Market conditions.

***Threshold; Maximum***

Having set the targets, the Compensation Committee also set the threshold and maximum performance levels. For 2022, the Committee set the threshold level at a relatively high-performance level that equates to approximately 92% of the target for Adjusted Earnings. The Committee set the maximum level at a performance level that equates to approximately 107% of target for Adjusted Earnings, a level that presented a significant challenge requiring exceptionally strong performance.

The Compensation Committee assesses performance achievement against the performance metric and determines the rating, and then, based on the weighting, determines the results, which yields an overall BPI rating for this metric. The Company Measures (BPI) rating may range from 0 (at or below threshold) to 1.0 (target) to 2.0 (maximum).

***Determination of Performance***

In connection with the annual incentive program, the Compensation Committee monitors performance relative to established targets throughout the year. The Company's targets included a proportionate contribution from operations in Russia. In February 2022, Russia invaded Ukraine, and, in April 2022, our Board of Directors approved the termination of the Company's business and operations in Russia. The

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**41**

[Back to contents](#toc)

Company did not make changes to the design, metrics, or measurement periods of the incentive pay programs approved by the Committee at the beginning of 2022. In connection with the Board's decision to discontinue operations in Russia and in recognition that these events were beyond the control of the Company or management, while factoring in that the NEOs' efforts led to solid overall Company financial performance and total shareholder returns, the Compensation Committee determined to exclude the impact of the Company's exit from its Russia operations. This exclusion was a direct result of the decision to exit Russia and was not reflective of management performance. As such, the Company's Adjusted Earnings performance was $959 million, or a BPI Rating of 1.99, and the adjusted Cash Flow Modifier was $532 million, which triggered the 10% reduction. The Adjusted Earnings before this treatment would have been $938 million, or a BPI Rating of 1.77; the reduction for the Cash Flow Modifier would have been the same. These adjustments were made to both the annual incentive plan for the CEO and NEOs as well as for the broad-based annual bonus plans for eligible employees.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2022 Company Measures** | **2022 Company Measures** | **2022 Company Measures** | **2022 Company Measures** | **2022 Company Measures** | **2022 Company Measures** | **2022 Company Measures** |
| **Performance Metric** | **Below**<br> **Threshold**<br> **($ in millions)** | **Threshold**<br> **($ in millions)** | **Target**<br> **($ in millions)** | **Maximum**<br> **($ in millions)** | **Actual**<br> **Results<sup>(1)</sup>**<br> **($ in millions)** | **% Achievement<sup>(1)(2)</sup>** | **Equivalent**<br> **Company**<br> **Measures (BPI)**<br> **Rating** |
| Adjusted Earnings<sup>(2)</sup> | Less than 822 | 822 | 896 | 959 | 959 | 107 | 1.99 |
| *Percentage of Target* | *Less than ~92%* | *~92%* | *100%* | *~107%* |  |  |  |
| Payout Percentage | *0%* | *0%* | *100%* | *200%* |  |  |  |
| Cash Flow Modifier | *Less than 575* | 575 | *Between 575<br> and 675* | *More than 675* | 532 | (10)% | (.20) |
| BPI Rating Percentage | *(10)%* | *0%* | *0%* | *10%* |  |  |  |
| Final Company Measure (BPI) Rating |  |  |  |  |  |  | 1.79 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The amounts shown for the performance measure may differ from the amount reported
 in our financial statements because it has been adjusted to exclude gains or losses attributable to (i) certain extraordinary
 and/or non-recurring events (such as business acquisitions or dispositions or business restructuring charges), and (ii) certain
 other items not reflective of operating performance (such as the impact of changes in accounting principles).

(2) Adjusted Earnings: Payouts for performance over the applicable payout range between threshold
 and target and between target and maximum are determined based on a payout curve, as described in the section above entitled
 "Adjusted Earnings." No additional payout is made for Adjusted Earnings achievement in excess of $959 million.

***Company Measures for Dr. Shelton (Sole) and Mr. Pereira (Primary)***

The Company Measure (BPI), which represents the entire (100% of 70%, or 70% total) annual incentive opportunity for Dr. Shelton, our Chief Technology Officer, and half (50% of 70%, or 35% total) of the annual incentive opportunity for Mr. Pereira, our Executive Vice President and President, FMC Americas, is the following:

***Adjusted EBITDA***

The Compensation Committee used Adjusted EBITDA, a non-GAAP measure, as a performance metric in structuring the annual incentive for Dr. Shelton and Mr. Pereira. Adjusted EBITDA is defined as Income (loss) from continuing operations before income taxes, plus the sum of Corporate special (charges) income and Interest expense, net and total depreciation and amortization.

The Compensation Committee defined a payout curve for the Adjusted EBITDA metric which sets out the amount to be paid depending on actual performance; the curve is similar to the curve for Adjusted Earnings, with a threshold level of performance at 0% and the payout increasing through various bend points up to 100% of the target opportunity for achieving target performance, and through various bend points up to 200% for maximum performance or above.

***Free Cash Flow***

The Compensation Committee included the same modifier to the Adjusted EBITDA metric for Dr. Shelton and Mr. Pereira as was used with respect to the Adjusted Earnings metric for Messrs. Douglas, Sandifer and Reilly: Free Cash Flow.

***Performance Goal for Company Measure for Dr. Shelton and Mr. Pereira***

***Target***

In setting the target for this Company Measure, Adjusted EBITDA, the Compensation Committee set it at a level that it considered rigorous and challenging, which took into account the relevant risks and opportunities. The target was set at a 2% increase above the prior year level of actual performance.

***Threshold; Maximum***

Having set the target, the Compensation Committee also set the threshold and maximum performance levels. For 2022, the Committee set the threshold level at a relatively high-performance level that equates to approximately 94% of the target for Adjusted EBITDA. The Committee set the maximum level at a performance level that equates to approximately 105% of target for Adjusted EBITDA, a level that presented a significant challenge requiring exceptionally strong performance.

The Compensation Committee assesses performance achievement against the performance metric and determines the rating, including the effect of the modifier, which yields an overall BPI rating for this metric.

***Determination of Performance***

As disclosed above, the Compensation Committee determined to exclude the impact of the Company's exit from Russia. As such, the Company's Adjusted EBITDA performance was $1,434 million, or a BPI rating of 2.00, and the Cash Flow Modifier was $532 million, which triggered the 10% reduction. The Adjusted EBITDA before this treatment would have been $1,407 million, or a BPI Rating of 1.90; the reduction for the Cash Flow Modifier would have been the same.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**42**

[Back to contents](#toc)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2022 Company Measure: Dr. Shelton and Mr. Pereira** | **2022 Company Measure: Dr. Shelton and Mr. Pereira** | **2022 Company Measure: Dr. Shelton and Mr. Pereira** | **2022 Company Measure: Dr. Shelton and Mr. Pereira** | **2022 Company Measure: Dr. Shelton and Mr. Pereira** | **2022 Company Measure: Dr. Shelton and Mr. Pereira** | **2022 Company Measure: Dr. Shelton and Mr. Pereira** |
| **Performance Metric** | **Below**<br> **Threshold**<br> **($ in millions)** | **Threshold**<br> **($ in millions)** | **Target**<br> **($ in millions)** | **Maximum**<br> **($ in millions)** | **Actual**<br> **Results<sup>(1)</sup>**<br> **($ in millions)** | **% Achievement<sup>(1)(2)</sup>** | **Equivalent**<br> **Company**<br> **Measures (BPI)**<br> **Rating** |
| Adjusted EBITDA<sup>(2)</sup> | Less than 1,258 | 1258 | 1344 | 1417 | 1434 | 107 | 2.00 |
| *Percentage of Target* | *Less than ~95* | *~94%* | *100%* | *~105%* |  |  |  |
| Payout Percentage | *0%* | *0%* | *100%* | *200%* |  |  |  |
| Cash Flow Modifier | *Less than 575* | *575* | *Between 575 and 675* | *More than 675* | 532 | (10)% | (.20) |
| BPI Rating Percentage | *(10)%* | *(10)%* | *0%* | *10%* |  |  |  |
| Rating for Dr. Shelton and Mr. Pereira |  |  |  |  |  |  | 1.80 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The amounts shown for the performance measures may differ from the amount reported
 in our financial statements.

(2) Adjusted EBITDA: Payouts for performance over the applicable payout range between threshold
 and target and between target and maximum are determined based on a payout curve, as described in the section above entitled
 "Adjusted EBITDA." No additional payout is made for Adjusted EBITDA achievement in excess of $1,417 million.

***Additional Company Measure for Mr. Pereira***

In addition to Adjusted EBITDA, the other half of the Company Measure (35% of the total) for Mr. Pereira is represented by operating profitability for the geographic regions he oversees. The Compensation Committee utilized this measure in order to align the incentive for Mr. Pereira with his area of responsibility. This measure gives him a clear line of sight and sufficient control over the performance toward the goal to effectively motivate him to achieve our business objectives. (We do not publicly disclose the regional targets because of the potential for competitive harm from such disclosure, as they would provide our competitors with information about our strategy and profitability in subsets of our business that is not otherwise public, the revelation of which would be harmful to us.) The Compensation Committee believes that it has set the performance goal at a rigorous and challenging level so as to require significant effort and achievement to be attained. The Compensation Committee assesses Mr. Pereira's achievement against this performance metric and determines the rating. Like the other Company Measures, there are cash flow modifiers associated with the measure, similarly designed to motivate target cash flow achievement and to reward or penalize achievement outside the target range. The Compensation Committee then determined the weighted average of the rating on this measure, which has an aggregate 35% weighting (50% of 70%) and the rating given to the Adjusted EBITDA metric (35% weighting). Based on achievement on Adjusted EBITDA, very strong performance relative to the demanding regional operating profitability measure and the cash flow modifiers, the Compensation Committee determined an overall BPI rating for Mr. Pereira of 1.855 for the Company Measures.

***Individual Measures***

The Compensation Committee also considers Individual Measures ("Annual Performance Incentive," or "API"), which represent 30% of the annual incentive target opportunity. The Individual Measures generally consist of non-financial objectives specific to each NEO but may include financial measures at the discretion of the CEO. The non-financial objectives include measures that relate to our Sustainability objectives, including our Net Zero goal. In early 2022, the Board met with Mr. Douglas in his capacity as President and CEO, and Mr. Douglas met with the NEOs to discuss the specific items, and expectations of achievement, constituting the Individual Measures portion of the annual incentive for such individual executive officer.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement*&nbsp;&nbsp;&nbsp;&nbsp;**43**

[Back to contents](#toc)

The CEO's 2022 Individual Measures and performance with respect thereto resulting in the API rating set forth in the table below include the following:

---

| | | |
|:---|:---|:---|
|  | **Individual Measures** | **Performance** |
| **Mark Douglas** | • <u>Safety</u>: Drive TRIR <0.05% on the way to Zero injuries. Continue to drive process safety improvements and PHA plan | • TRIR at 0.0795. First calendar year with zero PS1 incidents. 26 cyclical PHAs completed, and 14 CDP PHAs completed |
|  | • <u>Strategy</u>: Develop process and timeline for next long-range plan; complete acquisition and integration of BioPhero; enhance sustainability work and progress the net zero strategy; complete relocation of Hong Kong operations to Singapore; expand ethics and compliance visibility and training; continue investment in FMC Ventures | • Launched and staffed the long-range plan initiative with a process in place to complete the work in the second-half of 2023<br> • BioPhero acquisition completed with integration on track, including first commercial sales<br> • Reduced our absolute scopes 1 and 2 emissions in our global operations and made improvements in waste metrics<br> • Successful relocation of Hong Kong operations with no business interruption<br> • Championed ethics and compliance training in all regions, delivered several ethics and compliance messages via global town halls<br> • Closed multiple investments in the biologicals space, actively partnered with portfolio companies to pilot and commercialize their technologies, continued growth of the ventures pipeline for future investment |
|  | • <u>People/DEI</u>: Take action to create opportunities and remove barriers for a more inclusive workplace and make progress towards the goals of 14% U.S. Black/African Americans and 50% women globally; continue to manage COVID impacts; executive training leadership program for senior executives; succession planning continued development | • Increased representation of women employees globally and Black/African American employees in the US<br> • Doubled the net gain of women employees compared to 2021<br> • Increased engagement in all underrepresented groups from the 2021 baseline<br> • Gender and Race Task Forces launched multiple initiatives to improve recruiting and retention<br> • Continued to support COVID-19 safety measures (especially in Asia), and flexible work opportunities in numerous locations<br> • Evaluating proposals for executive leadership programs<br> • Several key executive moves achieved via strong succession planning |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement***&nbsp;&nbsp;&nbsp;&nbsp;44**

[Back to contents](#toc)

In addition, Mr. Douglas as President and CEO established 2022 Individual Measures unique to each officer who serves on the Company's Operating Committee, including those NEOs set forth below, which is set forth together with their performance against such measures:

---

| | | |
|:---|:---|:---|
|  | **Individual Measures** | **Performance** |
| **Andrew Sandifer** | • <u>Safety</u>: Support delivery of <0.05 OII rate and journey to zero injuries | • Set tone for the top with high expectation for safety awareness<br> • Extra emphasis on safety during each site visit made in 2022<br> • No safety recordable incidents in CFO organization in 2022 |
|  | • <u>People/Diversity & Inclusion</u>: Take actions to support the Company's journey to increase global female and US African American employees in the workforce to 50% and 14% respectively, through focused recruiting, retention, and development efforts; reinforce use of diverse service providers | • Ensured diverse candidate and interview slates for all roles recruited in 2022<br> • Increased female representation to 46.5% in 2022 from 46.1% in 2021, with strongest gains in Corporate Strategy/Business Development<br> • Increased US B/AA representation to 8.6% in 2022 from 7.8% in 2021, with strong gains in core Finance areas offset somewhat by retrenchment in non-Finance areas<br> • Refreshed development planning for all CFO-2 level female leaders, progressing several to new positions both within and outside of CFO organization<br> • Renewed engagement for second year with Black-owned accounting firm for Benefit Plans audits |
|  | • <u>Strategy</u>: Drive further improvement in forecasting and management of free cash flow; ensure Corporate Business Development efforts drive broad-based business value; entrench gains in cybersecurity; capabilities and governance; complete first major upgrade of SAP S/4HANA system. | • Broadened inputs for cash flow forecasting process and reinforced cross-functional cash flow management team, delivering free cash flow above midpoint of updated guidance range despite unprecedented volatility and inflationary impacts on working capital<br> • BioPhero acquisition demonstrated value of early-stage investment as precursor to potential subsequent strategic action<br> • Formalized Cybersecurity Scorecard for review with Audit Committee<br> • Conducted integrated ransomware/business interruption table-top exercise<br> • Completed SAP upgrade with no interruptions while adding meaningful new capabilities |
|  | • <u>Organizational development:</u> | • Refreshed succession plans for all direct reports<br> • Drove a number of initiatives to better align country, regional, and shared service teams to improve effectiveness of Finance Service Delivery Model<br> • Realigned roles and responsibilities across IT and Business Process Governance and Improvement organizations for greater clarity and impact |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement***&nbsp;&nbsp;&nbsp;&nbsp;45**

[Back to contents](#toc)

---

| | | |
|:---|:---|:---|
|  | **Individual Measures** | **Performance** |
| **Ronaldo Pereira** | • <u>Safety</u>: Drive OII rate to <0.05 on the journey to zero injuries, with particular focus on preventing driving accidents | • Two recordable incidents in 2022 in the Americas with no lost working days<br> • More than 300 drivers were trained on behind-the-wheels defensive driving<br> • All country leaders have individual goals related to the safety performance of their corresponding organizations |
|  | • <u>People/Diversity & Inclusion:</u> Take actions to support the Company's 2022 goal to achieve 50% female and 14% US Black/African American representation in the workforce by 2027, through creating opportunities and removing barriers to a more inclusive workplace; ensure smooth transition on various OC-1 transitions without disruption for the business | • Continued to make progress leading the Social Justice and Race Equity task force<br> • Engagement of US Black/African American employees improved by 11% vs. 2021 as measured by employee survey<br> • The Black/African American representation in the commercial organization grew by 3 employees (net), while the total net addition in the US was 14 employees, increasing total representation from 9.6% to 10.1%<br> • Increased female representation in the commercial teams across the Americas, with a net addition of 39 female employees<br> • Ensured smooth transition on the leadership positions in the Southern Cone, US Crop and Canada with no impact on the business results |
|  | • <u>Strategy</u>: Increase demand generation in US Crop by establishing close relationships with key retailers; review and improve go-to-market strategy in Brazil; successfully integrate BioPhero into the Plant Health structure | • Successful implementation of a territory-by-territory analysis that led to increase in field personnel (sales and technical service), improving our service and relationship with key retailers and driving an increase in EDI (2022 was a record year for moving products through the distribution channel)<br> • Strategy review concluded; sales force was increased and adjusted to support sales to key cooperatives and end-users<br> • BioPhero integration 2022 milestones completed; new pheromone targets were identified, becoming new projects in full alignment with FMC's target business areas<br> • Extensive training and on-boarding program for the new employees (US Crop expanded field personnel, legacy BioPhero employees), with focus on processes and polices as well as our culture, ensuring a smooth integration and full alignment to FMC standards<br> • Succession planning in place for all direct reports and mission critical roles<br> • Development plan in place for next leaders and minority employees, ensuring focus and fairness in their career development opportunities |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement***&nbsp;&nbsp;&nbsp;&nbsp;46**

[Back to contents](#toc)

---

| | | |
|:---|:---|:---|
|  | **Individual Measures** | **Performance** |
| **Michael Reilly** | • <u>Safety</u>: Demonstrate leadership in support of TRIR <0.05, driving to Zero injuries | • Demonstrated consistent emphasis safety within its own organization and also supported corporate/business initiatives on safety, including particularly the "Focus" initiative<br> • No safety recordables on the legal team |
|  | • <u>People/Diversity & Inclusion:</u> Take actions to support the Company's 2022 goal to increase global female and US Black/African American employees in the workforce, through creating opportunities and removing barriers to a more inclusive workplace; advance succession planning for all department leadership roles | • Law department is a diverse team, with a very strong cadre of female leaders all around the world, and an overall female representation of 70+%<br> • Served as executive sponsor of employee resource group and sponsor of several female or ethnically diverse employees<br> • Drove initiatives to improve female and ethnic/racial diversity in leading outside law firms<br> • Succession planning on track for all key legal roles |
|  | • <u>Strategy</u>: Drive effective and efficient legal enforcement of diamides IP; as well as effective legal support of regulatory and commercial components of diamides strategy; drive effective legal support and execution of M&A projects | • Many successful litigation and other legal-driven accomplishments re: diamides enforcement throughout 2022<br> • New or amended important diamide commercial agreements achieved with key partners<br> • Key role in the acquisition and integration of BioPhero and other Plant Health initiatives, and 2022 projects have delivered more effective legal support on Precision Ag, Ventures, and Sustainability |
|  | • <u>Core Values — Compliance & Ethics, Integrity:</u> Lead overall compliance efforts in the Company, including working with Internal Audit, Comms, Finance and other functions on enhanced communications, training and auditing of key elements of compliance programs | • Communications and other awareness processes led to significantly increased use of Ethics Response Line, which have been handled by the Ethics Office to address all reported concerns<br> • Led extensive training on compliance issues took place in all regions throughout the world, with strong engagement from business management as well legal and compliance teams<br> • Partnered with Internal Audit and external resources, the Ethics Office undertook risk-based assessments of several processes<br> • Compliance processes were strengthened during 2022 |
|  | • <u>General Sustainability</u>: Support Sustainability efforts on key actions aligned with ESG goals, including particularly communications with investors or other stakeholders regarding governance elements of ESG | • Participated in the successful 2022 stockholder outreach which highlighted FMC's Sustainability program, covering governance processes |
|  | **Individual Measures** | **Performance** |
| **Kathleen Shelton** | • <u>Safety</u>: TRIR <0.05% at Stine site for Global R&D | • Injury-free year at FMC Stine site<br> • Surpassed one million injury-free hours worked by both contractors and FMC employees<br> • Stine site was certified by third-party auditor under the Responsible Care Management Systems |
|  | • <u>Strategy</u>: Further integration and combined efforts of Plant Health and Synthetic Chemistry R&D efforts across the portfolio and execution of third-party efforts to continue for integration of new technologies; advance one molecule from discovery to development and assure development pipeline advances as planned for 2022; and develop short-term and long-term plan to improve data analysis and tools for advanced uses of data | • Efforts on multiple third parties are being executed with cross functional teams, specifically over 150 opportunities were identified, over 100 companies were assessed, and due diligence was conducted on 11 companies, with 4 new research agreements signed<br> • BioPhero integration 2022 milestones completed<br> • Advanced a new active ingredient in July with the scope of each development molecule being fulfilled as planned for 2022<br> • Continued engagements with external partners to bring new tools to FMC<br> • Work with a key partner over the past year has led to a set of projects that are enabling a higher level of computer science and synthesis of information |
|  | • <u>Diversity and Inclusion</u>: Executive sponsor of Women's Initiative Network (WIN), an employee resource group, and the female engagement team to motivate and retain women across FMC; drive attainment of increased diversity through stronger connections to universities with strong talent pipelines | • WIN has maintained its momentum and added new initiatives to its work across FMC<br> • Diversity, engagement and inclusion events were held at Stine, with local universities participating in the poster sessions<br> • Continuing to work closely with Delaware State and with University of Delaware, notably as first corporate sponsor for University of Delaware's "Ag Day" |
|  | • <u>Core Values</u>: Active communication on key priorities including safety, sustainability, FMC pipeline and core values | • Utilized both internal and external opportunities to engage with key stakeholders, to share context and gain more engagement<br> • Featured as key-note speaker at the Delaware Chamber's annual dinner |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement***&nbsp;&nbsp;&nbsp;&nbsp;47**

[Back to contents](#toc)

For Individual Measures, the Compensation Committee assesses performance achievement against goals and determines the individual performance rating on each individual objective, and then, based on the weighting given to each goal, determines the weighted average of the results, which yields an overall individual rating. The Individual Measures rating may range from 0 to 2.0. The Compensation Committee determined that for 2022, Mr. Douglas received a 1.60 rating, Mr. Sandifer received a 1.55 rating, Mr. Pereira received a 1.65 rating, Mr. Reilly received a 1.25 rating and Dr. Shelton received a 1.50 rating.

##### **Payout Calculation** 
Finally, the Compensation Committee takes 70% of the target cash incentive opportunity of each executive officer for the Company Measures component and multiplies it by the applicable Company Measures ratings for the applicable performance metrics to determine the Company Measures amount to be paid. Similarly, the Compensation Committee takes 30% of the target cash incentive opportunity of each executive officer for the Individual Measures component and multiplies it by the applicable Individual Measures rating to determine the Individual Measures amount to be paid.

The Compensation Committee then adds the amounts for the Company Measures component and the Individual Measures components to determine the total 2022 annual incentive payout for each NEO. The Compensation Committee then presents the determination of incentive payout amounts to the Board for its review and approval.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **NEO** | **Target<br> Incentive** | **Company<br> Measures<br> (BPI):<br> 70% of<br> Target<br> Incentive** | **Company<br> Measures<br> Rating** | **Company<br> Measures<br> Incentive<br> Payout<br> Amount** | **Individual<br> Measures<br> (API)<br> 30% of<br> Target** | **Individual<br> Measures<br> (API)<br> Rating** | **Individual<br> Measures<br> Incentive<br> Payout<br> Amount** | **Total 2022<br> Incentive<br> Payout<br> Amount** |
| Mark Douglas | $1495000 | $1046500 | 1.79 | $1873235 | $448500 | 1.60 | $717600 | $2590835 |
| Andrew Sandifer | $581740 | $407218 | 1.79 | $728920 | $174522 | 1.55 | $270509 | $999429 |
| Ronaldo Pereira | $350400 | $245280 | 1.855 | $454994 | $105120 | 1.65 | $173448 | $628442 |
| Michael Reilly | $386190 | $270333 | 1.79 | $483896 | $115857 | 1.25 | $144821 | $628717 |
| Kathleen Shelton | $246180 | $172326 | 1.80 | $310187 | $73854 | 1.50 | $110781 | $420968 |

---

#### **Long-Term Incentives** 
The third and largest main component of the executive compensation program is long-term equity incentives. The Compensation Committee has designed the long-term incentive opportunity to motivate and reward executive officers to achieve multiyear strategic goals and deliver sustained long-term value to stockholders.

In 2022, long-term incentives ("LTI") were granted to executives via three different vehicles: performance-based restricted stock unit awards, stock options and time-based restricted stock unit awards.

The Compensation Committee believes that LTI awards should compensate NEOs, in a meaningful way, for delivering sustainable long-term value to stockholders. LTI awards for the NEOs, except for the CEO, are recommended by the CEO and approved by the Compensation Committee. The LTI awards for the CEO are recommended by the Compensation Committee and approved by the full Board of Directors. All LTI awards are approved during the February meetings of the Compensation Committee and the Board.

Generally, LTI grants vest based on Company performance and/or the NEO's continued service over a three-year period, except that NEO grants vest sooner in certain retirement-eligible situations. Unvested LTI grants are generally forfeited upon a cessation of service, but in certain scenarios, awards may vest upon or following a termination, as further described in the "Potential Payments Upon Termination or Change in Control" section of this proxy statement.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement***&nbsp;&nbsp;&nbsp;&nbsp;48**

[Back to contents](#toc)

**2022 LTI VEHICLE MIX**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Equity Vehicle** | **2022 Allocation** | **Performance Metric;** <br> **How Payouts Are** <br> **Determined** | **Performance** <br> **Period; Vesting** <br> **Period** | **Rationale for Use** |
| **Performance-Based Restricted Stock Units (PRSUs)** | 50% (CEO);<br> 40% (NEOs) | • 70%: Relative TSR | • 25% three-year period,<br>• 25% each individual 1-year period | • Links with stockholder value creation<br>• Aligns with stockholders<br>• Filters out macroeconomic and other factors not within management's control |
|  |  | • 30%: three-year cumulative operating cash flow | • Three-year period | • Aligns with operational focus on returning cash to stockholders<br>• Aligns with role of cash flow as a key driver of long-term value<br>• Gives management more direct control over outcome |
| **Stock Options** | 30% (CEO and NEOs) | • Share price appreciation | • Three-year cliff vesting<br>• Exercise price: closing price on grant date<br>• 10-year term | • Prioritizes increasing stockholder value<br>• Promotes long-term focus |
| **Time-Based Restricted<br> Stock Units (RSUs)** | 20% (CEO); <br> 30% (NEOs) | • Value of stock | • Three-year cliff vesting | • Aligns with stockholders<br>• Promotes retention and reinforces ownership culture<br>• Provides value even during stock price or market underperformance |

---

The target values for the annual LTI awards granted in February of 2022 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **NEO** | **PRSUs ($)** | **Options ($)** | **RSUs ($)** | **Total ($)** |
| Mark Douglas | 3000000 | 1800000 | 1200000 | 6000000 |
| Andrew Sandifer | 632760 | 474570 | 474570 | 1581900 |
| Ronaldo Pereira | 319920 | 239940 | 239940 | 799800 |
| Michael Reilly | 319920 | 239940 | 239940 | 799800 |
| Kathleen Shelton | 199640 | 149730 | 149730 | 499100 |

---

##### **Performance-Based Restricted Stock Unit Awards** 
Performance-based awards are granted in the form of performance-based restricted stock units. The Compensation Committee believes that having share-based performance awards closely aligns pay with performance in the interests of the stockholders.

The number of performance-based restricted stock units earned is based on our achievement against two performance metrics, Relative TSR and three-year cumulative operating cash flow. The Compensation Committee utilized these two in order to focus executive officers on the critical strategic priorities of generating superior stockholder returns and generating long-term cash flow. Relative TSR represents 70% of overall performance, and three-year cumulative operating cash flow represents 30%. The Compensation Committee considers both metrics as building blocks to achieve our key strategic goals.

***Relative TSR***

The Compensation Committee has selected relative TSR because it ties executive officer compensation to the creation of stockholder value and aligns the interests of executive officers with those of our stockholders. By measuring our stock performance relative to peers, it mitigates the impact of macroeconomic factors, both positive and negative, that affect the industry and/or stock price performance and are beyond the control of management, and it provides rewards that are more directly aligned with performance through different economic cycles.

With respect to the relative TSR portion, following the same approach as last year and in an effort to maintain a consistent and robust peer group of relevant performance peers, the 2022-2024 peer group reflects all companies included in the S&P 1500 Composite Chemical Index plus select additional chemical company peers, including companies not included in the index but a part of the Company's compensation peer group, as described above. The 2022-2024 peer group differs from the 2021-2023 peer group due to changes in the companies included in the S&P 1500 Composite Chemical Index and a change in the companies included in the FMC compensation peer group, as described above.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***49**

[Back to contents](#toc)

---

| | |
|:---|:---|
| AdvanSix Inc. | Ingredion Incorporated |
| Air Products and Chemicals, Inc. | Innospec Inc. |
| Akzo Nobel N.V. | International Flavors & Fragrances, Inc. |
| Albemarle Corporation | Koppers Holdings, Inc. |
| American Vanguard Corporation | Kraton Corporation |
| Ashland Global Holdings Inc. | Linde plc |
| Avient Corporation | Livent Corporation |
| Axalta Coatings Systems Ltd. | LyondellBasell Industries N.V. |
| Balchem Corporation | Minerals Technologies, Inc. |
| BASF SE | The Mosaic Company |
| Cabot Corporation | NewMarket Corporation |
| Celanese Corporation | Nutrien Ltd. |
| CF Industries Holdings, Inc. | Olin Corporation |
| The Chemours Company | PPG Industries, Inc. |
| Dow Inc. | Quaker Chemical Company |
| DuPont de Nemours, Inc. | Rayonier Advanced Materials, Inc. |
| Eastman Chemical Company | RPM International, Inc. |
| Ecolab, Inc. | The Scotts Miracle-Gro Company |
| Ferro Corporation | Sensient Technologies Corporation |
| FutureFuel Corp. | The Sherwin-Williams Company |
| GCP Applied Technologies Inc. | Stepan Company |
| H. B Fuller Company | Tredegar Corporation |
| Hawkins, Inc. | Trinseo S.A. |
| Huntsman Corporation | Valhi, Inc. |
| Ingevity Corporation | Valvoline |
|  | Westlake Chemical Corporation |

---

In 2022, the Compensation Committee again selected relative TSR to incentivize management to achieve long-term stockholder returns and to reflect relative performance, not merely broad stock market moves. This metric also directly aligns management with stockholder interests. Relative TSR performance is calculated as four point-to-point measurements from 2022 to 2024. TSR performance is calculated for each of the three calendar years, as well as for the three-year period as a whole. Each of these four measurement periods carries a weight of 25% in calculating the final number of shares due. When the performance measure has been met for a particular calendar year during the three-year period of the award, that portion of units is "banked", but is not considered "earned" and shares will not be delivered unless and until the executive remains in service for the three-year performance period (except in certain circumstances as described below under the heading entitled "Potential Payments Upon Termination or Change in Control") and the performance is approved by the Compensation Committee. In addition, if cash dividends were paid to the Company's stockholders during the applicable measurement period, dividend equivalent units are credited with respect to the banked units and are delivered to the executive if and when the banked units are delivered.

Any value earned by executives for these awards is based on the Company achieving a relative performance measure of TSR at or above the 35<sup>th</sup> percentile (the threshold), and units will be banked as set forth in the table below.

---

| | | |
|:---|:---|:---|
| **Level** | **Percentile Ranking of Company's Total Stockholder Return**<br> **Versus Peer Group Total Stockholder Return** | **Percentage of the Target Units Banked** |
| Below Threshold | Below the 35<sup>th</sup> Percentile | 0% |
| Threshold |  | 50% |
| Target |  | 100% |
| Maximum |  | 200% |

---

If the cumulative three-year TSR performance for the period is negative, that portion (25%) of the payout is capped at 100% (target). For example, in the event of a broad and protracted market downturn, if the Company's cumulative three-year TSR performance is negative, but still superior to most of the peer group, the payout for the three-year measurement period will be limited to target (even though performance in that scenario would have exceeded target). The Compensation Committee believes it is appropriate to limit the payout in such circumstances, notwithstanding relative outperformance.

The Compensation Committee believes that the increasing cyclicality of the Company's business – particularly given its status as a 100% agricultural sciences company following the separation of its Lithium business in 2019 – and the difficulty of finding peers with the same type of industry exposure, necessitate both a payment for performance beginning at the 35% TSR percentile, and a system for banking payouts based in part on one-year periods with a continuing service condition.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***50**

[Back to contents](#toc)

***Cumulative Three-Year Operating Cash Flow***

Beginning in 2019, the Compensation Committee added "Three-Year Cumulative Operating Cash Flow" as a performance metric, representing 30% of the performance-based RSUs. This metric was added because it is highly aligned with our strategy for creating stockholder value, including our operational focus on returning cash to stockholders, it is something over which management has substantial control, and it unites management toward a common goal.

Operating Cash Flow is calculated as Adjusted EBITDA plus or minus the change in working capital. The change in working capital is defined as the sum of (a) trade receivables (net), (b) guarantees of vendor financing, (c) inventories, (d) accounts payable (trade and other), (e) advance payments from customers, and (f) accrued customer rebates, each as reported in the Company's consolidated statements of cash flow for the relevant year. Three-Year Operating Cash Flow will be the sum of Operating Cash Flow of each individual year in the three-year period. The performance period for the 2022 award runs from January 1, 2022 through December 31, 2024.

We do not publicly disclose our specific performance measure targets and the corresponding minimums and maximums before the conclusion of the three-year performance period, because of the potential for competitive harm from such disclosure. This measure is competitively sensitive and would reveal information about our view of our anticipated trajectory, which is not otherwise public. The Compensation Committee believes that it has set the performance goal at a rigorous and challenging level so as to require significant effort and achievement by our executive officers to be attained, and that such goal has been established in light of the macroeconomic and industry environments, as well as our internal forecast. After the end of the performance period, the targets and achievement relative to such targets will be disclosed.

The Compensation Committee granted the following number of performance-based restricted stock units to the NEOs in early 2022:

---

| | |
|:---|:---|
| NEO | **PRSUs (#)** |
| Mark Douglas | 26874 |
| Andrew Sandifer | 5669 |
| Ronaldo Pereira | 2869 |
| Michael Reilly | 2869 |
| Kathleen Shelton | 1,789 |

---

***Performance Periods Completed as of 2022 Year End***

Below are the performance results for performance-based RSU performance periods that closed on or before December 31, 2022.

 ****

***2020-2022 Performance-Based RSU Awards***

For the 2020-2022 performance periods, the Company's relative TSR performance was as follows, resulting in a payout at 122.5% of target:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **TSR** | **Peer Group<sup>†</sup>** | **Target** | **Target** | **Target** | **TSR** |
| **Measurement Periods** | **Performance** | **Percentile** | **0.0** | **1.0** | **2.0** | **Rating** |
| 2020-2022 Grant Year 1 (2020 TSR) | 16.00% | 66.0% | 35% | 50% | 80% | 1.53 |
| 2020-2022 Grant Year 2 (2021 TSR) | (5.93)% | 13.5% | 35% | 50% | 80% | 0.00 |
| 2020-2022 Grant Year 3 (2022 TSR) | 16.77% | 87.8% | 35% | 50% | 80% | 2.00 |
| 3 Year TSR 2020-2022 | 31.91% | 61.2% | 35% | 50% | 80% | 1.37 |
| *Total* |  |  |  |  |  | 122.50 |

---

<sup>†</sup> As described above, peer group composition varies by grant year.

For the 2020-2022 performance period, the Company's cumulative operating cash flow performance was as follows, resulting in a payout at 84% of target:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2020-2022 Measurement Period** | **2020-2022 Measurement Period** | **2020-2022 Measurement Period** | **2020-2022 Measurement Period** | **2020-2022 Measurement Period** | **2020-2022 Measurement Period** | **2020-2022 Measurement Period** |
| **Performance Metric** | **Below** <br> **Threshold** <br> **($ in millions)** | **Threshold** <br> **($ in millions)** | **Target** <br> **($ in millions)** | **Maximum** <br> **($ in millions)** | **Actual** <br> **Results** <br> **($ in millions)** | **% Achievement** | **Rating** |
| Cumulative Three-Year<br> Operating Cash Flow | Less than 3,000 | 3000 | 3602 | 4052 | 3475 | 96% | 0.84 |
| *Percentage of Units Earned <sup>(1)</sup>* | *0*% | *25*% | *100*% | *200*% |  |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Payouts for performance between the levels set forth above will be ratably interpolated. No additional
 payout is made for Cumulative Operating Cash Flow achievement in excess of $4,052 million.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***51**

[Back to contents](#toc)

***2021-2023 Performance-Based RSU Awards***

For the performance periods of 2021 and 2022, the Company's relative TSR performance was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **TSR** | **Peer Group<sup>†</sup>** | | **Target** | **Target** |  |
| **Measurement Periods** | **Performance** | **Percentile** | **0.0** | **1.0** | **2.0** | **TSR Rating** |
| 2021-2023 Grant Year 1 (2021 TSR) | (5.93)% | 13.5% | 35% | 50% | 80% | 0.00 |
| 2021-2023 Grant Year 2 (2022 TSR) | 16.77% | 89.8% | 35% | 50% | 80% | 2.00 |

---

<sup>†</sup> As described above, peer group composition varies by grant year.

 ****

***2022-2024 Performance-Based RSU Awards***

For the 2022 performance period, the Company's relative TSR performance was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **TSR** | **Peer Group<sup>†</sup>** | | **Target** | **Target** |  |
| **Measurement Periods** | **Performance** | **Percentile** | **0.0** | **1.0** | **2.0** | **TSR Rating** |
| 2022-2024 Grant Year 1 (2022 TSR) | 16.77% | 89.8% | 35% | 50% | 80% | 2.00 |

---

<sup>†</sup> As described above, peer group composition varies by grant year.

##### **Stock Option Awards and Time-Based Restricted Stock Unit Awards** 
In addition to motivating performance through the performance-based restricted stock units, the Committee structured the balance of the equity vehicles and the relative weight assigned to each type (1) to motivate stock price appreciation over the long term through stock options, which deliver value only if the stock price increases, and (2) to ensure some amount of value delivery through time-based restricted stock units, which are complementary because they have upside potential but deliver some value even if the stock price does not go up, while also reinforcing an ownership culture and commitment to us.

Stock options cliff-vest after three years, which reinforces the creation of sustainable long-term stockholder value and promotes retention.

In determining the number of options required to meet the compensation level approved for an NEO, the Company divides that portion of the Compensation Committee-approved LTI award value related to stock options by the fair value of the option based on a Black-Scholes pricing model calculation using a 30-day average stock price for the period immediately preceding the February meeting of the Compensation Committee.

The exercise price of all stock option awards to NEOs is equal to the closing price of the Company's stock on the date of the grant.

Time-based restricted stock units also cliff-vest after three years.

In determining the amount of restricted stock units required to meet the compensation level approved for an NEO, the Company divides that portion of the LTI award value related to restricted stock units for that year by a 30-day average stock price for the period immediately preceding the February meeting of the Compensation Committee. During the vesting period, if cash dividends are paid to the Company's stockholders, the NEO will generally receive a special cash payment equal to the amount the NEO would have received had the NEO been the record holder of the shares underlying the RSUs when the dividend was declared and paid.

Generally, once the vesting condition is satisfied, the shares, less any shares used to satisfy statutory tax withholding obligations, are issued to the NEO.

#### **Additional Compensation Policies and Practices** 

##### **Executive Stock Ownership Policy** 
The Company has established guidelines setting expectations for the ownership of Common Stock by executive officers, which were most recently amended and restated on December 14, 2022. The ownership targets are as follows:

---

| | |
|:---|:---|
| Position | **Guideline Salary Multiple** |
| Chief Executive Officer | 6x base salary |
| Chief Financial Officer | 3x base salary |
| All other Executive Officers | 2x base salary |

---

These ownership guidelines are reviewed against our peer company practices and, if necessary, adjusted every other year in conjunction with the formal market study of executive compensation. Generally, shares owned directly or beneficially by an executive or the executive's family, and shares held through Company qualified and non-qualified plans, count for purposes of compliance. Outstanding equity incentive awards under our current LTI program that count toward the guidelines are time-based restricted stock units and performance-based restricted stock units that have been earned (i.e., applicable performance conditions have been satisfied), in each case whether or not subject to continued time-based vesting conditions. Unexercised stock options, including vested in-the-money options, are not counted for purposes of compliance and performance-based restricted stock/restricted stock units that are unearned (i.e., performance-based awards for which the applicable performance conditions have not been satisfied) are not counted for purposes of compliance.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***52**

[Back to contents](#toc)

Executives have a phase-in period of up to five years from the date of their appointment or promotion to meet the guidelines. A retention requirement applies during the phase-in period until the executive meets the applicable guideline, which generally restricts the executive from selling more than 50% of the shares received in connection with equity incentive awards. The Compensation Committee will determine the consequences for each executive that fails to be in compliance with the applicable guideline on the measurement date, and retains the discretion to grant exceptions to the guidelines if an executive, due to unique circumstances, would incur a hardship by complying.

As of December 31, 2022, all NEOs who were required to be in compliance with the Executive Stock Ownership Policy were in compliance.

#### **Anti-Hedging and Anti-Pledging Policies** 
The Company considers it inappropriate for directors and officers to engage in certain transactions related to the securities of the Company which could result in their interests no longer being aligned with the interests of other stockholders of the Company. Therefore, its securities trading policy and Anti-Hedging Policy restrict these persons from hedging and pledging the Company's Common Stock.

The restrictions apply to all of the Company's directors and executive officers and to immediate family members residing in their households (the "insiders"), to trusts maintained for the principal benefit of an insider, and to other entities (such as partnerships or corporations) which are effectively controlled by an insider.

##### **Hedging** 
Certain hedging and monetization transactions, such as zero-cost collars and forward sale contracts, allow an investor to lock in much of the value of the investor's stock holdings and provide protection from decreases in the value of the stock and also limit or eliminate the investor's ability to profit from an increase in the value of the stock. These transactions can therefore cause an investor's interests to be misaligned with other stockholders of the Company. Accordingly, the Company prohibits insiders from engaging in any hedging transactions, including short sales and monetization transactions involving options, puts, calls, prepaid variable forward contracts, equity swaps, collars and exchange funds or other derivatives, that are designed to hedge or speculate on any change in the market value of Common Stock. The Company further prohibits any transaction that would directly or indirectly reduce the risk of holding Common Stock.

##### **Pledging** 
The Company prohibits insiders from pledging or creating a security interest in the Common Stock, including by purchasing Common Stock on margin or holding Common Stock in a margin account.

#### **Clawback Policy** 
The Company has adopted a clawback policy designed to recoup incentive compensation paid to executive officers based on erroneously prepared financial statements. If an accounting restatement is required because of material non-compliance with any financial reporting requirement, all incentive compensation paid or credited to each current or former executive officer for the restated period (up to three years) will be recalculated based on restated results. To the extent the recalculated incentive compensation is less than the incentive compensation actually paid or credited to such executive officer for that period, the excess amount must be forfeited or returned to the Company. Alternatively, the Company is authorized to offset the forfeitable amount from compensation owed currently or in the future to such executive officer. The Compensation Committee is authorized to interpret this policy and make all determinations necessary for the policy's operation.

The Committee is reviewing the final rule adopted by the SEC that implements the applicable provision of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the NYSE's related proposed listing standard, in each case relating to recoupment of incentive-based compensation. The Company will amend its clawback policy in accordance with the new listing standard when the new listing standard becomes final.

In addition to FMC's Clawback Policy, FMC's Incentive Compensation and Stock Plan includes a provision that allows the Company to effectuate a clawback in the event of serious misconduct or competitive activity by the recipient of an equity award.

#### **Risk Assessment** 
The Compensation Committee has determined, based in part on an assessment of the Company's executive compensation programs by its consultant, that its compensation policies and programs do not give rise to inappropriate risk taking or risks that are reasonably likely to have a material adverse effect on the Company.

#### **Tax Deductibility of Executive Compensation** 
Generally, a public company cannot deduct compensation in excess of $1 million paid in any year to a Company's chief executive officer, chief financial officer and the three other most highly compensated officers. Traditionally, certain "qualified performance-based compensation" was not subject to this $1 million limitation. 2017 tax reform, however, eliminated the "qualified performance-based compensation" exemption. Nevertheless, our Compensation Committee continues to view pay for performance as an important part of our executive compensation policy. The Compensation Committee, after considering the potential impact of the application of this Section 162(m) of the Code, may provide compensation to executive officers that may not be tax deductible if it believes that providing that compensation is in the best interests of the Company and its stockholders.

#### **Potential Benefits Related to Change in Control or NEO Termination** 
The Compensation Committee believes that the long-term interests of stockholders are best served by providing reasonable income protection for NEOs to address potential change in control situations in which they may otherwise be distracted by their potential loss of employment in the event of a successful transaction. The Company has entered into an executive severance agreement with each NEO that provides certain financial benefits in the event of a change in control. These are "double trigger" arrangements –i.e., severance benefits under these arrangements are only triggered by a qualifying event (see section of this proxy statement entitled "Potential Payments Upon Termination

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***53**

[Back to contents](#toc)

or Change in Control") that also results in the executive's termination of employment under certain specified circumstances within 24 months following the event. Likewise, unless the Board decides otherwise, upon a change in control, the vesting of otherwise unvested LTI awards will accelerate only upon the occurrence of a termination of employment in connection with the change in control. The Compensation Committee also determined that, beginning in 2010, the Company would not enter into any agreements to pay an additional cash amount to cover any excise or similar tax under Section 4999 of the IRC (an "excise tax gross-up") in respect of any of the benefits subject to such excise taxes for any individual newly eligible for a change-in-control agreement. None of the NEOs have an entitlement to an excise tax gross-up. In addition, the Compensation Committee has approved severance guidelines applicable to the NEOs in the event of the termination of their employment unrelated to a change in control, which are intended to provide reasonable transition assistance. The details of all of the above-described benefits are set forth in the section of this proxy statement entitled "Potential Payments Upon Termination or Change in Control".

#### **Pension Benefits** 
Only Mr. Reilly is eligible for retirement benefits under (i) a qualified defined benefit plan (the "Qualified Plan") available on a non-discriminatory basis to all U.S.-based employees hired before July 2007 who meet the service criteria; and (ii) a nonqualified defined benefit plan (the "Nonqualified Plan"), which is designed to restore the benefits that would have been earned under the Qualified Plan, absent the limits placed by the Internal Revenue Code. The details of these defined benefit plans are set forth in the 2022 Pension Benefits Table and the narrative that follows it.

#### **Perquisites and Other Personal Benefits** 
We do not generally provide our executive officers, including the NEOs, with perquisites or other personal benefits, except for financial planning, reserved parking, tax preparation and, in the case of the CEO, use of corporate aircraft and a club membership. We do provide benefits to executives who relocate internationally, including tax preparation, relocation and support services, and related tax gross-ups. The goal of these benefits is that the employee not be financially advantaged or disadvantaged as a result of relocating to another country and incurring associated taxes. These items are provided because we believe that they support our executive officers, serve a necessary business purpose and enable us to be competitive, and because the related amounts of compensation are not material to the overall executive compensation program. The incremental costs of these items are reported in the Summary Compensation Table.

## **Compensation and Organization Committee Report** 
This Compensation and Organization Committee Report shall not be deemed to be incorporated by reference into any filing made by the Company under the Securities Act of 1933 or the Exchange Act, notwithstanding any general statement contained in any such filing incorporating this proxy statement by reference, except to the extent the Company incorporates such Report by specific reference.

The Compensation and Organization Committee has reviewed and discussed the Compensation Discussion and Analysis with the management of the Company. Based on this review and these discussions, we have recommended to the Board of Directors that the Compensation Discussion and Analysis be included in the Company's Annual Report on Form 10-K and the Company's proxy statement.

The preceding report has been furnished by the following members of the Compensation and Organization Committee:

K'Lynne Johnson, *Chair*

Kathy L. Fortmann

Dirk A. Kempthorne

Paul J. Norris

Vincent R. Volpe, Jr.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***54**

[Back to contents](#toc)

## **Executive Compensation Tables** 
**SUMMARY COMPENSATION TABLE 2022**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position <br> (a)** | **Year <br> (b)** | **Salary<br> ($)<br> (c)** | **Bonus <br> ($)<br> (d)** | **Stock**<br> **Awards**<sup>(1)(2)</sup><br> **($)**<br> **(e)** | **Option**<br> **Awards**<sup>(1)</sup><br> **($)**<br> **(f)** | **Non-Equity**<br> **Incentive Plan**<br> **Compensation**<sup>(3)</sup><br> **($)**<br> **(g)** | **Change**<br> **In**<br> **Pension**<br> **Value<sup>(4)</sup>**<br> **($)**<br> **(h)** | **All Other**<br> **Compensation**<sup>(5)</sup><br> **($)**<br> **(i)** | **Total<br> ($)<br> (j)** |
| MARK DOUGLAS | 2022 | 1138125 |  | 5038115 | 1879021 | 2590835 | N/A | 423803 | 11069899 |
| &nbsp;&nbsp;&nbsp;President and | 2021 | 1089375 |  | 3296620 | 1426937 | 2320763 | N/A | 355976 | 8489671 |
| &nbsp;&nbsp;&nbsp;Chief Executive Officer | 2020 | 931250 |  | 2681040 | 966971 | 1076421 | N/A | 249784 | 5905466 |
| ANDREW SANDIFER | 2022 | 662075 |  | 1290671 | 495406 | 999429 | N/A | 138536 | 3586117 |
| &nbsp;&nbsp;&nbsp;Executive Vice President | 2021 | 581575 |  | 759484 | 327801 | 836653 | N/A | 112384 | 2617897 |
| &nbsp;&nbsp;&nbsp;and Chief Financial Officer | 2020 | 534500 |  | 740404 | 273476 | 508107 | N/A | 105647 | 2162134 |
| RONALDO PEREIRA | 2022 | 458550 |  | 653027 | 250503 | 628442 | N/A | 155054 | 2145576 |
| &nbsp;&nbsp;&nbsp;Executive Vice President and | 2021 | 427450 |  | 539098 | 155677 | 532511 | N/A | 49090 | 1703826 |
| &nbsp;&nbsp;&nbsp;President, FMC Americas | 2020 |  |  |  |  |  |  |  |  |
| MICHAEL REILLY | 2022 | 541485 |  | 653027 | 250503 | 628717 |  | 54871 | 2128603 |
| &nbsp;&nbsp;&nbsp;Executive Vice President, | 2021 | 501380 |  | 423093 | 182656 | 569996 | 675569 | 45863 | 2398557 |
| &nbsp;&nbsp;&nbsp;General Counsel, Chief Compliance | 2020 | 467250 |  | 365041 | 134761 | 324053 | 882582 | 39895 | 2213582 |
| &nbsp;&nbsp;&nbsp;Officer and Secretary |  |  |  |  |  |  |  |  |  |
| KATHLEEN SHELTON | 2022 | 400965 |  | 407353 | 156317 | 420968 | N/A | 54452 | 1440055 |
| &nbsp;&nbsp;&nbsp;Executive Vice President and | 2021 | 362970 |  | 222316 | 111711 | 330517 | N/A | 40592 | 1068106 |
| &nbsp;&nbsp;&nbsp;Chief Technology Officer | 2020 |  |  |  |  |  |  |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The amounts in these columns reflect
 the grant date fair value of stock and option awards computed in accordance with FASB ASC Topic 718, excluding the effect
 of estimated forfeitures. See Note 16 to the Consolidated Financial Statements contained in the Company's report on
 Form 10-K for the year ended December 31, 2022 for the assumptions used in the valuations that appear in these columns. The
 awards in column (e) are comprised of restricted stock units and performance-based restricted stock units.

(2) For 2022, the amounts listed in this column include
 the following grants: (i) performance-based restricted stock unit grants for Mr. Douglas, 26,874 units; for Mr. Sandifer,
 5,669 units; for Mr. Pereira, 2,869 units; for Mr. Reilly, 2,869 units; for Dr. Shelton, 1,789 units; and (ii) restricted
 stock unit grants, for Mr. Douglas, 10,749 units; for Mr. Sandifer, 4,251 units; for Mr. Pereira, 2,150 units; for Mr. Reilly,
 2,150 units; and for Dr. Shelton, 1,342 units. Per SEC rules, the values of PRSUs are reported in this column based on their
 probable (target) outcomes at the grant date. However, the terms of the PRSUs permit additional shares to be earned based
 on above-target performance. In each case, the maximum numbers of shares that may be earned is equal to twice the target amount.
 The grant date value of the maximum number of shares that may be earned under the PRSUs was $7,606,110 for Mr. Douglas, $1,604,463
 for Mr. Sandifer, $811,985 for Mr. Pereira, $811,985 for Mr. Reilly, and $506,314 for Dr. Shelton.

(3) For 2022, amounts listed in this column were amounts
 paid with respect to the Annual Incentive for 2022.

(4) For 2022, the amounts listed in this column are attributable
 to changes in the pension values under the Company's qualified and nonqualified defined benefit plans. Details of these
 defined benefit plans are set forth in the Pension Benefits Table 2022 and the narrative that follows. For 2022, Mr. Reilly
 was the only NEO with such a benefit. The change in the pension value for Mr. Reilly for 2022 was a decrease of $212,544.
 However, in accordance with SEC rules, a negative change in pension value is not reflected within the Summary Compensation
 Table.

(5) For 2022, the amounts stated in this column include:
 (i) with respect to the employer matching contribution to the FMC Corporation Savings and Investment Plan, for Messrs. Douglas,
 Sandifer, Pereira, and Reilly, $12,200; and for Dr. Shelton, $11,427; (ii) with respect to the employer matching contribution
 to the FMC Corporation Non-Qualified Savings and Investment Plan, for Mr. Douglas, $49,699; for Mr. Sandifer, $22,714; for
 Mr. Pereira, $15,602; for Mr. Reilly, $25,245; and for Dr. Shelton, $0.00; (iii) with respect to employer core contributions
 to the Qualified and Nonqualified Savings and Investment Plans, for Mr. Douglas, $15,250 for the Qualified Plan and $157,694
 for the Nonqualified Plan; for Mr. Sandifer, $15,250 for the Qualified Plan and $59,686 for the Nonqualified Plan; for Mr.
 Pereira, $15,250 for the Qualified Plan and $34,303 for the Nonqualified Plan; and for Dr. Shelton, $15,250 for the Qualified
 Plan and $21,324 for the Nonqualified Plan; (iv) dividend equivalent units granted in connection with banked PRSUs, for Mr. Douglas,
 $34,815; for Mr. Sandifer, $21,946; for Mr. Pereira, $4,251; for Mr. Reilly, $10,686; and for Dr. Shelton, $4,711; (v) for
 Mr. Douglas, $130,154, representing the aggregate incremental cost for personal use of the Company airplane, and (vi) for
 Mr. Pereira, in connection with his relocation to the U.S., $4,575 for tax preparation and $2,048 for related tax gross-ups,
 $28,222 for home leave expenses, $20,000 for a transition allowance and $11,363 for a related tax gross-up. The amounts in
 this column also include the aggregate incremental costs for the following: for Mr. Douglas, financial planning, club memberships,
 and reserved parking; for Mr. Sandifer, financial planning and reserved parking; for Mr. Pereira, financial planning, reserved
 parking, and family medical reimbursement; for Mr. Reilly, financial planning and reserved parking, and for Dr. Shelton, reserved
 parking. The aggregate incremental cost for each of the perquisites and personal benefits that was quantified in this footnote
 (5) was calculated based on the amount the Company or its affiliate paid for such benefit times the percentage of personal
 use not reimbursed to the Company or its affiliate.

The Summary Compensation Table lists all 2020, 2021 and 2022 compensation, as defined by the rules of the SEC, for the Chief Executive Officer, the Chief Financial Officer, and each of the Company's three most highly compensated other executive officers that served as of the end of the fiscal year. The base salary, Annual Incentives and Long-Term Incentives (consisting of stock options, restricted stock units and performance-based restricted stock units), paid or awarded to these officers were determined by the Compensation Committee, as also described in the Compensation Discussion and Analysis. The material terms of the Annual Incentive and Long-Term Incentive awards are also described under "Components of Executive Compensation" under the Compensation and Discussion Analysis. The material terms of the qualified and nonqualified defined benefit plans, which are the basis for the accruals reported in Column (h) of the Summary Compensation Table above, are described in the narrative to the Pension Benefits Table.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***55**

[Back to contents](#toc)

**GRANTS OF PLAN-BASED AWARDS TABLE 2022**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  | **Estimated Future Payouts Under** | **Estimated Future Payouts Under** | **Estimated Future Payouts Under** |  |  |  |  |
|  |  |  |  |  | **Equity Incentive Plan Awards** | **Equity Incentive Plan Awards** | **Equity Incentive Plan Awards** | **All Other** | **All Other** |  |  |
|  |  | **Estimated Future Payouts Under** | **Estimated Future Payouts Under** | **Estimated Future Payouts Under** | **Number of Shares of** | **Number of Shares of** | **Number of Shares of** | **Stock** | **Option** |  | **Grant** |
|  |  | **Non-Equity Incentive Plan Awards<sup>(1)</sup>** | **Non-Equity Incentive Plan Awards<sup>(1)</sup>** | **Non-Equity Incentive Plan Awards<sup>(1)</sup>** | **Stock or Units<sup>(2)</sup>** | **Stock or Units<sup>(2)</sup>** | **Stock or Units<sup>(2)</sup>** | **Awards:** | **Awards:** | **Exercise** | **Date Fair** |
|  |  |  |  |  |  |  |  | **Number of** | **Number of** | **or Base** | **Value of** |
|  |  |  |  |  |  |  |  | **Shares of** | **Securities** | **Price of** | **Stock and** |
|  |  |  |  |  |  |  |  | **Stock or** | **Underlying** | **Option** | **Option** |
|  | **Grant** | **Threshold** | **Target** | **Maximum** | **Threshold** | **Target** | **Maximum** | **Units** | **Options** | **Awards** | **Awards** |
| **Name** | **Date** | **($)** | **($)** | **($)** | **(#)** | **(#)** | **(#)** | **(#)** | **(#)** | **($/sh)** | **($)** |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** | **(g)** | **(h)** | **(i)** | **(j)** | **(k)** | **(l)** |
| Mark Douglas | N/A | 0 | 1495000 | 2990000 |  |  |  |  |  |  |  |
|  | 2/24/2022<sup>(3)</sup> |  |  |  | 9406 | 18812 | 37624 |  |  |  | 2876731 |
|  | 2/24/2022<sup>(4)</sup> |  |  |  | 4031 | 8062 | 16124 |  |  |  | 926324 |
|  | 2/24/2022 |  |  |  |  |  |  | 10749 |  |  | 1235060 |
|  | 2/24/2022 |  |  |  |  |  |  |  | 56040 | 114.90 | 1879021 |
| Andrew Sandifer | N/A | 0 | 581740 | 1163480 |  |  |  |  |  |  |  |
|  | 2/24/2022<sup>(3)</sup> |  |  |  | 1984 | 3968 | 7936 |  |  |  | 606787 |
|  | 2/24/2022<sup>(4)</sup> |  |  |  | 851 | 1701 | 3402 |  |  |  | 195445 |
|  | 2/24/2022 |  |  |  |  |  |  | 4251 |  |  | 488440 |
|  | 2/24/2022 |  |  |  |  |  |  |  | 14775 | 114.90 | 495406 |
| Ronaldo Pereira | N/A | 0 | 350400 | 700800 |  |  |  |  |  |  |  |
|  | 2/24/2022<sup>(3)</sup> |  |  |  | 1004 | 2008 | 4016 |  |  |  | 307063 |
|  | 2/24/2022<sup>(4)</sup> |  |  |  | 431 | 861 | 1722 |  |  |  | 98929 |
|  | 2/24/2022 |  |  |  |  |  |  | 2150 |  |  | 247035 |
|  | 2/24/2022 |  |  |  |  |  |  |  | 7471 | 114.90 | 250503 |
| Michael Reilly | N/A | 0 | 386190 | 772380 |  |  |  |  |  |  |  |
|  | 2/24/2022<sup>(3)</sup> |  |  |  | 1004 | 2008 | 4016 |  |  |  | 307063 |
|  | 2/24/2022<sup>(4)</sup> |  |  |  | 431 | 861 | 1722 |  |  |  | 98929 |
|  | 2/24/2022 |  |  |  |  |  |  | 2150 |  |  | 247035 |
|  | 2/24/2022 |  |  |  |  |  |  |  | 7471 | 114.90 | 250503 |
| Kathleen Shelton | N/A | 0 | 246180 | 492360 |  |  |  |  |  |  |  |
|  | 2/24/2022<sup>(3)</sup> |  |  |  | 626 | 1252 | 2504 |  |  |  | 191456 |
|  | 2/24/2022<sup>(4)</sup> |  |  |  | 269 | 537 | 1074 |  |  |  | 61701 |
|  | 2/24/2022 |  |  |  |  |  |  | 1342 |  |  | 154196 |
|  | 2/24/2022 |  |  |  |  |  |  |  | 4662 | 114.90 | 156317 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The actual amount of the Annual Incentive
 paid to the NEO with respect to 2022 is stated in Column (g) of the Summary Compensation Table. The threshold, target and
 maximum performance signify performance that will yield a BPI rating of 0, 1.0 and 2.0, respectively. In order for any payout
 to be earned, performance must exceed the threshold level. The percentage of salary awarded for performance falling between
 the threshold and target achievement levels and the target and maximum achievement levels is determined using straight-line
 interpolation.

(2) Consists of performance-based RSUs awarded under our
 long-term equity incentive compensation plan. Each PRSU is equivalent to one share of our common stock.

(3) The PRSUs reflected in this row are earned for achieving
 specified relative TSR percentile ranks during the three-year performance period beginning January 1, 2022 and ending December
 31, 2024. See "Performance-Based Restricted Stock Unit Awards" under Compensation Discussion and Analysis, Long-Term
 Incentives for a discussion of the terms of these performance-based RSUs.

(4) The PRSUs reflected in this row are earned for achieving
 specified three-year cumulative operating cash flow levels during the three-year performance period beginning January 1, 2022
 and ending December 31, 2024. See "Cumulative Three-Year Operating Cash-Flow" under Compensation Discussion and
 Analysis, Long-Term Incentives for a discussion of the terms of these performance-based RSUs.

Each of the awards contained in the Grants of Plan-Based Awards Table above were granted under the FMC Incentive Compensation and Stock Plan, which is administered by the Compensation Committee. The FMC Incentive Compensation and Stock Plan provides for annual, as well as long-term incentive awards.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***56**

[Back to contents](#toc)

**OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE 2022**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** |
| **Name<br> (a)** | **Number of<br> Securities<br> Underlying<br> Unexercised<br> Options<br> Exercisable<br> (#)<br> (b)** | **Number of**<br> **Securities**<br> **Underlying**<br> **Unexercised**<br> **Options**<br> **Unexercisable**<sup>(1)</sup><br> **(#)**<br> **(c)** | **Equity<br> Incentive<br> Plan Awards:<br> Number of<br> Securities<br> Underlying<br> Unexercised<br> Unearned<br> Options<br> (#)<br> (d)** | **Option<br> Exercise<br> Price<br> ($)<br> (e)** | **Option<br> Expiration<br> Date<br> (f)** | **Number**<br> **of Shares**<br> **or Units of**<br> **Stock That**<br> **Have Not**<br> **Vested**<sup>(2)</sup><br> **(#)**<br> **(g)** | **Market<br> Value of<br> Shares or<br> Units of<br> Stock That<br> Have Not<br> Vested<br> ($)<br> (h)** | **Equity**<br> **Incentive**<br> **Plan Awards:**<br> **Number of**<br> **Unearned**<br> **Shares, Units or**<br> **Other Rights**<br> **That Have Not**<br> **Vested**<sup>(3)</sup><br> **(#)**<br> **(i)** | **Equity<br> Incentive Plan<br> Awards: Market<br> or Payout Value<br> of Unearned<br> Shares, Units or<br> Other Rights<br> That Have Not<br> Vested<br> ($)<br> (j)** |
| Mark Douglas | 9969 |  |  | 63.13 | 2/17/2024 | 7310<sup>(4)</sup> | 912288 |  |  |
|  | 12585 |  |  | 73.78 | 2/15/2028 | 9083<sup>(5)</sup> | 1133558 |  |  |
|  | 27964 |  |  | 75.69 | 2/20/2029 | 10749<sup>(6)</sup> | 1341475 |  |  |
|  |  | 47681 |  | 92.36 | 2/27/2030 | 8087<sup>(7)</sup> | 1009258 | 15896<sup>(8)</sup> | 1983821 |
|  |  | 50404 |  | 104.97 | 2/24/2031 |  |  | 1703<sup>(9)</sup> | 212534 |
|  |  | 56040 |  | 114.90 | 2/24/2032 |  |  | 9570<sup>(10)</sup> | 1194336 |
|  |  |  |  |  |  |  |  | 28218<sup>(11)</sup> | 3521606 |
|  |  |  |  |  |  |  |  | 2016<sup>(12)</sup> | 251597 |
| Andrew Sandifer | 3352 |  |  | 73.78 | 2/15/2028 |  |  |  |  |
|  | 17569 |  |  | 75.69 | 2/20/2029 | 3101<sup>(4)</sup> | 387005 |  |  |
|  |  | 13485 |  | 92.36 | 2/27/2030 | 3130<sup>(5)</sup> | 390624 |  |  |
|  |  | 11579 |  | 104.97 | 2/24/2031 | 4251<sup>(6)</sup> | 530525 |  |  |
|  |  | 14775 |  | 114.90 | 2/24/2032 | 1488<sup>(7)</sup> | 185702 | 2924<sup>(8)</sup> | 364915 |
|  |  |  |  |  |  |  |  | 313<sup>(9)</sup> | 39062 |
|  |  |  |  |  |  |  |  | 2019<sup>(10)</sup> | 251971 |
|  |  |  |  |  |  |  |  | 5952<sup>(11)</sup> | 742810 |
|  |  |  |  |  |  |  |  | 426<sup>(12)</sup> | 53165 |
| Ronaldo Pereira | 2933 |  |  | 73.78 | 2/15/2028 | 1331<sup>(4)</sup> | 166109 |  |  |
|  | 4374 |  |  | 75.69 | 2/20/2029 | 1486<sup>(5)</sup> | 185453 |  |  |
|  |  | 5787 |  | 92.36 | 2/27/2030 | 2150<sup>(6)</sup> | 268320 |  |  |
|  |  | 5499 |  | 104.97 | 2/24/2031 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2184<sup>(13)</sup> | 272563 |  |  |
|  |  | 7471 |  | 114.90 | 2/24/2032 | 532<sup>(7)</sup> | 66394 | 1044<sup>(8)</sup> | 130291 |
|  |  |  |  |  |  |  |  | 112<sup>(9)</sup> | 13978 |
|  |  |  |  |  |  |  |  | 1022<sup>(10)</sup> | 127546 |
|  |  |  |  |  |  |  |  | 3012<sup>(11)</sup> | 375898 |
|  |  |  |  |  |  |  |  | 216<sup>(12)</sup> | 26957 |
| Michael Reilly | 9969 |  |  | 63.13 | 2/17/2024 |  |  |  |  |
|  | 12585 |  |  | 73.78 | 2/15/2028 | 1528<sup>(4)</sup> | 190694 |  |  |
|  | 27964 |  |  | 75.69 | 2/20/2029 | 1744<sup>(5)</sup> | 217651 |  |  |
|  |  | 6645 |  | 92.36 | 2/27/2030 | 2150<sup>(6)</sup> | 268320 |  |  |
|  |  | 6452 |  | 104.97 | 2/24/2031 | 829<sup>(7)</sup> | 103459 | 1628<sup>(8)</sup> | 203174 |
|  |  | 7471 |  | 114.90 | 2/24/2032 |  |  | 175<sup>(9)</sup> | 21840 |
|  |  |  |  |  |  |  |  | 1022<sup>(10)</sup> | 127546 |
|  |  |  |  |  |  |  |  | 3012<sup>(11)</sup> | 375898 |
|  |  |  |  |  |  |  |  | 216<sup>(12)</sup> | 26957 |
| Kathleen Shelton | 2604 |  |  | 73.78 | 2/15/2028 | 964<sup>(4)</sup> | 120307 |  |  |
|  | 5008 |  |  | 75.69 | 2/20/2029 | 1067<sup>(5)</sup> | 133162 |  |  |
|  |  | 4190 |  | 92.36 | 2/27/2030 | 1342<sup>(6)</sup> | 167482 |  |  |
|  |  | 3946 |  | 104.97 | 2/24/2031 | 381<sup>(7)</sup> | 47549 | 748<sup>(8)</sup> | 93350 |
|  |  | 4662 |  | 114.90 | 2/24/2032 |  |  | 81<sup>(9)</sup> | 10109 |
|  |  |  |  |  |  |  |  | 637<sup>(10)</sup> | 79498 |
|  |  |  |  |  |  |  |  | 1878<sup>(11)</sup> | 234374 |
|  |  |  |  |  |  |  |  | 135<sup>(12)</sup> | 16848 |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***57**

[Back to contents](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;(1) For the option awards with an expiration date of 2/27/2030, the vesting date is 2/27/2023;
 for the awards with an expiration date of 2/24/2031, the vesting date is 2/24/2024; and for the awards with an expiration
 date of 2/24/2032, the vesting date is 2/24/2025.

(2) The stock award numbers shown in column (g) indicate the number of shares subject to outstanding
 awards that were subject to time-based vesting conditions as of fiscal year-end. In the case of PRSUs banked based on relative
 TSR measures, the amounts in this column reflect the number of shares banked based on actual performance outcomes and dividend
 equivalent units credited with respect to those banked units.

(3) The stock award numbers shown in column (i) represent the portion(s) of PRSU awards that were
 subject to open performance periods at fiscal year-end. The numbers are presented in the table in accordance with SEC rules,
 but actual performance outcomes for those awards will not be determined until the applicable performance periods are completed.

(4) For all of these stock awards, the vesting date is 2/27/2023.

(5) For all of these stock awards, the vesting date is 2/24/2024.

(6) For all of these stock awards, the vesting date is 2/24/2025.

(7) These units represent the portion of PRSUs granted in 2021 that were banked based on 2022 TSR
 performance, at 200%. The numbers represented also include the dividend equivalent rights credited with respect to those banked
 units. These shares remain subject to time-based vesting based on continued service through 12/31/2023. Because Threshold
 performance was not achieved with respect to 2021 TSR, no PRSUs were banked under these grants based on 2021 TSR performance.

(8) These units represent the portion of PRSUs granted in 2021 with a TSR metric that remain subject
 to an open performance period. While no amount has yet been earned, they are shown here at 200% of target in accordance with
 SEC rules based on the most recent year's performance. If and to the extent earned, these units will become vested on
 12/31/2023.

(9) These units represent the PRSUs granted in 2021 with an operating cash-flow measure that remain
 subject to an open performance period through 12/31/2023. While no amount has yet been earned, they are shown here at 25%
 of target (or, "threshold") in accordance with SEC rules.

(10) These units represent the portion of PRSUs granted in 2022 that were banked based on 2022 TSR
 performance, at 200%. The numbers represented also include the dividend equivalent rights credited with respect to those banked
 units. These shares remain subject to time-based vesting based on continued service through 12/31/2024.

(11) These units represent the portion of PRSUs granted in 2022 with a TSR metric, that remain subject
 to an open performance period. While no amount has yet been earned, they are shown here at 200% of target in accordance with
 SEC rules based on the most recent year's performance. If and to the extent earned, these units will be banked and remain
 subject to time-based vesting based on continued service through 12/31/2024.

(12) These units represent the PRSUs granted in 2022 with an operating cash-flow measure that remain
 subject to an open performance period through 12/31/2024. While no amount has yet been earned, they are shown here at 25%
 of target (or, "threshold") in accordance with SEC rules.

(13) With respect to Mr. Pereira's one-time award granted on 2/24/2021, the vesting date is
 2/24/2025.

**OPTION EXERCISES AND STOCK VESTED TABLE 2022**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** |
| **Name<br> (a)** | **Number of Shares<br> Acquired On Exercise<br> (#)<br> (b)** | **Value Realized<br> On Exercise<br> ($)<br> (c)** | **Number of Shares<br> Acquired On Vesting<br> (#)<br> (d)** | **Value Realized<br> On Vesting<br> ($)<br> (e)** |
| Mark Douglas |  |  | 27446 | 3373529 |
| Andrew Sandifer | 5625 | 390769 | 8849 | 1071853 |
| Ronaldo Pereira |  |  | 2550 | 310148 |
| Michael Reilly | 9417 | 714809 | 4316 | 523015 |
| Kathleen Shelton |  |  | 2278 | 275032 |

---

**PENSION BENEFITS TABLE 2022**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name<br> (a)** | **Plan Name<br> (b)** | **Number of Years**<br> **Credited Service<sup>(1)</sup>**<br> **(#)**<br> **(c)** | **Present Value of<br> Accumulated Benefit<br> ($)<br> (d)** | **Payments During<br> Last Fiscal Year<br> ($)<br> (e)** |
| Mark Douglas | Qualified Plan | N/A | N/A | N/A |
|  | Nonqualified Plan | N/A | N/A | N/A |
| Andrew Sandifer | Qualified Plan | N/A | N/A | N/A |
|  | Nonqualified Plan | N/A | N/A | N/A |
| Ronaldo Pereira | Qualified Plan | N/A | N/A | N/A |
|  | Nonqualified Plan | N/A | N/A | N/A |
| Michael Reilly | Qualified Plan | 20.8333 | 894952 | 0 |
|  | Nonqualified Plan | 20.8333 | 2537842 | 0 |
| Kathleen Shelton | Qualified Plan | N/A | N/A | N/A |
|  | Nonqualified Plan | N/A | N/A | N/A |

---

(1) All credited years of service are the actual years of service under the relevant plan.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***58**

[Back to contents](#toc)

### **Pension Plans** 
The FMC Salaried and Nonunion Hourly Employees Retirement Plan (the "Qualified Plan") is a non-contributory defined benefit plan that is intended to meet the requirements of Section 401(a) of the Internal Revenue Code of 1986, as amended (the "IRC"), as a tax-qualified plan. Messrs. Douglas, Sandifer and Pereira and Dr. Shelton were hired after July 1, 2007 (or in the case of Mr. Pereira, became a U.S. employee after such date) when the Qualified Plan was closed to new employees, and accordingly these NEOs do not participate in the Qualified Plan, but do participate in defined contribution plans of the Company.

Under the Qualified Plan, an employee's pension benefit is calculated based on credited company service and a final average year earnings ("FAYE") formula, and the annual benefit payable is subject to a statutory cap of $265,000 for 2023 ("maximum benefit limitation" cap). FAYE is determined using earnings from the highest 60 consecutive months out of the last 120 calendar months that immediately precede the employee's retirement date. Eligible compensation includes base salary (see Column (c) of the Summary Compensation Table), Annual Incentive pay (see Column (g) of the Summary Compensation Table) and certain other performance payments and is subject to a statutory cap of $330,000 for 2023 ("total earnings" cap). However, stock option gains, other equity awards and long-term performance-based cash are not included in eligible compensation.

Normal retirement age is 65. Benefits at normal retirement are calculated using the formula described below.

The retirement formula is 1.0% of FAYE up to the Social Security covered compensation base plus 1.5% of FAYE in excess of the Social Security covered compensation base times years of credited service (up to 35 years) plus 1.5% of FAYE times years of credited service in excess of 35. The actual benefit amount depends on the form of payment selected by the employee, i.e., individual life annuity, joint and survivor annuity or level income option. All benefits under the Qualified Plan are paid as an annuity. The amounts reflected for the Qualified Plan in the Pension Table are actuarial present values of the single life annuity that would be payable at age 62, which is the earliest age an NEO can retire without a benefit reduction. There is no Social Security offset.

Early retirement is defined as retirement from active service when an employee reaches age 55 with a minimum of ten years credited service. Employees who elect early retirement receive an actuarially reduced pension. This reduction is 4% per year for each year prior to age 62. The maximum reduction is 28% (62-55 x .04) of the age 65 benefit calculation. The IRC limits the annual benefits that may be paid from a tax-qualified retirement plan and the compensation that may be taken into account in calculating those benefits, as noted above.

The Salaried Employees Equivalent Plan (the "Nonqualified Plan") is a non-contributory retirement restoration plan that restores the benefits earned under the Qualified Plan formula described above.

This plan represents an unfunded liability and all amounts listed in the table above for this plan are unsecured and therefore not guaranteed to be fully paid in the event of the Company's insolvency or bankruptcy. Messrs. Douglas, Sandifer and Pereira and Dr. Shelton are participants in defined contribution plans and are not eligible to participate in the Nonqualified Plan, as the plan does not cover employees who are not also covered by the Qualified Plan. These supplemental benefits are calculated using the same formula described above without regard to the IRC limits, less amounts payable under the Qualified Plan. The Nonqualified Plan amounts reflected in the Pension Benefits Table above are paid in a lump sum on the later of attainment of age 55 or six months following the employee's retirement.

Actuarial assumptions used to determine the present value of the accumulated benefits under the Qualified Plan and Nonqualified Plan as of December 31, 2022 are as follows.

**•** Sum of present value of Qualified Plan benefit accrued through December 31, 2022 plus present value of Nonqualified Plan benefit accrued through December 31, 2022

**•** Present value of Qualified Plan benefit calculated as amount payable at first unreduced age using December 31, 2022 ASC 715 disclosure assumptions (5.16%, Pri-2012 with generational MP2021 projection) and reflecting discounting of present value back to December 31, 2022 using ASC 715 interest only (5.16%)

**•** Present value of Nonqualified Plan benefit calculated as amount payable at first unreduced age using December 31, 2022 ASC 715 lump sum assumptions (4.00%, 417e2023) and reflecting discounting of present value back to December 31, 2022 using ASC 715 interest only (4.99%)

**•** Unreduced benefits are first available at age 62 for Mr. Reilly (assuming continued employment with FMC until that time).

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***59**

[Back to contents](#toc)

**NONQUALIFIED DEFERRED COMPENSATION TABLE 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name<br> (a)** | **Executive**<br> **Contributions**<br> **in Last FY<sup>(1)</sup>**<br> **($)**<br> **(b)** | **Registrant**<br> **Contributions**<br> **in Last FY<sup>(2)</sup>**<br> **($)**<br> **(c)** | **Aggregate<br> Earnings<br>in Last FY<br> ($)<br> (d)** | **Aggregate<br> Withdrawals/<br> Distributions<br>($)<br> (e)** | **Aggregate**<br> **Balance at**<br> **Last FYE<sup>(3)</sup>**<br> **($)**<br> **(f)** |
| Mark Douglas | 72156 | 207393<sup>(4)</sup> | 461819 |  | 4158837 |
| Andrew Sandifer | 33104 | 82401<sup>(5)</sup> | (60892) |  | 991706 |
| Ronaldo Pereira | 22928 | 49905<sup>(6)</sup> | 4712 |  | 118906 |
| Michael Reilly | 42324 | 25245<sup>(7)</sup> | (110190) |  | 603940 |
| Kathleen Shelton | 0 | 21324<sup>(8)</sup> | (13315) |  | 84216 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The amounts listed in this column are reported as compensation in the amounts stated
 in Column (c), Salary, of the Summary Compensation Table.

(2) The amounts listed in this column are reported as compensation in the amounts stated in Column
 (i), All Other Compensation, of the Summary Compensation Table.

(3) The amounts listed in this column include the following amounts which were reported in the Summary
 Compensation Table in previous years: for Mr. Douglas, $1,711,502; for Mr. Sandifer, $352,375; for Mr. Reilly, $125,918; for
 Mr. Pereira, $19,297; and for Dr. Shelton, $13,209, plus earnings on those amounts.

(4) In addition to the employer matching contribution of $49,699, Mr. Douglas received nonqualified
 core contributions of 5% of compensation on his eligible earnings in excess of $305,000, in lieu of his participation in the
 Salaried Employees' Equivalent Retirement Plan, which participation is not available to employees hired after July 1,
 2007. The amount of the 5% contribution was $157,694.

(5) In addition to the employer matching contribution of $22,714, Mr. Sandifer received nonqualified
 core contributions of 5% of compensation on his eligible earnings in excess of $305,000, in lieu of his participation in the
 Salaried Employees' Equivalent Retirement Plan, which participation is not available to employees hired after July 1,
 2007. The amount of the 5% contribution was $59,686.

(6) In addition to the employer matching contribution of $15,602, Mr. Pereira received nonqualified
 core contributions of 5% of compensation on his eligible earnings in excess of $305,000, in lieu of his participation in the
 Salaried Employees' Equivalent Retirement Plan, which participation is not available to employees hired after July 1,
 2007. The amount of the 5% contribution was $34,303.

(7) The amount listed represents an employer matching contribution of $25,245.

(8) Dr. Shelton received nonqualified core contributions of 5% of compensation on her eligible earnings
 in excess of $305,000, in lieu of her participation in the Salaried Employees' Equivalent Retirement Plan, which participation
 is not available to employees hired after July 1, 2007. The amount of the 5% contribution was $21,324.

The FMC Nonqualified Savings and Investment Plan (the "Nonqualified Savings Plan") is a voluntary deferred compensation plan available to certain highly compensated employees, including all of the NEOs. The Nonqualified Savings Plan mirrors the FMC Corporation Savings and Investment Plan (the "Qualified Savings Plan"), which is a tax-qualified savings plan under Section 401(k) of the IRC.

Participants in the Qualified Savings Plan are subject to certain contribution and earnings limits set under Sections 402(g) and 401(a) (17) of the IRC. The Nonqualified Savings Plan is used to facilitate the continuation of contributions beyond the limits allowed under the Qualified Savings Plan. Employees may defer 1% to 50% of their base salaries and up to 100% of their annual incentive compensation. In 2022, the Company's matching contribution under both plans was 80% of the amount deferred up to a maximum of 5% of eligible earnings, i.e., base salary and annual incentive paid in fiscal year 2022. In addition to the Company's matching contribution, employees hired after July 1, 2007, who are not eligible to participate in the Qualified and Non-Qualified Plans, are entitled to receive employer core contributions under the Qualified and Non-Qualified Savings Plans of 5% of eligible earnings in the aggregate.

Compensation deferred under the Nonqualified Savings Plan is deemed invested by the participant in his or her choice of more than 20 investment choices offered to all participants. All investments, except for the FMC Stock Fund, are mutual funds, and all investments may be exchanged by the participant at any time. Earnings on investments are market earnings. There are no programs or provisions for guaranteed rates of return. Distributions under the Nonqualified Savings Plan must occur or commence at the earlier of separation of service plus six months or at a designated time elected by the participant at the time of deferral. Distributions may be in lump sum or installments as determined by the participant's distribution election.

The Nonqualified Savings Plan is subject to certain disclosure and procedural requirements of ERISA, but as a "top hat" plan is not subject to the eligibility, vesting, accrual, funding, fiduciary responsibility and similar requirements of ERISA. This plan represents an unfunded liability and all amounts listed in the table above are unsecured and therefore not guaranteed to be fully paid in the event of the Company's insolvency or bankruptcy.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***60**

[Back to contents](#toc)

## **Pay Ratio Disclosure** 
We disclose here the FMC CEO to median employee pay ratio as calculated in accordance with Item 402(u) of Regulation S-K.

We initially identified our median employee in 2020 by examining the total cash compensation for all employees, excluding our CEO, who were employed by FMC on December 31, 2020. We included all employees, whether employed on a full-time, part-time, or seasonal basis. We annualized the compensation for any full-time employee who was not employed by FMC for the full year in 2020. For non-U.S. employees, we applied a published currency exchange rate in effect as of December 31, 2020. The median employee identified in this process and used in our 2021 proxy statement departed the Company prior to the end of 2021. Accordingly, in accordance with SEC rules, in our 2022 proxy statement we substituted another employee whose compensation was substantially similar to the original median employee based on the compensation measure used to select the original median employee. Under SEC rules, we may rely on last year's median employee for the purposes of this year's disclosure because there has been no change in our employee population or employee compensation arrangements that we reasonably believe would result in a significant change to our pay ratio disclosure.

We calculated annual total 2022 compensation for this median employee using the same methodology we use for our named executive officers, as set forth in the 2022 Summary Compensation Table in this proxy statement. Currency conversion was conducted using a published currency exchange rate in effect as of December 31, 2022. Using this methodology, we have estimated that the median of the annual total compensation of our employees, excluding our CEO, was $55,532.

The annual total compensation for our President and CEO, Mr. Douglas, for 2022 was $11,069,899, as reported in the "Total" column of the Summary Compensation Table in this proxy statement. Therefore, our 2022 CEO to median employee pay ratio is 199:1.

## **Potential Payments Upon Termination or Change in Control** 
In the following section, we discuss the consequences that various termination scenarios and a change in control would have on our NEOs' compensation. When we reference awards "vesting", it means that the awards are no longer subject to a risk of forfeiture. In some cases, the cash or shares will be delivered to the NEO promptly after a termination of employment. In other cases, the NEO must wait until the NEO would otherwise have received a payout had the NEO's employment not terminated (and such deferred payouts are referred to as being subject to a "Delayed Delivery").

### **Retirement** 
Under the terms of the Company's long-term equity incentive award agreements (with the exception of certain special one-time awards), NEOs are considered retirement eligible at age 65 ("Normal Retirement") or at age 62, once they have completed at least ten years of service with the Company ("Early Retirement").

If an NEO terminates employment after achieving Normal Retirement or Early Retirement:

&nbsp;&nbsp;&nbsp;&nbsp;**•** All unvested stock options will vest, and remain exercisable for up to five years

**•** All unvested restricted stock units will vest, with shares subject to a Delayed Delivery

**•** Banked performance-based restricted stock units will vest, with shares subject to a Delayed Delivery

**•** Pro rata portion of outstanding performance-based restricted stock units will vest at the end of the applicable performance
 period based on actual performance results, with shares subject to a Delayed Delivery

However, if an NEO terminates employment, effective after June 30 of the first year of the performance cycle for an outstanding performance-based restricted stock unit award, after the NEO has achieved Normal Retirement or Early Retirement and has commenced succession planning with our human resources department at least six months prior to the termination ("Approved Retirement"), those units will not be subject to proration. Rather, upon an Approved Retirement, the NEO will continue to earn the units as if the NEO had continued to be employed until the end of the full performance period.

Any vesting of the performance-based restricted stock units upon retirement is contingent on the NEO's execution of a release under the terms of the performance-based restricted stock unit award agreements.

None of the NEOs were eligible for Early Retirement or Normal Retirement as of December 31, 2022, and therefore they would not have been eligible for such benefits upon a termination of service on such date. Dr. Shelton became eligible for Early Retirement on January 19, 2023 and has announced that she will retire from the Company on March 31, 2023.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***61**

[Back to contents](#toc)

### **Termination Without Cause** 
The following disclosure and accompanying table reflect the amount of compensation that would have been payable to each of our NEOs, upon a termination by the Company without Cause on December 31, 2022.

The amounts shown in the table assume that such event was effective as of December 31, 2022, the last day of our fiscal year, and thus include amounts earned through such time. The amounts are calculated using various assumptions and are therefore only estimates of the amounts that could have become payable to our NEOs. The actual amounts to be paid out can only be determined at the time of an actual termination.

### **Termination Without Cause (Following a Change in Control)** 
Each NEO is party to an Executive Severance Agreement which provides that if a change in control (as described below) of the Company occurs and, within two years after that change in control, the employment of an NEO is terminated without cause or an NEO resigns his or her employment because his or her duties, location, salary, compensation or benefits were substantially changed or reduced (each a "Change in Control Termination"), then the NEO would be entitled, contingent on the NEO's execution of a release in favor of the Company, to the following payments and benefits:

&nbsp;&nbsp;&nbsp;&nbsp;**•** 24 months of base salary (36 months in the case of Messrs. Douglas and Sandifer), payable in a lump
 sum

**•** Two times (three times in the case of Messrs. Douglas and Sandifer) target annual incentive (based on NEO's highest
 historical target), payable in a lump sum

**•** Prorated bonus for year of termination

**•** Outplacement services, with cost capped at 15% of NEO's base salary

**•** Health and welfare benefits continuation for two years (three years in the case of Messrs. Douglas and Sandifer)

**•** For Mr. Reilly, credit for two additional age and service years under the Nonqualified Plan

Under the terms of the Company's equity incentive award agreements, contingent on the NEOs executing a release, upon a Change in Control Termination:

&nbsp;&nbsp;&nbsp;&nbsp;**•** All unvested stock options will vest and remain exercisable for up to three months

**•** All unvested restricted stock units will vest, and shares will be delivered promptly thereafter

**•** Banked performance-based restricted stock units will vest, and shares will be delivered thereafter

**•** Performance-based restricted stock units whose measurement periods are not yet complete will vest as though target level
 performance was attained for those measurement periods, and shares will be delivered thereafter

In general, the following are considered to be a change in control: (a) a third party's acquisition of 20% or more of the Company's Common Stock; (b) a change in the majority of the Board of Directors; (c) completing certain reorganization, merger, or consolidation transactions or a sale of all or substantially all of the Company's assets; or (d) the complete liquidation or dissolution of the Company.

As a general rule, no NEO has an entitlement to benefits upon a change in control that is not followed by a termination.

### **Termination Without Cause (Other than Following a Change in Control)** 
The Company maintains Executive Severance Guidelines ("Guidelines") setting forth payments and benefits to NEOs who are terminated without cause in the normal course. However, no NEO has a contractual entitlement to these benefits and the Compensation Committee has the discretion to enhance or reduce the benefits in any specific case. Nevertheless, we have assumed for illustrative purposes in the tabular disclosure that follows that the NEOs would have received the benefits set forth under the Guidelines upon a termination without cause on December 31, 2022. Any NEO receiving payments or benefits pursuant to the Guidelines must sign a non-solicitation, non-compete and confidentiality agreement as a condition to the payment of any benefit under the Guidelines.

The Guidelines provide:

&nbsp;&nbsp;&nbsp;&nbsp;**•** 12 months of base salary, payable in a lump sum

**•** One time target annual incentive

**•** Prorated target bonus for year of termination

**•** Transition benefits (outplacement assistance and financial/tax planning)

**•** Health benefits continuation for one year

Treatment of the NEOs' equity incentive awards is as follows:

&nbsp;&nbsp;&nbsp;&nbsp;**•** Vested options remain exercisable for one year following termination. Unvested options that would have
 vested within one year following termination become exercisable on regularly scheduled dates, and remain exercisable for one
 year thereafter

**•** Unvested restricted stock units will vest pro rata, and shares will be delivered promptly thereafter

**•** Banked performance-based restricted stock units will vest, with shares subject to a Delayed Delivery

**•** Pro rata portion of outstanding performance-based restricted stock units will vest at the end of the applicable performance
 period based on actual performance results, with shares subject to a Delayed Delivery

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***62**

[Back to contents](#toc)

**POTENTIAL PAYMENTS UPON TERMINATION**

The valuation of equity awards in the below table is based upon our stock price on December 31, 2022. The ultimate value of any equity awards in the event of a termination will depend upon the stock price, (i) in the case of options, on the date of exercise, and (ii) in the case of restricted stock units and performance-based restricted stock units, on vesting and delivery of the shares.

**MARK DOUGLAS**

---

| | | | |
|:---|:---|:---|:---|
| **Executive Benefits and Payments <br> Upon Termination or <br> Change in Control <br> (a)** | **Change in Control <br> Termination <br> ($) <br> (b)** | **Termination <br> Without Cause <br> ($)<br> (c)** | **Retirement<sup>(1)</sup>** <br> **($)** <br> **(d)** |
| Base Salary and Annual Incentive | 7935001<sup>(2)</sup> | 2645000<sup>(3)</sup> | N/A |
| Transition Benefits | 173000<sup>(4)</sup> | 20000<sup>(5)</sup> | N/A |
| Restricted Stock Units | 3387322<sup>(6)</sup> | 1926967<sup>(7)</sup> | N/A |
| Stock Options | 3101079<sup>(8)</sup> | 1546772<sup>(9)</sup> | N/A |
| Performance-Based Restricted Stock Units | 6812458<sup>(10)</sup> | 3631930<sup>(11)</sup> | N/A |
| Welfare Benefits | 70450<sup>(12)</sup> | 19509<sup>(13)</sup> | N/A |
| **TOTAL** | **21479310** | **9790178** |  |

---

**ANDREW SANDIFER**

---

| | | | |
|:---|:---|:---|:---|
| **Executive Benefits and Payments <br> Upon Termination or <br> Change in Control <br> (a)** | **Change in Control <br> Termination <br> ($) <br> (b)** | **Termination <br> Without Cause <br> ($) <br> (c)** | **Retirement<sup>(1)</sup>** <br> **($)** <br> **(d)** |
| Base Salary and Annual Incentive | 3798420<sup>(2)</sup> | 1266140<sup>(3)</sup> | N/A |
| Transition Benefits | 103000<sup>(4)</sup> | 20000<sup>(5)</sup> | N/A |
| Restricted Stock Units | 1308154<sup>(6)</sup> | 751587<sup>(7)</sup> | N/A |
| Stock Options | 813337<sup>(8)</sup> | 437453<sup>(9)</sup> | N/A |
| Performance-Based Restricted Stock Units | 1360070<sup>(10)</sup> | 714688<sup>(11)</sup> | N/A |
| Welfare Benefits | 75651<sup>(12)</sup> | 23205<sup>(13)</sup> | N/A |
| **TOTAL** | **7458632** | **3213073** |  |

---

**RONALDO PEREIRA**

---

| | | | |
|:---|:---|:---|:---|
| **Executive Benefits and Payments <br> Upon Termination or <br> Change in Control <br> (a)** | **Change in Control <br> Termination <br> ($) <br> (b)** | **Termination <br> Without Cause <br> ($) <br> (c)** | **Retirement<sup>(1)</sup>** <br> **($)** <br> **(d)** |
| Base Salary and Annual Incentive | 1635200<sup>(2)</sup> | 817600<sup>(3)</sup> | N/A |
| Transition Benefits | 70000<sup>(4)</sup> | 20000<sup>(5)</sup> | N/A |
| Restricted Stock Units | 892445<sup>(6)</sup> | 469671<sup>(7)</sup> | N/A |
| Stock Options | 370738<sup>(8)</sup> | 187730<sup>(9)</sup> | N/A |
| Performance-Based Restricted Stock Units | 610272<sup>(10)</sup> | 309546<sup>(11)</sup> | N/A |
| Welfare Benefits | 48602<sup>(12)</sup> | 23059<sup>(13)</sup> | N/A |
| Return Benefits | 60000<sup>(14)</sup> | 60000<sup>(14)</sup> | N/A |
| **TOTAL** | **3687257** | **1887606** |  |

---

**MICHAEL REILLY**

---

| | | | |
|:---|:---|:---|:---|
| **Executive Benefits and Payments <br> Upon Termination or <br> Change in Control <br> (a)** | **Change in Control <br> Termination <br> ($) <br> (b)** | **Termination <br> Without Cause <br> ($) <br> (c)** | **Retirement<sup>(1)</sup>** <br> **($)** <br> **(d)** |
| Base Salary and Annual Incentive | 1875780<sup>(2)</sup> | 937890<sup>(3)</sup> | N/A |
| Transition Benefits | 83000<sup>(4)</sup> | 20000<sup>(5)</sup> | N/A |
| Restricted Stock Units | 676666<sup>(6)</sup> | 387643<sup>(7)</sup> | N/A |
| Stock Options | 417470<sup>(8)</sup> | 215564<sup>(9)</sup> | N/A |
| Performance-Based Restricted Stock Units | 715104<sup>(10)</sup> | 379642<sup>(11)</sup> | N/A |
| Welfare Benefits | 49456<sup>(12)</sup> | 23205<sup>(13)</sup> | N/A |
| Pension Enhancement | 641667<sup>(15)</sup> | N/A | N/A |
| **TOTAL** | **4459143** | **1963943** |  |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***63**

[Back to contents](#toc)

**KATHLEEN SHELTON**

---

| | | | |
|:---|:---|:---|:---|
| **Executive Benefits and Payments <br> Upon Termination or <br> Change in Control <br> (a)** | **Change in Control <br> Termination <br> ($) <br> (b)** | **Termination <br> Without Cause <br> ($) <br> (c)** | **Retirement<sup>(1)</sup>** <br> **($)** <br> **(d)** |
| Base Salary and Annual Incentive | 1312960<sup>(2)</sup> | 656480<sup>(3)</sup> | N/A |
| Transition Benefits | 62000<sup>(4)</sup> | 20000<sup>(5)</sup> | N/A |
| Restricted Stock Units | 420950<sup>(6)</sup> | 241523<sup>(7)</sup> | N/A |
| Stock Options | 260327<sup>(8)</sup> | 135924<sup>(9)</sup> | N/A |
| Performance-Based Restricted Stock Units | 397987<sup>(10)</sup> | 204672<sup>(11)</sup> | N/A |
| Welfare Benefits | 33548<sup>(12)</sup> | 15745<sup>(13)</sup> | N/A |
| **TOTAL** | **2487772** | **1274344** |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) On December 31, 2022, none of the NEOs were considered eligible for Early Retirement or Normal Retirement
 and therefore there are no potential payments or benefits to report in this column.

(2) For Messrs. Douglas and Sandifer, the amount shown is equal to three times the sum of base salary plus target annual incentive,
 calculated by using the highest annualized target available to the NEO during his/her career with the Company; for Messrs.
 Pereira and Reilly and Dr. Shelton, the amount is limited to two times the sum of base salary and target annual incentive.

(3) The amount shown is equal to the sum of 12 months of base salary plus target annual incentive.

(4) The executives are entitled to outplacement services. The outplacement services are capped at 15% of the NEO's base
 salary. The actual amounts paid in respect of such services will be determined based upon the outplacement services obtained,
 if any, by an NEO upon termination. However, the amounts reflected in the table represent the maximum amounts that could be
 paid by the Company in respect of these services.

(5) Transition benefits consist of outplacement services up to $20,000.

(6) All unvested restricted stock units will vest. The amount shown is the market value of all unvested FMC restricted stock
 units based on the applicable company stock price on December 31, 2022.

(7) Unvested restricted stock units will vest pro rata, based on the amount of time that the NEO was employed during the vesting
 period. The amount shown is the market value of these FMC restricted stock units based on the applicable company stock price
 on December 31, 2022.

(8) All unvested stock options will vest. The amount shown is the value of all unvested stock options based on the difference
 between the exercise price and the FMC stock price on December 31, 2022. Please note, however, that the ultimate value of
 the foregoing options will depend on the stock price on the date of exercise.

(9) The NEO has the right to retain stock options that would have vested on their own terms within one year from the date
 of termination, with the right to exercise such options until twelve months after they vest, as well as the right to exercise
 vested options until twelve months after termination. The amount shown is the market value of these unvested options based
 on the difference between the exercise price and the stock price on December 31, 2022. Please note, however, that the ultimate
 value will depend on the stock price on the date of exercise.

(10) All PRSUs will vest as follows: those banked units whose measurement periods have ended will vest based on actual performance;
 those units whose measurement periods are not yet complete will vest as if the target level performance was attained. The
 amount shown in the table is the market value of such FMC PRSUs based on the applicable company stock price on December 31,
 2022.

(11) Banked PRSUs will vest. A prorated portion of all PRSUs subject to open performance periods will remain outstanding. The
 proration is determined based on the time actually worked during the applicable performance period. The payouts of these awards
 are illustrated above based on actual performance for banked units with completed measurement periods and assuming target
 levels of performance for those units whose measurement period has not yet been completed. In each case, the amounts actually
 due will be paid in a lump sum after the end of the normal three-year performance cycle, based on actual TSR performance,
 or operating cash flow performance, calculated in accordance with the terms of the awards.

(12) Welfare benefits of health care, life insurance and disability insurance continue for three years for Mr. Douglas and
 Mr. Sandifer. For Mr. Reilly, Mr. Pereira, and Dr. Shelton, the benefits continue for two years. The amounts shown are the
 estimated cost to the Company for such benefits during the period.

(13) Health care benefits continue for 12 months. The amounts shown are the estimated cost to the Company for such benefits
 during the period.

(14) In the event of a termination initiated by the Company, the Company will pay for the return of Mr. Pereira and his belongings
 to Brazil. As of December 31, 2022, these costs are estimated at $60,000 (the "Return Benefits").

(15) Under the terms of his Executive Severance Agreement with the Company, Mr. Reilly is credited with two additional age
 and service years under the Nonqualified Plan.

In addition to the amounts set forth in the table, upon termination each NEO would be allowed to retain his or her vested options set forth in Column (b) of the Outstanding Equity Awards at Fiscal Year-End Table 2022, subject to the expiration provisions described above. Each NEO would also be paid his or her Annual Incentive for 2022 (see Column (g) of the Summary Compensation Table for the amounts of these awards), and the aggregate benefits accrued by the NEO in the nonqualified defined contribution plan set forth in Column (f) of the Nonqualified Deferred Compensation Table, payable commencing six months after cessation of employment or in accordance with the NEO's predetermined distribution elections. Mr. Reilly would be entitled to his accumulated benefit under the Nonqualified Plan, payable in a lump sum at the later of six months after cessation of employment or attainment of age 55. The amounts described in this paragraph differ from the present values reflected in Column (d) of the Pension Benefits Table because, under applicable SEC rules, the Pension Benefits Table values are calculated using different interest rates and without regard to early retirement adjustments otherwise applicable under the plan.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***64**

[Back to contents](#toc)

### **Termination Under Certain Other Circumstances** 

#### **Death or Disability** 
In the event of termination upon death or disability, an NEO is eligible for benefits in programs available to US salaried employees generally, as well as a supplemental disability benefit (in the event of disability) and a surviving spouse benefit under the nonqualified deferred compensation plan (in the event of death). The supplemental disability benefit is an insured product intended to provide NEOs with additional disability benefits above the benefit level provided under the Company's group disability plan. The supplemental plan, in conjunction with the Company's group plan, will yield up to 70% of an NEO's annual salary with a maximum monthly benefit of $25,000.

Treatment of equity incentive awards is as follows:

&nbsp;&nbsp;&nbsp;&nbsp;**•** All unvested stock options will vest, and remain exercisable for up to five years

**•** All unvested restricted stock units will vest, and shares will be delivered promptly thereafter

**•** Banked performance-based restricted stock units will vest, with shares subject to a Delayed Delivery

**•** Pro rata portion of outstanding performance-based restricted stock units will vest at the end of the applicable performance
 period based on actual performance results, with shares subject to a Delayed Delivery

The market value for each NEO's unvested restricted stock units and stock option awards as of year-end 2021 is set forth in the relevant section of Column (b) of the table above. A value for each NEO's performance-based restricted stock unit awards, with the payout for banked units based on actual performance and the payout for unvested units calculated based on an assumed level of performance at target and prorated to reflect time employed during the applicable performance period, is set forth in the relevant section of Column (c) of the table above.

#### **Termination For Cause** 
In the event of a termination of an NEO for cause, all outstanding unvested equity awards would be cancelled. All vested stock option awards would expire immediately. Mr. Pereira would be entitled to receive the Return Benefits described above.

## **Pay vs. Performance** 
In accordance with rules adopted by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officer ("PEO") and Non-PEO NEOs and Company performance for the fiscal years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Summary <br> Compensation <br> Table Total** | **Summary <br> Compensation <br> Table Total** | **Compensation <br> Actually Paid** | **Compensation<br> Actually** | **Average <br> Summary <br> Compensation <br> Table Total** | **Average <br> Compensation <br> Actually Paid** | **Value of Initial Fixed** <br> **$100 Investment** <br> **based on:<sup>(4)</sup>** | **Value of Initial Fixed** <br> **$100 Investment** <br> **based on:<sup>(4)</sup>** |  |  |
| **Year <br> (a)** | **for Pierre** <br> **Brondeau<sup>(1)</sup>** <br> **($)** <br> **(b)** | **for Mark** <br> **Douglas<sup>(1)</sup>** <br> **($)** <br> **(b)** | **to Pierre** <br> **Brondeau<sup>(123)</sup>** <br> **($)** <br> **(c)** | **Paid to Mark** <br> **Douglas<sup>(123)</sup>** <br> **($)** <br> **(c)** | **for Non-PEO** <br> **NEOs<sup>(1)</sup>** <br> **($)** <br> **(d)** | **to Non-PEO** <br> **NEOs<sup>(123)</sup>** <br> **($)** <br> **(e)** | **TSR <br> ($) <br> (f)** | **Peer Group <br> TSR <br> ($) <br> (g)** | **Net Income <br> ($ Millions) <br> (h)** | **1-Year** <br> **Relative** <br> **TSR<sup>(5)</sup>** <br> **(i)** |
| 2022 |  | 11069899 |  | 16177222 | 2325088 | 3113105 | 131.35 | 131.42 | 742 | 87.8% |
| 2021 |  | 8489671 |  | 7040175 | 1947097 | 1584265 | 113.73 | 147.79 | 737 | 13.5% |
| 2020 | 4796809 | 5905466 | 10975502 | 8603809 | 1746567 | 2119814 | 116.90 | 117.59 | 552 | 66.0% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Pierre Brondeau was our PEO in 2020. Mark Douglas was our PEO for the years from 2020 to 2022. Pierre
 Brondeau served as our PEO through May 31, 2020 and Mark Douglas became our PEO effective June 1, 2020. The individuals
 comprising the Non-PEO NEOs for each year presented are listed below.

---

| | | |
|:---|:---|:---|
| **2020** | **2021** | **2022** |
| Andrew Sandifer | Andrew Sandifer | Andrew Sandifer |
| Michael Reilly | Ronaldo Pereira | Ronaldo Pereira |
|  | Michael Reilly | Michael Reilly |
| | Kathleen Shelton | Kathleen Shelton |

---

&nbsp;&nbsp;&nbsp;&nbsp;(2) The amounts shown for Compensation Actually Paid have been calculated in accordance
 with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company's
 NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.

(3) Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the
 PEOs and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts
 in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set
 forth in the Summary Compensation Table. Amounts in the Exclusion of Change in Pension Value column reflect the amounts attributable
 to the Change in Pension Value reported in the Summary Compensation Table. Amounts in the Inclusion of Pension Service Cost
 are based on the service cost for services rendered during the listed year.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***65**

[Back to contents](#toc)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Summary <br> Compensation Table <br> Total for Pierre <br> Brondeau <br> ($)** | **Exclusion of Change <br> in Pension Value for <br> Pierre Brondeau <br> ($)** | **Exclusion of Stock <br> Awards and Option <br> Awards for Pierre <br> Brondeau <br> ($)** | **Inclusion of Pension <br> Service Cost for <br> Pierre Brondeau <br> ($)** | **Inclusion of Equity <br> Values for Pierre <br> Brondeau <br> ($)** | **Compensation <br> Actually Paid to <br> Pierre Brondeau <br> ($)** |
| 2020 | 4796809 | 0 | (2653110) | 0 | 8831803 | 10975502 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Summary <br> Compensation <br> Table Total for <br> Mark Douglas <br> ($)** | **Exclusion of Change <br> in Pension Value for <br> Mark Douglas <br> ($)** | **Exclusion of Stock <br> Awards and Option <br> Awards for Mark <br> Douglas <br> ($)** | **Inclusion of <br> Pension Service <br> Cost for Mark <br> Douglas <br> ($)** | **Inclusion of Equity <br> Values for Mark <br> Douglas <br> ($)** | **Compensation <br> Actually Paid to Mark <br> Douglas <br> ($)** |
| 2022 | 11069899 | 0 | (6917136) | 0 | 12024459 | 161772<br> .22 |
| 2021 | 8489671 | 0 | (4723557) | 0 | 3274061 | 7040175 |
| 2020 | 5905466 | 0 | (3648011) | 0 | 6346354 | 8603809 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Average Summary <br> Compensation Table <br> Total for Non-PEO <br> NEOs <br> ($)** | **Average Exclusion of <br> Change in Pension <br> Value for Non-PEO <br> NEOs <br> ($)** | **Average Exclusion <br> of Stock Awards and <br> Option Awards for <br> Non-PEO NEOs <br> ($)** | **Average Inclusion of <br> Pension Service Cost <br> for Non-PEO NEOs <br> ($)** | **Average Inclusion <br> of Equity Values for <br> Non-PEO NEOs <br> ($)** | **Average <br> Compensation <br> Actually Paid to Non- <br> PEO NEOs <br> ($)** |
| 2022 | 2325088 | 0 | (1039202) | 43212 | 1784007 | 3113105 |
| 2021 | 1947097 | (168892) | (680459) | 43663 | 442857 | 1584265 |
| 2020 | 1746567 | (441291) | (756841) | 66327 | 1505052 | 2119814 |

---

The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Year-End Fair <br> Value of Equity <br> Awards Granted <br> During Year <br> That Remained <br> Unvested as of <br> Last Day of Year<br> for Pierre <br> Brondeau <br> ($)** | **Change in Fair <br> Value from Last <br> Day of Prior Year <br> to Last Day of <br> Year of Unvested <br> Equity Awards <br> for Pierre <br> Brondeau <br> ($)** | **Vesting-Date Fair <br> Value of Equity <br> Awards Granted <br> During Year that <br> Vested During <br> Year for Pierre <br> Brondeau <br> ($)** | **Change in Fair <br> Value from Last <br> Day of Prior Year <br> to Vesting Date of <br> Unvested Equity <br> Awards that <br> Vested During <br> Year for Pierre <br> Brondeau <br> ($)** | **Fair Value at Last <br> Day of Prior Year <br> of Equity Awards <br> Forfeited During <br> Year for Pierre <br> Brondeau <br> ($)** | **Value of <br> Dividends or <br> Other Earnings <br> Paid on Stock or <br> Option Awards <br> Not Otherwise <br> Included for <br> Pierre Brondeau <br> ($)** | **Total - Inclusion <br> of Equity <br> Values for <br> Pierre Brondeau <br> ($)** |
| 2020 | 3763724 | 4000778 | 0 | 1067301 | 0 | 0 | 8831803 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Year-End Fair <br> Value of Equity <br> Awards Granted <br> During Year <br> That Remained <br> Unvested as of <br> Last Day of Year <br> for Mark Douglas <br> ($)** | **Change in Fair <br> Value from Last <br> Day of Prior Year <br> to Last Day of <br> Year of Unvested <br> Equity Awards for <br> Mark Douglas <br> ($)** | **Vesting-Date Fair <br> Value of Equity <br> Awards Granted <br> During Year that <br> Vested During <br> Year for Mark <br> Douglas <br> ($)** | **Change in Fair <br> Value from Last <br> Day of Prior Year <br> to Vesting Date of <br> Unvested Equity <br> Awards that <br> Vested During <br> Year for Mark <br> Douglas <br> ($)** | **Fair Value at <br> Last Day of Prior <br> Year of Equity <br> Awards Forfeited <br> During Year for <br> Mark Douglas <br> ($)** | **Value of <br> Dividends or<br> Other Earnings <br> Paid on Stock or <br> Option Awards <br> Not Otherwise <br> Included for <br> Mark Douglas <br> ($)** | **Total - Inclusion <br> of Equity Values <br> for Mark Douglas <br> ($)** |
| 2022 | 8254 ,151 | 2645439 | 0 | 1124870 | 0 | 0 | 12024459 |
| 2021 | 4713217 | (1194558) | 0 | (244598) | 0 | 0 | 3274061 |
| 2020 | 5258635 | 960198 | 0 | 127521 | 0 | 0 | 6346354 |

---

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***66**

[Back to contents](#toc)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Average <br> Year-End Fair <br> Value of Equity <br> Awards Granted <br> During Year <br> That Remained <br> Unvested as of <br> Last Day of Year <br> for Non-PEO <br> NEOs <br> ($)** | **Average Change in <br> Fair Value <br> from Last Day <br> of Prior Year <br> to Last Day of <br> Year of Unvested <br> Equity Awards <br> for Non-PEO <br> NEOs <br> ($)** | **Average Vesting- <br> Date Fair Value <br> of Equity Awards <br> Granted During <br> Year that Vested <br> During Year for <br> Non-PEO NEOs <br> ($)** | **Average Change <br> in Fair Value <br> from Last Day <br> of Prior Year <br> to Vesting Date <br> of Unvested <br> Equity Awards <br> that Vested <br> During Year for <br> Non-PEO NEOs <br> ($)** | **Average Fair <br> Value at Last <br> Day of Prior <br> Year of Equity <br> Awards Forfeited <br> During Year for <br> Non-PEO NEOs <br> ($)** | **Average Value <br> of Dividends or <br> Other Earnings <br> Paid on Stock or <br> Option Awards <br> Not Otherwise <br> Included for Non- <br> PEO NEOs <br> ($)** | **Total - Average <br> Inclusion of <br> Equity Values <br> for Non-PEO <br> NEOs <br> ($)** |
| 2022 | 1231660 | 374677 | 0 | 177671 | 0 | 0 | 1784007 |
| 2021 | 693268 | (175374) | 0 | (75037) | 0 | 0 | 442857 |
| 2020 | 1091296 | 407398 | 0 | 6358 | 0 | 0 | 1505052 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(4) The Peer Group TSR set forth in this table utilizes the S&P 500 Chemicals Index ("S&P
 500 Chemicals Index"), which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K
 included in our Annual Report for the year ended December 31, 2022. The comparison assumes $100 was invested for the period
 starting December 31, 2019, through the end of the listed year in the Company and in the S&P 500 Chemicals Index, respectively.
 Historical stock performance is not necessarily indicative of future stock performance.

(5) We determined 1-Year Relative TSR to be the most important financial performance measure used to link Company performance
 to Compensation Actually Paid to our PEOs and Non-PEO NEOs in 2022. This performance measure may not have been the most important
 financial performance measure for years 2021 and 2020 and we may determine a different financial performance measure to be
 the most important financial performance measure in future years.

### **Description of Relationship Between PEO and Other NEO Compensation Actually Paid and Company Total Shareholder Return ("TSR")** 
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our other NEOs, and the Company's cumulative TSR over the three most recently completed fiscal years.

**PEO AND AVERAGE NEO COMPENSATION ACTUALLY PAID VERSUS FMC CORPORATION TSR**

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***67**

[Back to contents](#toc)

### **Description of Relationship Between PEO and Other NEO Compensation Actually Paid and Net Income** 
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our other NEOs, and our net income during the three most recently completed fiscal years.

**PEO AND AVERAGE NEO COMPENSATION ACTUALLY PAID VERSUS FMC CORPORATION NET INCOME**

![](lfmc025x68x1.jpg)

### **Description of Relationship Between PEO and Other NEO Compensation Actually Paid and 1-Year Relative TSR** 
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our other NEOs, and our 1-Year Relative TSR during the three most recently completed fiscal years.

**PEO AND AVERAGE NEO COMPENSATION ACTUALLY PAID VERSUS FMC CORPORATION 1-YEAR RELATIVE TSR**

![](lfmc025x68x2.jpg)

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***68**

[Back to contents](#toc)

### **Description of Relationship Between Company TSR and Peer Group TSR** 
The following chart compares our cumulative TSR over the three most recently completed fiscal years to that of the S&P 500 Chemicals Index over the same period.

**COMPARISON OF CUMULATIVE TSR OF FMC CORPORATION AND S&P 500 CHEMICALS INDEX (FYE 2019 = $100)**

![](lfmc025x69x1.jpg)

### **Tabular List of Most Important Financial Performance Measures** 
The following table presents the financial performance measures that the Company considers to have been the most important in linking Compensation Actually Paid to our PEO and other NEOs for 2022 to Company performance. The measures in this table are not ranked.

1-Year Relative TSR <br> Adjusted Earnings <br> <u>Free Cash Flow</u>

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***69**

[Back to contents](#toc)

VII. OTHER MATTERS

## **Audit Committee Report** 
The Audit Committee Report that follows shall not be deemed to be incorporated by reference into any filing made by the Company under the Securities Act of 1933 or the Exchange Act, notwithstanding any general statement contained in any such filing incorporating this proxy statement by reference, except to the extent the Company incorporates such Report by specific reference.

The Board of Directors has adopted a written charter that outlines the duties of the Audit Committee, which include, among other things, reviewing the effectiveness and adequacy of the Company's internal controls; review and discuss with management significant issues regarding accounting principles, financial reporting, financial statement presentation, and judgments made in the preparation of the Company's financial statements, including any significant changes in the Company's selection or application of accounting principles; reviewing the annual report, proxy statement and periodic SEC filings (such as the Company's reports on Form 10-K and 10-Q); and ensuring that the Company's financial reports fairly represent its operations. The Audit Committee of the Board of Directors is also directly responsible for the appointment, compensation, retention and oversight of KPMG, the Company's current independent external audit firm retained to audit the Company's financial statements. A further description of the duties and powers of the Audit Committee can be found in "Information about the Board of Directors and Corporate Governance—Committees and Independence of Directors—Audit Committee" section of this proxy statement.

During the 2022 fiscal year, the Audit Committee was comprised of Mr. Cordeiro (Chair), Mr. Davidson, Mr. Pallash, and Mr. Volpe. The Board of Directors has determined that both Messrs. Cordeiro and Davidson meet the SEC requirements for an "audit committee financial expert" and all current members of the Committee are "financially literate" as required by the NYSE. The Board has also determined that no current Audit Committee member sits on the audit committee of more than three public companies.

During the past year, the Audit Committee met nine times, including virtual meetings, to discuss quarterly results and other matters. In carrying out its duties, the Audit Committee has reviewed and discussed the audited consolidated financial statements with management and KPMG as well as discussed with KPMG the matters required to be discussed pursuant to the Public Company Accounting Oversight Board Auditing Standard No. 1301, "Communications with Audit Committees" and any additional applicable SEC requirements.

Further, the Audit Committee has discussed various matters with KPMG related to the Company's consolidated financial statements, including all critical accounting policies and practices used, all alternative treatments for material items that have been discussed with Company management, and all other material written communications between KPMG and management. The Audit Committee has also received the written disclosures and the letter from KPMG as required by The Public Company Accounting Oversight Board, and has confirmed with KPMG its independence.

In reliance upon the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.

The preceding report has been furnished by the following members of the Audit Committee:

Eduardo E. Cordeiro, *Chairman* 

Carol Anthony (John) Davidson

Robert C. Pallash

Vincent R. Volpe, Jr.

## **Householding** 
We have adopted a procedure approved by the SEC called householding. Under this procedure, we are permitted to deliver a single copy of annual reports, proxy statements (or Notice of Internet Availability, as applicable), prospectuses and other disclosure documents to stockholders sharing the same address who do not participate in electronic delivery of proxy materials and who did not otherwise notify us of their desire to receive multiple copies of our proxy materials. Householding allows us to reduce our printing and postage costs and limits the volume of duplicative information received at your household. A separate proxy card will continue to be mailed for each registered stockholder account who requests a paper copy of the proxy materials.

The Broadridge Householding Election system allows stockholders to decline or modify previous householding elections. Broadridge's Householding number has changed to 1-866-540-7095. You may also write to Broadridge c/o Householding Department, 51 Mercedes Way, Edgewood, New York 11717.

If you prefer, we will promptly deliver a separate copy of the proxy statement and related materials to you if you request one by writing or calling as follows: Corporate Secretary, FMC Corporation, FMC Tower at Cira Centre South, 2929 Walnut Street, Philadelphia, Pennsylvania 19104, telephone 1-215-299-6000.

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***70**

[Back to contents](#toc)

## **Expenses Relating to this Proxy Solicitation** 
The Company will pay all expenses relating to this proxy solicitation. In addition to this solicitation by mail, Company officers, directors and employees may solicit proxies by telephone or personal call without extra compensation for that activity. The Company also expects to reimburse banks, brokers and other persons for reasonable out-of-pocket expenses in forwarding proxy material to beneficial owners of Common Stock and obtaining the proxies of those owners.

![](lfmc025x71x1.jpg)

**Michael F. Reilly**

**FMC CORPORATION** - *Notice of Annual Meeting of Stockholders and Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;***71**

[Back to contents](#toc)

![](lfmc025_proxy1.jpg)

[Back to contents](#toc)

![](lfmc025_proxy2.jpg)